<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" lang="en" xml:lang="en"><head>

<meta charset="utf-8">
<meta name="generator" content="quarto-1.8.24">

<meta name="viewport" content="width=device-width, initial-scale=1.0, user-scalable=yes">

<meta name="author" content="Hubert Hickman">

<title>CTS API Introduction and Demo</title>
<style>
code{white-space: pre-wrap;}
span.smallcaps{font-variant: small-caps;}
div.columns{display: flex; gap: min(4vw, 1.5em);}
div.column{flex: auto; overflow-x: auto;}
div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
ul.task-list{list-style: none;}
ul.task-list li input[type="checkbox"] {
  width: 0.8em;
  margin: 0 0.8em 0.2em -1em; /* quarto-specific, see https://github.com/quarto-dev/quarto-cli/issues/4556 */ 
  vertical-align: middle;
}
/* CSS for syntax highlighting */
html { -webkit-text-size-adjust: 100%; }
pre > code.sourceCode { white-space: pre; position: relative; }
pre > code.sourceCode > span { display: inline-block; line-height: 1.25; }
pre > code.sourceCode > span:empty { height: 1.2em; }
.sourceCode { overflow: visible; }
code.sourceCode > span { color: inherit; text-decoration: inherit; }
div.sourceCode { margin: 1em 0; }
pre.sourceCode { margin: 0; }
@media screen {
div.sourceCode { overflow: auto; }
}
@media print {
pre > code.sourceCode { white-space: pre-wrap; }
pre > code.sourceCode > span { text-indent: -5em; padding-left: 5em; }
}
pre.numberSource code
  { counter-reset: source-line 0; }
pre.numberSource code > span
  { position: relative; left: -4em; counter-increment: source-line; }
pre.numberSource code > span > a:first-child::before
  { content: counter(source-line);
    position: relative; left: -1em; text-align: right; vertical-align: baseline;
    border: none; display: inline-block;
    -webkit-touch-callout: none; -webkit-user-select: none;
    -khtml-user-select: none; -moz-user-select: none;
    -ms-user-select: none; user-select: none;
    padding: 0 4px; width: 4em;
  }
pre.numberSource { margin-left: 3em;  padding-left: 4px; }
div.sourceCode
  {   }
@media screen {
pre > code.sourceCode > span > a:first-child::before { text-decoration: underline; }
}
</style>


<script src="https://cdn.jsdelivr.net/npm/jquery@3.5.1/dist/jquery.min.js" integrity="sha384-ZvpUoO/+PpLXR1lu4jmpXWu80pZlYUAfxl5NsBMWOEPSjUn/6Z/hRTt8+pR6L4N2" crossorigin="anonymous"></script><script src="demo_files/libs/clipboard/clipboard.min.js"></script>
<script src="demo_files/libs/quarto-html/quarto.js" type="module"></script>
<script src="demo_files/libs/quarto-html/tabsets/tabsets.js" type="module"></script>
<script src="demo_files/libs/quarto-html/axe/axe-check.js" type="module"></script>
<script src="demo_files/libs/quarto-html/popper.min.js"></script>
<script src="demo_files/libs/quarto-html/tippy.umd.min.js"></script>
<script src="demo_files/libs/quarto-html/anchor.min.js"></script>
<link href="demo_files/libs/quarto-html/tippy.css" rel="stylesheet">
<link href="demo_files/libs/quarto-html/quarto-syntax-highlighting-dc55a5b9e770e841cd82e46aadbfb9b0.css" rel="stylesheet" id="quarto-text-highlighting-styles">
<script src="demo_files/libs/bootstrap/bootstrap.min.js"></script>
<link href="demo_files/libs/bootstrap/bootstrap-icons.css" rel="stylesheet">
<link href="demo_files/libs/bootstrap/bootstrap-d6a003b94517c951b2d65075d42fb01b.min.css" rel="stylesheet" append-hash="true" id="quarto-bootstrap" data-mode="light">
<script src="https://cdn.jsdelivr.net/npm/requirejs@2.3.6/require.min.js" integrity="sha384-c9c+LnTbwQ3aujuU7ULEPVvgLs+Fn6fJUvIGTsuu1ZcCf11fiEubah0ttpca4ntM sha384-6V1/AdqZRWk1KAlWbKBlGhN7VG4iE/yAZcO6NZPMF8od0vukrvr0tg4qY6NSrItx" crossorigin="anonymous"></script>

<script type="application/javascript">define('jquery', [],function() {return window.jQuery;})</script>


</head>

<body class="quarto-light">

<div id="quarto-content" class="page-columns page-rows-contents page-layout-full">

<main class="content column-page" id="quarto-document-content">

<header id="title-block-header" class="quarto-title-block default">
<div class="quarto-title">
<h1 class="title">CTS API Introduction and Demo</h1>
</div>


<div class="quarto-title-meta-author column-page">
  <div class="quarto-title-meta-heading">Author</div>
  <div class="quarto-title-meta-heading">Affiliation</div>
  
    <div class="quarto-title-meta-contents">
    <p class="author">Hubert Hickman <a href="mailto:hubert.hickman@bsd.uchicago.edu" class="quarto-title-author-email"><i class="bi bi-envelope"></i></a> </p>
  </div>
  <div class="quarto-title-meta-contents">
        <p class="affiliation">
            <a href="https://commons.cri.uchicago.edu/">
            University of Chicago
            </a>
          </p>
      </div>
  </div>

<div class="quarto-title-meta column-page">

      
  
    
  </div>
  


</header>


<section id="cts-api" class="level2 smaller">
<h2 class="smaller anchored" data-anchor-id="cts-api">CTS API</h2>
<p>The Cancer Clinical Trials Search API <a href="https://www.cancer.gov/syndication/api" class="uri">https://www.cancer.gov/syndication/api</a> is a NCI supported API that provides a wide range of features including trial information and search capabilities. Much of the API content uses the NCI Thesaurus.</p>
<ul>
<li>CTS API Helpful links:
<ul>
<li>Swagger page - <a href="https://clinicaltrialsapi.cancer.gov/doc" class="uri">https://clinicaltrialsapi.cancer.gov/doc</a></li>
<li>You will need an API key - signup for a key here : <a href="https://clinicaltrialsapi.cancer.gov/signin" class="uri">https://clinicaltrialsapi.cancer.gov/signin</a></li>
<li>Rate limits for standard 1 request per second</li>
<li>Maximum number of trials returned per request is 50.</li>
</ul></li>
<li>Searching is supported via POST or GET. I typicall use POST for convenience.<br>
</li>
<li>Searching by code, strings, geolocation, and much much more.</li>
<li>Has both unstructured and structured eligibility criteria.</li>
</ul>
</section>
<section id="evs-api" class="level2 smaller">
<h2 class="smaller anchored" data-anchor-id="evs-api">EVS API</h2>
<p>NCIâ€™s Enterprise Vocabulary Services provides several tools and downloads of the National Institute Thesaurus.</p>
<ul>
<li>NCI Thesaurus Helpful links:
<ul>
<li>EVS Explore (defaults to NCIt) <a href="https://evsexplore.semantics.cancer.gov/evsexplore/welcome" class="uri">https://evsexplore.semantics.cancer.gov/evsexplore/welcome</a></li>
<li>EVS API : <a href="https://evsexplore.semantics.cancer.gov/evsexplore/evsapi" class="uri">https://evsexplore.semantics.cancer.gov/evsexplore/evsapi</a>
<ul>
<li>No API key required</li>
<li>Will timeout if too much activity (need sleep/backoff timing code)</li>
</ul></li>
<li>NCIt releases are available as for download as well as TSV and OWL files.
<ul>
<li><a href="https://evs.nci.nih.gov/evs-download/thesaurus-downloads" class="uri">https://evs.nci.nih.gov/evs-download/thesaurus-downloads</a></li>
</ul></li>
<li>I have used the TSV extensively in my work (computing the transitive closure of NCIt digraph and enumerating all the paths in a database table - it speeds up inheritance computations)</li>
<li>TSV file is a subset of the OWL representation.</li>
</ul></li>
</ul>
</section>
<section id="simple-example" class="level2 smaller">
<h2 class="smaller anchored" data-anchor-id="simple-example">Simple Example</h2>
<p>This example shows how to query the CTS API to get a count of active treatment trials. It retrieves one trial.</p>
<div id="46ef7206" class="cell" data-execution_count="1">
<details class="code-fold">
<summary>Code</summary>
<div class="code-copy-outer-scaffold"><div class="sourceCode cell-code" id="cb1"><pre class="sourceCode python code-with-copy"><code class="sourceCode python"><span id="cb1-1"><a href="#cb1-1" aria-hidden="true" tabindex="-1"></a><span class="im">import</span> requests</span>
<span id="cb1-2"><a href="#cb1-2" aria-hidden="true" tabindex="-1"></a><span class="im">import</span> sys</span>
<span id="cb1-3"><a href="#cb1-3" aria-hidden="true" tabindex="-1"></a><span class="im">import</span> json</span>
<span id="cb1-4"><a href="#cb1-4" aria-hidden="true" tabindex="-1"></a><span class="im">import</span> os</span>
<span id="cb1-5"><a href="#cb1-5" aria-hidden="true" tabindex="-1"></a><span class="im">import</span> pandas <span class="im">as</span> pd</span>
<span id="cb1-6"><a href="#cb1-6" aria-hidden="true" tabindex="-1"></a><span class="im">from</span> dotenv <span class="im">import</span> dotenv_values</span>
<span id="cb1-7"><a href="#cb1-7" aria-hidden="true" tabindex="-1"></a><span class="im">import</span> mercury <span class="im">as</span> mr</span>
<span id="cb1-8"><a href="#cb1-8" aria-hidden="true" tabindex="-1"></a><span class="im">import</span> time </span>
<span id="cb1-9"><a href="#cb1-9" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-10"><a href="#cb1-10" aria-hidden="true" tabindex="-1"></a>config <span class="op">=</span> dotenv_values(<span class="st">'.env'</span>)</span>
<span id="cb1-11"><a href="#cb1-11" aria-hidden="true" tabindex="-1"></a>CTS_API_KEY<span class="op">=</span>config[<span class="st">'CTS_API_KEY'</span>]</span>
<span id="cb1-12"><a href="#cb1-12" aria-hidden="true" tabindex="-1"></a>cts_api_header <span class="op">=</span> {<span class="st">"x-api-key"</span>: CTS_API_KEY,</span>
<span id="cb1-13"><a href="#cb1-13" aria-hidden="true" tabindex="-1"></a>                  <span class="st">"Content-Type"</span>: <span class="st">"application/json"</span>}</span>
<span id="cb1-14"><a href="#cb1-14" aria-hidden="true" tabindex="-1"></a>includes <span class="op">=</span> [<span class="st">'nct_id'</span>,</span>
<span id="cb1-15"><a href="#cb1-15" aria-hidden="true" tabindex="-1"></a>            <span class="st">'diseases'</span>,</span>
<span id="cb1-16"><a href="#cb1-16" aria-hidden="true" tabindex="-1"></a>            <span class="st">'biomarkers'</span>,</span>
<span id="cb1-17"><a href="#cb1-17" aria-hidden="true" tabindex="-1"></a>            <span class="st">'prior_therapy'</span>,</span>
<span id="cb1-18"><a href="#cb1-18" aria-hidden="true" tabindex="-1"></a>            <span class="st">'brief_title'</span></span>
<span id="cb1-19"><a href="#cb1-19" aria-hidden="true" tabindex="-1"></a>            ]</span>
<span id="cb1-20"><a href="#cb1-20" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-21"><a href="#cb1-21" aria-hidden="true" tabindex="-1"></a>active_treatment_trials_that_are_recruiting <span class="op">=</span> {<span class="st">'current_trial_status'</span>: <span class="st">'Active'</span>,</span>
<span id="cb1-22"><a href="#cb1-22" aria-hidden="true" tabindex="-1"></a>        <span class="st">'sites.recruitment_status'</span> : <span class="st">'ACTIVE'</span>,</span>
<span id="cb1-23"><a href="#cb1-23" aria-hidden="true" tabindex="-1"></a>        <span class="st">'primary_purpose'</span>: <span class="st">'TREATMENT'</span>,</span>
<span id="cb1-24"><a href="#cb1-24" aria-hidden="true" tabindex="-1"></a>        <span class="st">'size'</span>:<span class="dv">1</span>,</span>
<span id="cb1-25"><a href="#cb1-25" aria-hidden="true" tabindex="-1"></a>        <span class="st">'from'</span>:<span class="dv">0</span>,</span>
<span id="cb1-26"><a href="#cb1-26" aria-hidden="true" tabindex="-1"></a>        <span class="st">'include'</span>:includes</span>
<span id="cb1-27"><a href="#cb1-27" aria-hidden="true" tabindex="-1"></a>        }          </span>
<span id="cb1-28"><a href="#cb1-28" aria-hidden="true" tabindex="-1"></a>r <span class="op">=</span> requests.post(<span class="st">'https://clinicaltrialsapi.cancer.gov/api/v2/trials'</span>,</span>
<span id="cb1-29"><a href="#cb1-29" aria-hidden="true" tabindex="-1"></a>                  json <span class="op">=</span> active_treatment_trials_that_are_recruiting, headers<span class="op">=</span>cts_api_header)</span>
<span id="cb1-30"><a href="#cb1-30" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-31"><a href="#cb1-31" aria-hidden="true" tabindex="-1"></a>j <span class="op">=</span> r.json()   </span>
<span id="cb1-32"><a href="#cb1-32" aria-hidden="true" tabindex="-1"></a>mr.JSON(j)</span>
<span id="cb1-33"><a href="#cb1-33" aria-hidden="true" tabindex="-1"></a>time.sleep(<span class="dv">2</span>)</span></code></pre></div><button title="Copy to Clipboard" class="code-copy-button"><i class="bi"></i></button></div>
</details>
<div class="cell-output cell-output-display">
<style>.renderjson a              { text-decoration: none; }
.renderjson .disclosure    { color: grey; font-size: 125%; }
.renderjson .syntax        { color: grey; }
.renderjson .string        { color: #fe46a5; }
.renderjson .number        { color: #0f9b8e; }
.renderjson .boolean       { color: black; }
.renderjson .key           { color: #2684ff; }
.renderjson .keyword       { color: gray; }
.renderjson .object.syntax { color: gray; }
.renderjson .array.syntax  { color: gray; }</style><div id="2d36fc5e-537c-4600-9231-a328220bfdab"></div>
</div>
<div class="cell-output cell-output-display">
<script>var renderjson=function(){var t=function(){for(var t=[];arguments.length;)t.push(n(s(Array.prototype.shift.call(arguments)),o(Array.prototype.shift.call(arguments))));return t},n=function(){for(var t=Array.prototype.shift.call(arguments),e=0;e<arguments.length;e++)arguments[e].constructor==Array?n.apply(this,[t].concat(arguments[e])):t.appendChild(arguments[e]);return t},e=function(t,n){return t.insertBefore(n,t.firstChild),t},r=function(t,n){var e=n||Object.keys(t);for(var r in e)if(Object.hasOwnProperty.call(t,e[r]))return!1;return!0},o=function(t){return document.createTextNode(t)},s=function(t){var n=document.createElement("span");return t&&(n.className=t),n},l=function(t,n,e){var r=document.createElement("a");return n&&(r.className=n),r.appendChild(o(t)),r.href="#",r.onclick=function(t){return e(),t&&t.stopPropagation(),!1},r};function a(i,c,u,p,y){var _=u?"":c,f=function(r,a,i,c,u){var f,g=s(c),h=function(){f||n(g.parentNode,f=e(u(),l(y.hide,"disclosure",(function(){f.style.display="none",g.style.display="inline"})))),f.style.display="inline",g.style.display="none"};n(g,l(y.show,"disclosure",h),t(c+" syntax",r),l(a,null,h),t(c+" syntax",i));var d=n(s(),o(_.slice(0,-1)),g);return p>0&&"string"!=c&&h(),d};return null===i?t(null,_,"keyword","null"):void 0===i?t(null,_,"keyword","undefined"):"string"==typeof i&&i.length>y.max_string_length?f('"',i.substr(0,y.max_string_length)+" ...",'"',"string",(function(){return n(s("string"),t(null,_,"string",JSON.stringify(i)))})):"object"!=typeof i||[Number,String,Boolean,Date].indexOf(i.constructor)>=0?t(null,_,typeof i,JSON.stringify(i)):i.constructor==Array?0==i.length?t(null,_,"array syntax","[]"):f("[",y.collapse_msg(i.length),"]","array",(function(){for(var e=n(s("array"),t("array syntax","[",null,"\n")),r=0;r<i.length;r++)n(e,a(y.replacer.call(i,r,i[r]),c+"    ",!1,p-1,y),r!=i.length-1?t("syntax",","):[],o("\n"));return n(e,t(null,c,"array syntax","]")),e})):r(i,y.property_list)?t(null,_,"object syntax","{}"):f("{",y.collapse_msg(Object.keys(i).length),"}","object",(function(){var e=n(s("object"),t("object syntax","{",null,"\n"));for(var r in i)var l=r;var u=y.property_list||Object.keys(i);for(var _ in y.sort_objects&&(u=u.sort()),u){(r=u[_])in i&&n(e,t(null,c+"    ","key",'"'+r+'"',"object syntax",": "),a(y.replacer.call(i,r,i[r]),c+"    ",!0,p-1,y),r!=l?t("syntax",","):[],o("\n"))}return n(e,t(null,c,"object syntax","}")),e}))}var i=function t(e){var r=new Object(t.options);r.replacer="function"==typeof r.replacer?r.replacer:function(t,n){return n};var o=n(document.createElement("pre"),a(e,"",!1,r.show_to_level,r));return o.className="renderjson",o};return i.set_icons=function(t,n){return i.options.show=t,i.options.hide=n,i},i.set_show_to_level=function(t){return i.options.show_to_level="string"==typeof t&&"all"===t.toLowerCase()?Number.MAX_VALUE:t,i},i.set_max_string_length=function(t){return i.options.max_string_length="string"==typeof t&&"none"===t.toLowerCase()?Number.MAX_VALUE:t,i},i.set_sort_objects=function(t){return i.options.sort_objects=t,i},i.set_replacer=function(t){return i.options.replacer=t,i},i.set_collapse_msg=function(t){return i.options.collapse_msg=t,i},i.set_property_list=function(t){return i.options.property_list=t,i},i.set_show_by_default=function(t){return i.options.show_to_level=t?Number.MAX_VALUE:0,i},i.options={},i.set_icons("âŠ•","âŠ–"),i.set_show_by_default(!1),i.set_sort_objects(!1),i.set_max_string_length("none"),i.set_replacer(void 0),i.set_property_list(void 0),i.set_collapse_msg((function(t){return t+" item"+(1==t?"":"s")})),i}(); renderjson.set_show_to_level(1); document.getElementById("2d36fc5e-537c-4600-9231-a328220bfdab").appendChild(renderjson({"total": 3888, "data": [{"nct_id": "NCT05879926", "biomarkers": [{"eligibility_criterion": "inclusion", "inclusion_indicator": "TREE", "synonyms": ["Observable Entity"], "nci_thesaurus_concept_id": "C3367", "name": "Finding", "semantic_types": ["Finding"], "type": ["branch"], "ancestors": [], "parents": [], "assay_purpose": "Eligibility Criterion - Inclusion"}, {"eligibility_criterion": "inclusion", "inclusion_indicator": "TREE", "synonyms": ["ER", "ESR1", "Estrogen Receptor 1 Gene"], "nci_thesaurus_concept_id": "C38349", "name": "ESR1 Gene", "semantic_types": ["Gene or Genome"], "type": ["reference_gene"], "ancestors": ["C20103", "C20420", "C16612", "C21295", "C54362", "C20709"], "parents": ["C20709"], "assay_purpose": "Eligibility Criterion - Inclusion"}, {"eligibility_criterion": "inclusion", "inclusion_indicator": "TREE", "synonyms": [], "nci_thesaurus_concept_id": "C54362", "name": "Transcription Regulation Gene", "semantic_types": ["Gene or Genome"], "type": [], "ancestors": ["C16612"], "parents": ["C16612"], "assay_purpose": "Eligibility Criterion - Inclusion"}, {"eligibility_criterion": "inclusion", "inclusion_indicator": "TREE", "synonyms": ["RTK Family Gene"], "nci_thesaurus_concept_id": "C20719", "name": "Receptor Tyrosine Kinase Gene", "semantic_types": ["Gene or Genome"], "type": [], "ancestors": ["C25870", "C25872", "C21295", "C20103", "C25871", "C16612", "C21281"], "parents": ["C20103", "C25872"], "assay_purpose": "Eligibility Criterion - Inclusion"}, {"eligibility_criterion": "inclusion", "inclusion_indicator": "TREE", "synonyms": ["LAB_RESULT", "Lab Findings", "Lab Value", "Laboratory Finding", "Laboratory Report", "Labs", "Test Result", "test_result"], "nci_thesaurus_concept_id": "C36292", "name": "Laboratory Test Result", "semantic_types": ["Laboratory or Test Result"], "type": [], "ancestors": ["C3367", "C77140"], "parents": ["C77140"], "assay_purpose": "Eligibility Criterion - Inclusion"}, {"eligibility_criterion": "inclusion", "inclusion_indicator": "TREE", "synonyms": ["Genes"], "nci_thesaurus_concept_id": "C16612", "name": "Gene", "semantic_types": ["Gene or Genome"], "type": ["branch"], "ancestors": [], "parents": [], "assay_purpose": "Eligibility Criterion - Inclusion"}, {"eligibility_criterion": "inclusion", "inclusion_indicator": "TREE", "synonyms": ["Proto-Oncogene, Transcription Factor"], "nci_thesaurus_concept_id": "C20420", "name": "Transcription Factor Gene", "semantic_types": ["Gene or Genome"], "type": [], "ancestors": ["C16612", "C54362"], "parents": ["C54362"], "assay_purpose": "Eligibility Criterion - Inclusion"}, {"eligibility_criterion": "inclusion", "inclusion_indicator": "TREE", "synonyms": ["Positive", "positive test result"], "nci_thesaurus_concept_id": "C35682", "name": "Positive Laboratory Test Result", "semantic_types": ["Laboratory or Test Result"], "type": [], "ancestors": ["C36292", "C3367", "C77140"], "parents": ["C36292"], "assay_purpose": "Eligibility Criterion - Inclusion"}, {"eligibility_criterion": "inclusion", "inclusion_indicator": "TREE", "synonyms": ["PgR Status", "Progesterone Receptor"], "nci_thesaurus_concept_id": "C16149", "name": "Progesterone Receptor Status", "semantic_types": ["Laboratory or Test Result"], "type": [], "ancestors": ["C188928", "C3367", "C36292", "C20709", "C20420", "C20103", "C77140", "C16612", "C54362", "C94299", "C28656", "C21295"], "parents": ["C188928", "C28656"], "assay_purpose": "Eligibility Criterion - Inclusion"}, {"eligibility_criterion": "inclusion", "inclusion_indicator": "TREE", "synonyms": [], "nci_thesaurus_concept_id": "C20103", "name": "Receptor Gene", "semantic_types": ["Gene or Genome"], "type": [], "ancestors": ["C21295", "C16612"], "parents": ["C21295"], "assay_purpose": "Eligibility Criterion - Inclusion"}, {"eligibility_criterion": "inclusion", "inclusion_indicator": "TRIAL", "synonyms": ["ERBB2 Negative", "HER-2 Negative", "HER2 Negative"], "nci_thesaurus_concept_id": "C68749", "name": "HER2/Neu Negative", "semantic_types": ["Laboratory or Test Result"], "type": [], "ancestors": ["C36292", "C35681", "C25870", "C25871", "C20103", "C16152", "C165233", "C16612", "C77140", "C3367", "C21295", "C17756", "C25872", "C21281", "C20719", "C94299"], "parents": ["C16152", "C165233", "C17756"], "assay_purpose": "Eligibility Criterion - Inclusion"}, {"eligibility_criterion": "inclusion", "inclusion_indicator": "TREE", "synonyms": ["ERBB2", "Erb-b2 Receptor Tyrosine Kinase 2 Gene", "HER2", "HER2/Neu", "NEU"], "nci_thesaurus_concept_id": "C17756", "name": "ERBB2 Gene", "semantic_types": ["Gene or Genome"], "type": ["reference_gene"], "ancestors": ["C20103", "C20719", "C21281", "C16612", "C21295", "C25870", "C25871", "C25872"], "parents": ["C20719"], "assay_purpose": "Eligibility Criterion - Inclusion"}, {"eligibility_criterion": "inclusion", "inclusion_indicator": "TREE", "synonyms": [], "nci_thesaurus_concept_id": "C25872", "name": "Kinase Family Gene", "semantic_types": ["Gene or Genome"], "type": [], "ancestors": ["C25871", "C16612", "C21281", "C25870"], "parents": ["C25871"], "assay_purpose": "Eligibility Criterion - Inclusion"}, {"eligibility_criterion": "inclusion", "inclusion_indicator": "TREE", "synonyms": [], "nci_thesaurus_concept_id": "C21295", "name": "Ligand Binding Protein Gene", "semantic_types": ["Gene or Genome"], "type": [], "ancestors": ["C16612"], "parents": ["C16612"], "assay_purpose": "Eligibility Criterion - Inclusion"}, {"eligibility_criterion": "inclusion", "inclusion_indicator": "TREE", "synonyms": ["PGR", "PR", "Progesterone Receptor Gene"], "nci_thesaurus_concept_id": "C28656", "name": "PGR Gene", "semantic_types": ["Gene or Genome"], "type": ["reference_gene"], "ancestors": ["C20709", "C20420", "C16612", "C54362", "C20103", "C21295"], "parents": ["C20709"], "assay_purpose": "Eligibility Criterion - Inclusion"}, {"eligibility_criterion": "inclusion", "inclusion_indicator": "TREE", "synonyms": [], "nci_thesaurus_concept_id": "C94299", "name": "Receptor Status", "semantic_types": ["Laboratory or Test Result"], "type": [], "ancestors": ["C77140", "C36292", "C3367"], "parents": ["C36292"], "assay_purpose": "Eligibility Criterion - Inclusion"}, {"eligibility_criterion": "inclusion", "inclusion_indicator": "TREE", "synonyms": ["Absent", "LOST", "Loss of Expression", "Negative", "Not Expressed"], "nci_thesaurus_concept_id": "C165233", "name": "Expression Negative", "semantic_types": ["Cell or Molecular Dysfunction"], "type": [], "ancestors": ["C77140", "C3367", "C35681"], "parents": ["C35681"], "assay_purpose": "Eligibility Criterion - Inclusion"}, {"eligibility_criterion": "inclusion", "inclusion_indicator": "TREE", "synonyms": ["Expressed", "Expression Detected"], "nci_thesaurus_concept_id": "C177692", "name": "Expression Positive", "semantic_types": ["Laboratory or Test Result"], "type": [], "ancestors": ["C35682", "C77140", "C36292", "C3367"], "parents": ["C35682"], "assay_purpose": "Eligibility Criterion - Inclusion"}, {"eligibility_criterion": "inclusion", "inclusion_indicator": "TREE", "synonyms": ["ERBB2 Status", "Her2/Neu Value"], "nci_thesaurus_concept_id": "C16152", "name": "HER2/Neu Status", "semantic_types": ["Laboratory or Test Result"], "type": [], "ancestors": ["C36292", "C25870", "C25871", "C20103", "C16612", "C77140", "C3367", "C21295", "C17756", "C25872", "C21281", "C20719", "C94299"], "parents": ["C17756", "C94299"], "assay_purpose": "Eligibility Criterion - Inclusion"}, {"eligibility_criterion": "inclusion", "inclusion_indicator": "TREE", "synonyms": ["HR Status"], "nci_thesaurus_concept_id": "C188928", "name": "Hormone Receptor Status", "semantic_types": ["Laboratory or Test Result"], "type": [], "ancestors": ["C94299", "C77140", "C3367", "C36292"], "parents": ["C94299"], "assay_purpose": "Eligibility Criterion - Inclusion"}, {"eligibility_criterion": "inclusion", "inclusion_indicator": "TREE", "synonyms": [], "nci_thesaurus_concept_id": "C25871", "name": "Phosphotransferase Gene", "semantic_types": ["Gene or Genome"], "type": [], "ancestors": ["C16612", "C21281", "C25870"], "parents": ["C25870"], "assay_purpose": "Eligibility Criterion - Inclusion"}, {"eligibility_criterion": "inclusion", "inclusion_indicator": "TREE", "synonyms": ["Negative"], "nci_thesaurus_concept_id": "C35681", "name": "Negative Test Result", "semantic_types": ["Finding"], "type": [], "ancestors": ["C77140", "C3367"], "parents": ["C77140"], "assay_purpose": "Eligibility Criterion - Inclusion"}, {"eligibility_criterion": "inclusion", "inclusion_indicator": "TREE", "synonyms": [], "nci_thesaurus_concept_id": "C21281", "name": "Enzyme Gene", "semantic_types": ["Gene or Genome"], "type": [], "ancestors": ["C16612"], "parents": ["C16612"], "assay_purpose": "Eligibility Criterion - Inclusion"}, {"eligibility_criterion": "inclusion", "inclusion_indicator": "TREE", "synonyms": [], "nci_thesaurus_concept_id": "C25870", "name": "Transferase Gene", "semantic_types": ["Gene or Genome"], "type": [], "ancestors": ["C16612", "C21281"], "parents": ["C21281"], "assay_purpose": "Eligibility Criterion - Inclusion"}, {"eligibility_criterion": "inclusion", "inclusion_indicator": "TRIAL", "synonyms": ["PGR Positive", "PR Positive", "PR+", "Positive"], "nci_thesaurus_concept_id": "C15496", "name": "Progesterone Receptor Positive", "semantic_types": ["Laboratory or Test Result"], "type": [], "ancestors": ["C35682", "C38349", "C101267", "C36292", "C188928", "C20420", "C20103", "C77140", "C16612", "C177692", "C21295", "C54362", "C20709", "C28656", "C16149", "C94299", "C3367"], "parents": ["C101267", "C16149", "C28656"], "assay_purpose": "Eligibility Criterion - Inclusion"}, {"eligibility_criterion": "inclusion", "inclusion_indicator": "TREE", "synonyms": ["ER Alpha Status", "ER Status", "ER-Alpha Status", "ERA Status", "ESR Status", "ESR1 Status", "ESRA Status", "ESTRR Status", "Estrogen Receptor", "Estrogen Receptor 1 Status", "Estrogen Receptor Alpha Status", "NR3A1 Status", "Nuclear Receptor Subfamily 3 Group A Member 1 Status"], "nci_thesaurus_concept_id": "C16150", "name": "Estrogen Receptor Status", "semantic_types": ["Laboratory or Test Result"], "type": [], "ancestors": ["C188928", "C16612", "C20709", "C54362", "C21295", "C20420", "C38349", "C36292", "C77140", "C20103", "C94299", "C3367"], "parents": ["C188928", "C38349"], "assay_purpose": "Eligibility Criterion - Inclusion"}, {"eligibility_criterion": "inclusion", "inclusion_indicator": "TRIAL", "synonyms": ["ER Alpha Positive", "ER Positive", "ER+", "ER-Alpha Positive", "ERA Positive", "ESR Positive", "ESR1 Positive", "ESRA Positive", "ESTRR Positive", "Estrogen Receptor 1 Positive", "Estrogen Receptor Alpha Positive", "NR3A1 Positive", "Nuclear Receptor Subfamily 3 Group A Member 1 Positive", "Positive", "Positive Estrogen Receptor"], "nci_thesaurus_concept_id": "C15492", "name": "Estrogen Receptor Positive", "semantic_types": ["Laboratory or Test Result"], "type": [], "ancestors": ["C35682", "C38349", "C20103", "C36292", "C188928", "C20420", "C16612", "C77140", "C101267", "C177692", "C21295", "C54362", "C28656", "C20709", "C16150", "C94299", "C3367"], "parents": ["C101267", "C16150", "C38349"], "assay_purpose": "Eligibility Criterion - Inclusion"}, {"eligibility_criterion": "inclusion", "inclusion_indicator": "TREE", "synonyms": ["Clinical Measurement", "Diagnostic Test Result"], "nci_thesaurus_concept_id": "C77140", "name": "Clinical Test Result", "semantic_types": ["Finding"], "type": [], "ancestors": ["C3367"], "parents": ["C3367"], "assay_purpose": "Eligibility Criterion - Inclusion"}, {"eligibility_criterion": "inclusion", "inclusion_indicator": "TREE", "synonyms": [], "nci_thesaurus_concept_id": "C20709", "name": "Nuclear Receptor Gene", "semantic_types": ["Gene or Genome"], "type": [], "ancestors": ["C20420", "C16612", "C54362", "C20103", "C21295"], "parents": ["C20103", "C20420"], "assay_purpose": "Eligibility Criterion - Inclusion"}, {"eligibility_criterion": "inclusion", "inclusion_indicator": "TREE", "synonyms": [], "nci_thesaurus_concept_id": "C101267", "name": "Hormone Receptor Positive", "semantic_types": ["Laboratory or Test Result"], "type": [], "ancestors": ["C35682", "C38349", "C36292", "C188928", "C20420", "C94299", "C77140", "C16612", "C177692", "C21295", "C54362", "C28656", "C20709", "C20103", "C3367"], "parents": ["C177692", "C188928", "C28656", "C38349"], "assay_purpose": "Eligibility Criterion - Inclusion"}], "brief_title": "Testing the Addition of Chemotherapy to the Usual Treatment of Ovarian Function Suppression plus Hormonal Therapy in Premenopausal ER-Positive/HER2-Negative Breast Cancer Patients Who Are At High Risk of Cancer Returning, OFSET Trial", "prior_therapy": [], "diseases": [{"inclusion_indicator": "TRIAL", "is_lead_disease": true, "synonyms": ["Anatomic Stage I Breast Cancer AJCC v8", "Anatomic Stage I Breast Carcinoma AJCC v8"], "nci_thesaurus_concept_id": "C139535", "name": "Stage I Breast Cancer", "type": ["stage"], "parents": ["C139533"]}, {"inclusion_indicator": "TRIAL", "is_lead_disease": false, "synonyms": ["Anatomic Stage II Breast Cancer AJCC v8", "Anatomic Stage II Breast Carcinoma AJCC v8"], "nci_thesaurus_concept_id": "C139538", "name": "Stage II Breast Cancer", "type": ["stage"], "parents": ["C139533"]}, {"inclusion_indicator": "TRIAL", "is_lead_disease": false, "synonyms": ["Anatomic Stage IIIA Breast Cancer AJCC v8", "Anatomic Stage IIIA Breast Carcinoma AJCC v8"], "nci_thesaurus_concept_id": "C139542", "name": "Stage IIIA Breast Cancer", "type": ["stage"], "parents": ["C139541"]}, {"inclusion_indicator": "TRIAL", "is_lead_disease": false, "synonyms": ["Hormone Receptor Positive Breast Adenocarcinoma", "Hormone Receptor-Positive Breast Carcinoma"], "nci_thesaurus_concept_id": "C157056", "name": "Hormone Receptor Positive Breast Carcinoma", "type": ["subtype"], "parents": ["C5214"]}, {"inclusion_indicator": "TRIAL", "is_lead_disease": false, "synonyms": ["HER2 Negative Breast Adenocarcinoma", "HER2-Negative Breast Carcinoma"], "nci_thesaurus_concept_id": "C168519", "name": "HER2 Negative Breast Carcinoma", "type": ["subtype"], "parents": ["C5214"]}, {"inclusion_indicator": "TREE", "is_lead_disease": true, "synonyms": ["Condition", "Diagnosis", "Disease", "Disease or Disorder", "Disease or Disorder, Non-Neoplastic", "disease term", "disease type", "disease_term", "disease_type", "Diseases", "Diseases and Disorders", "Disorder", "Disorders"], "nci_thesaurus_concept_id": "C2991", "name": "Other Disease", "type": ["maintype"], "parents": []}, {"inclusion_indicator": "TREE", "is_lead_disease": true, "synonyms": ["Malignant Breast Tumor", "Malignant Neoplasm of Breast", "Malignant Neoplasm of the Breast", "Malignant Tumor of Breast", "Malignant Tumor of the Breast"], "nci_thesaurus_concept_id": "C9335", "name": "Malignant Breast Neoplasm", "type": ["subtype"], "parents": ["C9305", "C2910"]}, {"inclusion_indicator": "TREE", "is_lead_disease": true, "synonyms": ["Breast Carcinoma by AJCC v8 Anatomic Stage"], "nci_thesaurus_concept_id": "C139533", "name": "Breast Cancer by AJCC v8 Anatomic Stage", "type": ["stage"], "parents": ["C139532"]}, {"inclusion_indicator": "TREE", "is_lead_disease": true, "synonyms": ["Tumor Morphology", "Tumor_Morphology"], "nci_thesaurus_concept_id": "C4741", "name": "Neoplasm by Morphology", "type": ["subtype"], "parents": ["C3262"]}, {"inclusion_indicator": "TREE", "is_lead_disease": true, "synonyms": ["Breast cancer, NOS", "Breast Carcinoma", "Cancer of Breast", "Cancer of the Breast", "Carcinoma of Breast", "Carcinoma of the Breast", "Mammary Carcinoma"], "nci_thesaurus_concept_id": "C4872", "name": "Breast Cancer", "type": ["maintype"], "parents": ["C2916", "C9335"]}, {"inclusion_indicator": "TREE", "is_lead_disease": true, "synonyms": ["Epithelial Neoplasms, NOS", "Epithelioma", "Epithelioma, malignant"], "nci_thesaurus_concept_id": "C3709", "name": "Epithelial Neoplasm", "type": ["subtype"], "parents": ["C4741"]}, {"inclusion_indicator": "TREE", "is_lead_disease": true, "synonyms": [], "nci_thesaurus_concept_id": "C7062", "name": "Neoplasm by Special Category", "type": ["subtype"], "parents": ["C3262"]}, {"inclusion_indicator": "TREE", "is_lead_disease": true, "synonyms": ["Neoplasia", "Neoplasm", "Neoplasm, NOS", "Neoplasms, NOS", "Neoplastic Disease", "Neoplastic Growth", "tumor", "Tumor, NOS"], "nci_thesaurus_concept_id": "C3262", "name": "Other Neoplasm", "type": ["maintype"], "parents": ["C2991"]}, {"inclusion_indicator": "TREE", "is_lead_disease": true, "synonyms": ["Breast Carcinoma by AJCC v8 Stage"], "nci_thesaurus_concept_id": "C139532", "name": "Breast Cancer by AJCC v8 Stage", "type": ["stage"], "parents": ["C4872"]}, {"inclusion_indicator": "TREE", "is_lead_disease": true, "synonyms": ["Carcinoma", "CARCINOMA, MALIGNANT", "Carcinoma, NOS", "Epithelial Carcinoma", "Epithelial tumor, malignant", "Epithelioma Malignant", "Malignant Epithelial Neoplasm", "Malignant Epithelial Tumor", "Malignant Epithelioma"], "nci_thesaurus_concept_id": "C2916", "name": "Other Carcinoma", "type": ["maintype"], "parents": ["C3709", "C9305"]}, {"inclusion_indicator": "TREE", "is_lead_disease": true, "synonyms": ["Breast Disease", "Breast Diseases"], "nci_thesaurus_concept_id": "C26709", "name": "Breast Disorder", "type": ["subtype"], "parents": ["C27551"]}, {"inclusion_indicator": "TREE", "is_lead_disease": true, "synonyms": ["CA", "Cancer", "Malignancy", "Malignant Growth", "Malignant Neoplastic Disease", "Malignant Tumor", "Neoplasm, malignant", "Tumor, malignant, NOS", "Unclassified tumor, malignant"], "nci_thesaurus_concept_id": "C9305", "name": "Malignant Neoplasm", "type": ["subtype"], "parents": ["C7062"]}, {"inclusion_indicator": "TREE", "is_lead_disease": true, "synonyms": [], "nci_thesaurus_concept_id": "C7057", "name": "Disease, Disorder or Finding", "type": ["finding"], "parents": []}, {"inclusion_indicator": "TREE", "is_lead_disease": true, "synonyms": ["Disease by Site"], "nci_thesaurus_concept_id": "C27551", "name": "Disorder by Site", "type": ["subtype"], "parents": ["C2991"]}, {"inclusion_indicator": "TREE", "is_lead_disease": true, "synonyms": ["Breast Tumor", "Neoplasm of Breast", "Neoplasm of the Breast", "Tumor of Breast", "Tumor of the Breast"], "nci_thesaurus_concept_id": "C2910", "name": "Breast Neoplasm", "type": ["subtype"], "parents": ["C3263", "C26709"]}, {"inclusion_indicator": "TREE", "is_lead_disease": true, "synonyms": [], "nci_thesaurus_concept_id": "C3263", "name": "Neoplasm by Site", "type": ["subtype"], "parents": ["C3262"]}, {"inclusion_indicator": "TREE", "is_lead_disease": false, "synonyms": ["Anatomic Stage III Breast Cancer AJCC v8", "Anatomic Stage III Breast Carcinoma AJCC v8"], "nci_thesaurus_concept_id": "C139541", "name": "Stage III Breast Cancer", "type": ["stage"], "parents": ["C139533"]}]}]}))</script>
</div>
</div>
</section>
<section id="diseases" class="level2">
<h2 class="anchored" data-anchor-id="diseases">Diseases</h2>
<p>Expanding upon the above example, let us look at the diseases returned from the trial.</p>
<div id="9b04eef4" class="cell" data-execution_count="2">
<details class="code-fold">
<summary>Code</summary>
<div class="code-copy-outer-scaffold"><div class="sourceCode cell-code" id="cb2"><pre class="sourceCode python code-with-copy"><code class="sourceCode python"><span id="cb2-1"><a href="#cb2-1" aria-hidden="true" tabindex="-1"></a><span class="im">import</span> requests</span>
<span id="cb2-2"><a href="#cb2-2" aria-hidden="true" tabindex="-1"></a><span class="im">import</span> sys</span>
<span id="cb2-3"><a href="#cb2-3" aria-hidden="true" tabindex="-1"></a><span class="im">import</span> json</span>
<span id="cb2-4"><a href="#cb2-4" aria-hidden="true" tabindex="-1"></a><span class="im">import</span> os</span>
<span id="cb2-5"><a href="#cb2-5" aria-hidden="true" tabindex="-1"></a><span class="im">import</span> pandas <span class="im">as</span> pd</span>
<span id="cb2-6"><a href="#cb2-6" aria-hidden="true" tabindex="-1"></a><span class="im">from</span> dotenv <span class="im">import</span> dotenv_values</span>
<span id="cb2-7"><a href="#cb2-7" aria-hidden="true" tabindex="-1"></a><span class="im">import</span> mercury <span class="im">as</span> mr</span>
<span id="cb2-8"><a href="#cb2-8" aria-hidden="true" tabindex="-1"></a><span class="im">import</span> itables</span>
<span id="cb2-9"><a href="#cb2-9" aria-hidden="true" tabindex="-1"></a><span class="im">import</span> time</span>
<span id="cb2-10"><a href="#cb2-10" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb2-11"><a href="#cb2-11" aria-hidden="true" tabindex="-1"></a>config <span class="op">=</span> dotenv_values(<span class="st">'.env'</span>)</span>
<span id="cb2-12"><a href="#cb2-12" aria-hidden="true" tabindex="-1"></a>CTS_API_KEY<span class="op">=</span>config[<span class="st">'CTS_API_KEY'</span>]</span>
<span id="cb2-13"><a href="#cb2-13" aria-hidden="true" tabindex="-1"></a>cts_api_header <span class="op">=</span> {<span class="st">"x-api-key"</span>: CTS_API_KEY,</span>
<span id="cb2-14"><a href="#cb2-14" aria-hidden="true" tabindex="-1"></a>                  <span class="st">"Content-Type"</span>: <span class="st">"application/json"</span>}</span>
<span id="cb2-15"><a href="#cb2-15" aria-hidden="true" tabindex="-1"></a>includes <span class="op">=</span> [<span class="st">'nct_id'</span>,</span>
<span id="cb2-16"><a href="#cb2-16" aria-hidden="true" tabindex="-1"></a>            <span class="st">'diseases'</span>,</span>
<span id="cb2-17"><a href="#cb2-17" aria-hidden="true" tabindex="-1"></a>            <span class="st">'biomarkers'</span>,</span>
<span id="cb2-18"><a href="#cb2-18" aria-hidden="true" tabindex="-1"></a>            <span class="st">'prior_therapy'</span>,</span>
<span id="cb2-19"><a href="#cb2-19" aria-hidden="true" tabindex="-1"></a>            <span class="st">'brief_title'</span></span>
<span id="cb2-20"><a href="#cb2-20" aria-hidden="true" tabindex="-1"></a>            ]</span>
<span id="cb2-21"><a href="#cb2-21" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb2-22"><a href="#cb2-22" aria-hidden="true" tabindex="-1"></a>active_treatment_trials_that_are_recruiting <span class="op">=</span> {<span class="st">'current_trial_status'</span>: <span class="st">'Active'</span>,</span>
<span id="cb2-23"><a href="#cb2-23" aria-hidden="true" tabindex="-1"></a>        <span class="st">'sites.recruitment_status'</span> : <span class="st">'ACTIVE'</span>,</span>
<span id="cb2-24"><a href="#cb2-24" aria-hidden="true" tabindex="-1"></a>        <span class="st">'primary_purpose'</span>: <span class="st">'TREATMENT'</span>,</span>
<span id="cb2-25"><a href="#cb2-25" aria-hidden="true" tabindex="-1"></a>        <span class="st">'size'</span>:<span class="dv">1</span>,</span>
<span id="cb2-26"><a href="#cb2-26" aria-hidden="true" tabindex="-1"></a>        <span class="st">'from'</span>:<span class="dv">0</span>,</span>
<span id="cb2-27"><a href="#cb2-27" aria-hidden="true" tabindex="-1"></a>        <span class="st">'include'</span>:includes</span>
<span id="cb2-28"><a href="#cb2-28" aria-hidden="true" tabindex="-1"></a>        }          </span>
<span id="cb2-29"><a href="#cb2-29" aria-hidden="true" tabindex="-1"></a>r <span class="op">=</span> requests.post(<span class="st">'https://clinicaltrialsapi.cancer.gov/api/v2/trials'</span>,</span>
<span id="cb2-30"><a href="#cb2-30" aria-hidden="true" tabindex="-1"></a>                  json <span class="op">=</span> active_treatment_trials_that_are_recruiting, headers<span class="op">=</span>cts_api_header)</span>
<span id="cb2-31"><a href="#cb2-31" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb2-32"><a href="#cb2-32" aria-hidden="true" tabindex="-1"></a>j <span class="op">=</span> r.json()   </span>
<span id="cb2-33"><a href="#cb2-33" aria-hidden="true" tabindex="-1"></a>diseases_df <span class="op">=</span> pd.DataFrame(j[<span class="st">'data'</span>][<span class="dv">0</span>][<span class="st">'diseases'</span>])</span>
<span id="cb2-34"><a href="#cb2-34" aria-hidden="true" tabindex="-1"></a>itables.show(diseases_df, column_filters<span class="op">=</span><span class="st">"header"</span>)</span>
<span id="cb2-35"><a href="#cb2-35" aria-hidden="true" tabindex="-1"></a>time.sleep(<span class="dv">2</span>)</span></code></pre></div><button title="Copy to Clipboard" class="code-copy-button"><i class="bi"></i></button></div>
</details>
<div class="cell-output cell-output-display">
<!--| quarto-html-table-processing: none -->
<table id="itables_66902701_d9a6_4df1_ba04_6ccbeceebde4"><tbody><tr>
    <td style="vertical-align:middle; text-align:left">
    <a href="https://mwouts.github.io/itables/"><svg class="main-svg" xmlns="http://www.w3.org/2000/svg" xlink="http://www.w3.org/1999/xlink" width="64" viewbox="0 0 500 400" style="font-family: 'Droid Sans', sans-serif;">
    <g style="fill:#d9d7fc">
        <path d="M100,400H500V357H100Z"></path>
        <path d="M100,300H400V257H100Z"></path>
        <path d="M0,200H400V157H0Z"></path>
        <path d="M100,100H500V57H100Z"></path>
        <path d="M100,350H500V307H100Z"></path>
        <path d="M100,250H400V207H100Z"></path>
        <path d="M0,150H400V107H0Z"></path>
        <path d="M100,50H500V7H100Z"></path>
    </g>
    <g style="fill:#1a1366;stroke:#1a1366;">
   <rect x="100" y="7" width="400" height="43">
    <animate attributename="width" values="0;400;0" dur="5s" repeatcount="indefinite"></animate>
      <animate attributename="x" values="100;100;500" dur="5s" repeatcount="indefinite"></animate>
  </rect>
        <rect x="0" y="107" width="400" height="43">
    <animate attributename="width" values="0;400;0" dur="3.5s" repeatcount="indefinite"></animate>
    <animate attributename="x" values="0;0;400" dur="3.5s" repeatcount="indefinite"></animate>
  </rect>
        <rect x="100" y="207" width="300" height="43">
    <animate attributename="width" values="0;300;0" dur="3s" repeatcount="indefinite"></animate>
    <animate attributename="x" values="100;100;400" dur="3s" repeatcount="indefinite"></animate>
  </rect>
        <rect x="100" y="307" width="400" height="43">
    <animate attributename="width" values="0;400;0" dur="4s" repeatcount="indefinite"></animate>
      <animate attributename="x" values="100;100;500" dur="4s" repeatcount="indefinite"></animate>
  </rect>
        <g style="fill:transparent;stroke-width:8; stroke-linejoin:round" rx="5">
            <g transform="translate(45 50) rotate(-45)">
                <circle r="33" cx="0" cy="0"></circle>
                <rect x="-8" y="32" width="16" height="30"></rect>
            </g>

            <g transform="translate(450 152)">
                <polyline points="-15,-20 -35,-20 -35,40 25,40 25,20"></polyline>
                <rect x="-15" y="-40" width="60" height="60"></rect>
            </g>

            <g transform="translate(50 352)">
                <polygon points="-35,-5 0,-40 35,-5"></polygon>
                <polygon points="-35,10 0,45 35,10"></polygon>
            </g>

            <g transform="translate(75 250)">
                <polyline points="-30,30 -60,0 -30,-30"></polyline>
                <polyline points="0,30 -30,0 0,-30"></polyline>
            </g>

            <g transform="translate(425 250) rotate(180)">
                <polyline points="-30,30 -60,0 -30,-30"></polyline>
                <polyline points="0,30 -30,0 0,-30"></polyline>
            </g>
        </g>
    </g>
</svg>
</a>
    Loading ITables v2.5.2 from the internet...
    (need <a href="https://mwouts.github.io/itables/troubleshooting.html">help</a>?)</td>
    </tr></tbody></table>
<link href="https://www.unpkg.com/dt_for_itables@2.4.0/dt_bundle.css" rel="stylesheet">
<script type="module">
    import { ITable, jQuery as $ } from 'https://www.unpkg.com/dt_for_itables@2.4.0/dt_bundle.js';

    document.querySelectorAll("#itables_66902701_d9a6_4df1_ba04_6ccbeceebde4:not(.dataTable)").forEach(table => {
        if (!(table instanceof HTMLTableElement))
            return;

        let dt_args = {"column_filters": "header", "layout": {"topStart": "pageLength", "topEnd": "search", "bottomStart": "info", "bottomEnd": "paging"}, "order": [], "style": {"table-layout": "auto", "width": "auto", "margin": "auto", "caption-side": "bottom"}, "classes": ["display", "nowrap"], "text_in_header_can_be_selected": true, "table_html": "<table><thead><th>inclusion_indicator</th><th>is_lead_disease</th><th>synonyms</th><th>nci_thesaurus_concept_id</th><th>name</th><th>type</th><th>parents</th></thead></table>", "data_json": "[[\"TRIAL\", true, \"[Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage I Breast Carcinoma AJCC v8]\", \"C139535\", \"Stage I Breast Cancer\", \"[stage]\", \"[C139533]\"], [\"TRIAL\", false, \"[Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage II Breast Carcinoma AJCC v8]\", \"C139538\", \"Stage II Breast Cancer\", \"[stage]\", \"[C139533]\"], [\"TRIAL\", false, \"[Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Carcinoma AJCC v8]\", \"C139542\", \"Stage IIIA Breast Cancer\", \"[stage]\", \"[C139541]\"], [\"TRIAL\", false, \"[Hormone Receptor Positive Breast Adenocarcinoma, Hormone Receptor-Positive Breast Carcinoma]\", \"C157056\", \"Hormone Receptor Positive Breast Carcinoma\", \"[subtype]\", \"[C5214]\"], [\"TRIAL\", false, \"[HER2 Negative Breast Adenocarcinoma, HER2-Negative Breast Carcinoma]\", \"C168519\", \"HER2 Negative Breast Carcinoma\", \"[subtype]\", \"[C5214]\"], [\"TREE\", true, \"[Condition, Diagnosis, Disease, Disease or Disorder, Disease or Disorder, Non-Neoplastic, disease term, disease type, disease_term, disease_type, Diseases, Diseases and Disorders, Disorder, Disorders]\", \"C2991\", \"Other Disease\", \"[maintype]\", \"[]\"], [\"TREE\", true, \"[Malignant Breast Tumor, Malignant Neoplasm of Breast, Malignant Neoplasm of the Breast, Malignant Tumor of Breast, Malignant Tumor of the Breast]\", \"C9335\", \"Malignant Breast Neoplasm\", \"[subtype]\", \"[C9305, C2910]\"], [\"TREE\", true, \"[Breast Carcinoma by AJCC v8 Anatomic Stage]\", \"C139533\", \"Breast Cancer by AJCC v8 Anatomic Stage\", \"[stage]\", \"[C139532]\"], [\"TREE\", true, \"[Tumor Morphology, Tumor_Morphology]\", \"C4741\", \"Neoplasm by Morphology\", \"[subtype]\", \"[C3262]\"], [\"TREE\", true, \"[Breast cancer, NOS, Breast Carcinoma, Cancer of Breast, Cancer of the Breast, Carcinoma of Breast, Carcinoma of the Breast, Mammary Carcinoma]\", \"C4872\", \"Breast Cancer\", \"[maintype]\", \"[C2916, C9335]\"], [\"TREE\", true, \"[Epithelial Neoplasms, NOS, Epithelioma, Epithelioma, malignant]\", \"C3709\", \"Epithelial Neoplasm\", \"[subtype]\", \"[C4741]\"], [\"TREE\", true, \"[]\", \"C7062\", \"Neoplasm by Special Category\", \"[subtype]\", \"[C3262]\"], [\"TREE\", true, \"[Neoplasia, Neoplasm, Neoplasm, NOS, Neoplasms, NOS, Neoplastic Disease, Neoplastic Growth, tumor, Tumor, NOS]\", \"C3262\", \"Other Neoplasm\", \"[maintype]\", \"[C2991]\"], [\"TREE\", true, \"[Breast Carcinoma by AJCC v8 Stage]\", \"C139532\", \"Breast Cancer by AJCC v8 Stage\", \"[stage]\", \"[C4872]\"], [\"TREE\", true, \"[Carcinoma, CARCINOMA, MALIGNANT, Carcinoma, NOS, Epithelial Carcinoma, Epithelial tumor, malignant, Epithelioma Malignant, Malignant Epithelial Neoplasm, Malignant Epithelial Tumor, Malignant Epithelioma]\", \"C2916\", \"Other Carcinoma\", \"[maintype]\", \"[C3709, C9305]\"], [\"TREE\", true, \"[Breast Disease, Breast Diseases]\", \"C26709\", \"Breast Disorder\", \"[subtype]\", \"[C27551]\"], [\"TREE\", true, \"[CA, Cancer, Malignancy, Malignant Growth, Malignant Neoplastic Disease, Malignant Tumor, Neoplasm, malignant, Tumor, malignant, NOS, Unclassified tumor, malignant]\", \"C9305\", \"Malignant Neoplasm\", \"[subtype]\", \"[C7062]\"], [\"TREE\", true, \"[]\", \"C7057\", \"Disease, Disorder or Finding\", \"[finding]\", \"[]\"], [\"TREE\", true, \"[Disease by Site]\", \"C27551\", \"Disorder by Site\", \"[subtype]\", \"[C2991]\"], [\"TREE\", true, \"[Breast Tumor, Neoplasm of Breast, Neoplasm of the Breast, Tumor of Breast, Tumor of the Breast]\", \"C2910\", \"Breast Neoplasm\", \"[subtype]\", \"[C3263, C26709]\"], [\"TREE\", true, \"[]\", \"C3263\", \"Neoplasm by Site\", \"[subtype]\", \"[C3262]\"], [\"TREE\", false, \"[Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage III Breast Carcinoma AJCC v8]\", \"C139541\", \"Stage III Breast Cancer\", \"[stage]\", \"[C139533]\"]]"};
        new ITable(table, dt_args);
    });
</script>
</div>
</div>
<p>TRIAL level diseases are those coded to the trial by clinical trial abstractors at NCI. TREE level diseases go â€˜upâ€™ the NCIt digraph.</p>
<p>Lead disease is/are the most focused trial level disease for the trial. Other trial level diseases are generally more broad or alternative matches.</p>
</section>
<section id="biomarkers" class="level2">
<h2 class="anchored" data-anchor-id="biomarkers">Biomarkers</h2>
<p>Biomarkers are abstracted as discrete data using NCIt codes. Biomarkers have been coded on new trials for a couple of years now â€“ older trials may not have them even if the trial calls has biomarkers as inclucsion/exclusion criteria.</p>
<p>As with diseases, the TREE terms go â€˜upâ€™ the NCIt digraph. Note that NCIt is a multiaxial hierarchy, and hence you may â‰¥ 1 parent node.</p>
<div id="fcf80d8f" class="cell" data-execution_count="3">
<details class="code-fold">
<summary>Code</summary>
<div class="code-copy-outer-scaffold"><div class="sourceCode cell-code" id="cb3"><pre class="sourceCode python code-with-copy"><code class="sourceCode python"><span id="cb3-1"><a href="#cb3-1" aria-hidden="true" tabindex="-1"></a><span class="im">import</span> requests</span>
<span id="cb3-2"><a href="#cb3-2" aria-hidden="true" tabindex="-1"></a><span class="im">import</span> sys</span>
<span id="cb3-3"><a href="#cb3-3" aria-hidden="true" tabindex="-1"></a><span class="im">import</span> json</span>
<span id="cb3-4"><a href="#cb3-4" aria-hidden="true" tabindex="-1"></a><span class="im">import</span> os</span>
<span id="cb3-5"><a href="#cb3-5" aria-hidden="true" tabindex="-1"></a><span class="im">import</span> pandas <span class="im">as</span> pd</span>
<span id="cb3-6"><a href="#cb3-6" aria-hidden="true" tabindex="-1"></a><span class="im">from</span> dotenv <span class="im">import</span> dotenv_values</span>
<span id="cb3-7"><a href="#cb3-7" aria-hidden="true" tabindex="-1"></a><span class="im">import</span> mercury <span class="im">as</span> mr</span>
<span id="cb3-8"><a href="#cb3-8" aria-hidden="true" tabindex="-1"></a><span class="im">import</span> itables</span>
<span id="cb3-9"><a href="#cb3-9" aria-hidden="true" tabindex="-1"></a><span class="im">import</span> time</span>
<span id="cb3-10"><a href="#cb3-10" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb3-11"><a href="#cb3-11" aria-hidden="true" tabindex="-1"></a>config <span class="op">=</span> dotenv_values(<span class="st">'.env'</span>)</span>
<span id="cb3-12"><a href="#cb3-12" aria-hidden="true" tabindex="-1"></a>CTS_API_KEY<span class="op">=</span>config[<span class="st">'CTS_API_KEY'</span>]</span>
<span id="cb3-13"><a href="#cb3-13" aria-hidden="true" tabindex="-1"></a>cts_api_header <span class="op">=</span> {<span class="st">"x-api-key"</span>: CTS_API_KEY,</span>
<span id="cb3-14"><a href="#cb3-14" aria-hidden="true" tabindex="-1"></a>                  <span class="st">"Content-Type"</span>: <span class="st">"application/json"</span>}</span>
<span id="cb3-15"><a href="#cb3-15" aria-hidden="true" tabindex="-1"></a>includes <span class="op">=</span> [<span class="st">'nct_id'</span>,</span>
<span id="cb3-16"><a href="#cb3-16" aria-hidden="true" tabindex="-1"></a>            <span class="st">'diseases'</span>,</span>
<span id="cb3-17"><a href="#cb3-17" aria-hidden="true" tabindex="-1"></a>            <span class="st">'biomarkers'</span>,</span>
<span id="cb3-18"><a href="#cb3-18" aria-hidden="true" tabindex="-1"></a>            <span class="st">'prior_therapy'</span>,</span>
<span id="cb3-19"><a href="#cb3-19" aria-hidden="true" tabindex="-1"></a>            <span class="st">'brief_title'</span></span>
<span id="cb3-20"><a href="#cb3-20" aria-hidden="true" tabindex="-1"></a>            ]</span>
<span id="cb3-21"><a href="#cb3-21" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb3-22"><a href="#cb3-22" aria-hidden="true" tabindex="-1"></a>active_treatment_trials_that_are_recruiting <span class="op">=</span> {<span class="st">'current_trial_status'</span>: <span class="st">'Active'</span>,</span>
<span id="cb3-23"><a href="#cb3-23" aria-hidden="true" tabindex="-1"></a>        <span class="st">'sites.recruitment_status'</span> : <span class="st">'ACTIVE'</span>,</span>
<span id="cb3-24"><a href="#cb3-24" aria-hidden="true" tabindex="-1"></a>        <span class="st">'primary_purpose'</span>: <span class="st">'TREATMENT'</span>,</span>
<span id="cb3-25"><a href="#cb3-25" aria-hidden="true" tabindex="-1"></a>        <span class="st">'size'</span>:<span class="dv">1</span>,</span>
<span id="cb3-26"><a href="#cb3-26" aria-hidden="true" tabindex="-1"></a>        <span class="st">'from'</span>:<span class="dv">0</span>,</span>
<span id="cb3-27"><a href="#cb3-27" aria-hidden="true" tabindex="-1"></a>        <span class="st">'include'</span>:includes</span>
<span id="cb3-28"><a href="#cb3-28" aria-hidden="true" tabindex="-1"></a>        }          </span>
<span id="cb3-29"><a href="#cb3-29" aria-hidden="true" tabindex="-1"></a>r <span class="op">=</span> requests.post(<span class="st">'https://clinicaltrialsapi.cancer.gov/api/v2/trials'</span>,</span>
<span id="cb3-30"><a href="#cb3-30" aria-hidden="true" tabindex="-1"></a>                  json <span class="op">=</span> active_treatment_trials_that_are_recruiting, headers<span class="op">=</span>cts_api_header)</span>
<span id="cb3-31"><a href="#cb3-31" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb3-32"><a href="#cb3-32" aria-hidden="true" tabindex="-1"></a>j <span class="op">=</span> r.json()   </span>
<span id="cb3-33"><a href="#cb3-33" aria-hidden="true" tabindex="-1"></a>biomarkers_df <span class="op">=</span> pd.DataFrame(j[<span class="st">'data'</span>][<span class="dv">0</span>][<span class="st">'biomarkers'</span>])</span>
<span id="cb3-34"><a href="#cb3-34" aria-hidden="true" tabindex="-1"></a>itables.show(biomarkers_df, column_filters<span class="op">=</span><span class="st">"header"</span>,</span>
<span id="cb3-35"><a href="#cb3-35" aria-hidden="true" tabindex="-1"></a> buttons<span class="op">=</span>[<span class="st">"pageLength"</span>, <span class="st">"copyHtml5"</span>, <span class="st">"csvHtml5"</span>, <span class="st">"excelHtml5"</span>])</span>
<span id="cb3-36"><a href="#cb3-36" aria-hidden="true" tabindex="-1"></a>time.sleep(<span class="dv">2</span>)</span></code></pre></div><button title="Copy to Clipboard" class="code-copy-button"><i class="bi"></i></button></div>
</details>
<div class="cell-output cell-output-display">
<!--| quarto-html-table-processing: none -->
<table id="itables_482c450e_3183_434d_9aa9_ff034a935e63"><tbody><tr>
    <td style="vertical-align:middle; text-align:left">
    <a href="https://mwouts.github.io/itables/"><svg class="main-svg" xmlns="http://www.w3.org/2000/svg" xlink="http://www.w3.org/1999/xlink" width="64" viewbox="0 0 500 400" style="font-family: 'Droid Sans', sans-serif;">
    <g style="fill:#d9d7fc">
        <path d="M100,400H500V357H100Z"></path>
        <path d="M100,300H400V257H100Z"></path>
        <path d="M0,200H400V157H0Z"></path>
        <path d="M100,100H500V57H100Z"></path>
        <path d="M100,350H500V307H100Z"></path>
        <path d="M100,250H400V207H100Z"></path>
        <path d="M0,150H400V107H0Z"></path>
        <path d="M100,50H500V7H100Z"></path>
    </g>
    <g style="fill:#1a1366;stroke:#1a1366;">
   <rect x="100" y="7" width="400" height="43">
    <animate attributename="width" values="0;400;0" dur="5s" repeatcount="indefinite"></animate>
      <animate attributename="x" values="100;100;500" dur="5s" repeatcount="indefinite"></animate>
  </rect>
        <rect x="0" y="107" width="400" height="43">
    <animate attributename="width" values="0;400;0" dur="3.5s" repeatcount="indefinite"></animate>
    <animate attributename="x" values="0;0;400" dur="3.5s" repeatcount="indefinite"></animate>
  </rect>
        <rect x="100" y="207" width="300" height="43">
    <animate attributename="width" values="0;300;0" dur="3s" repeatcount="indefinite"></animate>
    <animate attributename="x" values="100;100;400" dur="3s" repeatcount="indefinite"></animate>
  </rect>
        <rect x="100" y="307" width="400" height="43">
    <animate attributename="width" values="0;400;0" dur="4s" repeatcount="indefinite"></animate>
      <animate attributename="x" values="100;100;500" dur="4s" repeatcount="indefinite"></animate>
  </rect>
        <g style="fill:transparent;stroke-width:8; stroke-linejoin:round" rx="5">
            <g transform="translate(45 50) rotate(-45)">
                <circle r="33" cx="0" cy="0"></circle>
                <rect x="-8" y="32" width="16" height="30"></rect>
            </g>

            <g transform="translate(450 152)">
                <polyline points="-15,-20 -35,-20 -35,40 25,40 25,20"></polyline>
                <rect x="-15" y="-40" width="60" height="60"></rect>
            </g>

            <g transform="translate(50 352)">
                <polygon points="-35,-5 0,-40 35,-5"></polygon>
                <polygon points="-35,10 0,45 35,10"></polygon>
            </g>

            <g transform="translate(75 250)">
                <polyline points="-30,30 -60,0 -30,-30"></polyline>
                <polyline points="0,30 -30,0 0,-30"></polyline>
            </g>

            <g transform="translate(425 250) rotate(180)">
                <polyline points="-30,30 -60,0 -30,-30"></polyline>
                <polyline points="0,30 -30,0 0,-30"></polyline>
            </g>
        </g>
    </g>
</svg>
</a>
    Loading ITables v2.5.2 from the internet...
    (need <a href="https://mwouts.github.io/itables/troubleshooting.html">help</a>?)</td>
    </tr></tbody></table>
<link href="https://www.unpkg.com/dt_for_itables@2.4.0/dt_bundle.css" rel="stylesheet">
<script type="module">
    import { ITable, jQuery as $ } from 'https://www.unpkg.com/dt_for_itables@2.4.0/dt_bundle.js';

    document.querySelectorAll("#itables_482c450e_3183_434d_9aa9_ff034a935e63:not(.dataTable)").forEach(table => {
        if (!(table instanceof HTMLTableElement))
            return;

        let dt_args = {"column_filters": "header", "buttons": ["pageLength", "copyHtml5", "csvHtml5", "excelHtml5"], "layout": {"topStart": "buttons", "topEnd": "search", "bottomStart": "info", "bottomEnd": "paging"}, "order": [], "style": {"table-layout": "auto", "width": "auto", "margin": "auto", "caption-side": "bottom"}, "classes": ["display", "nowrap"], "text_in_header_can_be_selected": true, "table_html": "<table><thead><th>eligibility_criterion</th><th>inclusion_indicator</th><th>synonyms</th><th>nci_thesaurus_concept_id</th><th>name</th><th>semantic_types</th><th>type</th><th>ancestors</th><th>parents</th><th>assay_purpose</th></thead></table>", "data_json": "[[\"inclusion\", \"TREE\", \"[Observable Entity]\", \"C3367\", \"Finding\", \"[Finding]\", \"[branch]\", \"[]\", \"[]\", \"Eligibility Criterion - Inclusion\"], [\"inclusion\", \"TREE\", \"[ER, ESR1, Estrogen Receptor 1 Gene]\", \"C38349\", \"ESR1 Gene\", \"[Gene or Genome]\", \"[reference_gene]\", \"[C20103, C20420, C16612, C21295, C54362, C20709]\", \"[C20709]\", \"Eligibility Criterion - Inclusion\"], [\"inclusion\", \"TREE\", \"[]\", \"C54362\", \"Transcription Regulation Gene\", \"[Gene or Genome]\", \"[]\", \"[C16612]\", \"[C16612]\", \"Eligibility Criterion - Inclusion\"], [\"inclusion\", \"TREE\", \"[RTK Family Gene]\", \"C20719\", \"Receptor Tyrosine Kinase Gene\", \"[Gene or Genome]\", \"[]\", \"[C25870, C25872, C21295, C20103, C25871, C16612, C21281]\", \"[C20103, C25872]\", \"Eligibility Criterion - Inclusion\"], [\"inclusion\", \"TREE\", \"[LAB_RESULT, Lab Findings, Lab Value, Laboratory Finding, Laboratory Report, Labs, Test Result, test_result]\", \"C36292\", \"Laboratory Test Result\", \"[Laboratory or Test Result]\", \"[]\", \"[C3367, C77140]\", \"[C77140]\", \"Eligibility Criterion - Inclusion\"], [\"inclusion\", \"TREE\", \"[Genes]\", \"C16612\", \"Gene\", \"[Gene or Genome]\", \"[branch]\", \"[]\", \"[]\", \"Eligibility Criterion - Inclusion\"], [\"inclusion\", \"TREE\", \"[Proto-Oncogene, Transcription Factor]\", \"C20420\", \"Transcription Factor Gene\", \"[Gene or Genome]\", \"[]\", \"[C16612, C54362]\", \"[C54362]\", \"Eligibility Criterion - Inclusion\"], [\"inclusion\", \"TREE\", \"[Positive, positive test result]\", \"C35682\", \"Positive Laboratory Test Result\", \"[Laboratory or Test Result]\", \"[]\", \"[C36292, C3367, C77140]\", \"[C36292]\", \"Eligibility Criterion - Inclusion\"], [\"inclusion\", \"TREE\", \"[PgR Status, Progesterone Receptor]\", \"C16149\", \"Progesterone Receptor Status\", \"[Laboratory or Test Result]\", \"[]\", \"[C188928, C3367, C36292, C20709, C20420, C20103, C77140, C16612, C54362, C94299, C28656, C21295]\", \"[C188928, C28656]\", \"Eligibility Criterion - Inclusion\"], [\"inclusion\", \"TREE\", \"[]\", \"C20103\", \"Receptor Gene\", \"[Gene or Genome]\", \"[]\", \"[C21295, C16612]\", \"[C21295]\", \"Eligibility Criterion - Inclusion\"], [\"inclusion\", \"TRIAL\", \"[ERBB2 Negative, HER-2 Negative, HER2 Negative]\", \"C68749\", \"HER2/Neu Negative\", \"[Laboratory or Test Result]\", \"[]\", \"[C36292, C35681, C25870, C25871, C20103, C16152, C165233, C16612, C77140, C3367, C21295, C17756, C25872, C21281, C20719, C94299]\", \"[C16152, C165233, C17756]\", \"Eligibility Criterion - Inclusion\"], [\"inclusion\", \"TREE\", \"[ERBB2, Erb-b2 Receptor Tyrosine Kinase 2 Gene, HER2, HER2/Neu, NEU]\", \"C17756\", \"ERBB2 Gene\", \"[Gene or Genome]\", \"[reference_gene]\", \"[C20103, C20719, C21281, C16612, C21295, C25870, C25871, C25872]\", \"[C20719]\", \"Eligibility Criterion - Inclusion\"], [\"inclusion\", \"TREE\", \"[]\", \"C25872\", \"Kinase Family Gene\", \"[Gene or Genome]\", \"[]\", \"[C25871, C16612, C21281, C25870]\", \"[C25871]\", \"Eligibility Criterion - Inclusion\"], [\"inclusion\", \"TREE\", \"[]\", \"C21295\", \"Ligand Binding Protein Gene\", \"[Gene or Genome]\", \"[]\", \"[C16612]\", \"[C16612]\", \"Eligibility Criterion - Inclusion\"], [\"inclusion\", \"TREE\", \"[PGR, PR, Progesterone Receptor Gene]\", \"C28656\", \"PGR Gene\", \"[Gene or Genome]\", \"[reference_gene]\", \"[C20709, C20420, C16612, C54362, C20103, C21295]\", \"[C20709]\", \"Eligibility Criterion - Inclusion\"], [\"inclusion\", \"TREE\", \"[]\", \"C94299\", \"Receptor Status\", \"[Laboratory or Test Result]\", \"[]\", \"[C77140, C36292, C3367]\", \"[C36292]\", \"Eligibility Criterion - Inclusion\"], [\"inclusion\", \"TREE\", \"[Absent, LOST, Loss of Expression, Negative, Not Expressed]\", \"C165233\", \"Expression Negative\", \"[Cell or Molecular Dysfunction]\", \"[]\", \"[C77140, C3367, C35681]\", \"[C35681]\", \"Eligibility Criterion - Inclusion\"], [\"inclusion\", \"TREE\", \"[Expressed, Expression Detected]\", \"C177692\", \"Expression Positive\", \"[Laboratory or Test Result]\", \"[]\", \"[C35682, C77140, C36292, C3367]\", \"[C35682]\", \"Eligibility Criterion - Inclusion\"], [\"inclusion\", \"TREE\", \"[ERBB2 Status, Her2/Neu Value]\", \"C16152\", \"HER2/Neu Status\", \"[Laboratory or Test Result]\", \"[]\", \"[C36292, C25870, C25871, C20103, C16612, C77140, C3367, C21295, C17756, C25872, C21281, C20719, C94299]\", \"[C17756, C94299]\", \"Eligibility Criterion - Inclusion\"], [\"inclusion\", \"TREE\", \"[HR Status]\", \"C188928\", \"Hormone Receptor Status\", \"[Laboratory or Test Result]\", \"[]\", \"[C94299, C77140, C3367, C36292]\", \"[C94299]\", \"Eligibility Criterion - Inclusion\"], [\"inclusion\", \"TREE\", \"[]\", \"C25871\", \"Phosphotransferase Gene\", \"[Gene or Genome]\", \"[]\", \"[C16612, C21281, C25870]\", \"[C25870]\", \"Eligibility Criterion - Inclusion\"], [\"inclusion\", \"TREE\", \"[Negative]\", \"C35681\", \"Negative Test Result\", \"[Finding]\", \"[]\", \"[C77140, C3367]\", \"[C77140]\", \"Eligibility Criterion - Inclusion\"], [\"inclusion\", \"TREE\", \"[]\", \"C21281\", \"Enzyme Gene\", \"[Gene or Genome]\", \"[]\", \"[C16612]\", \"[C16612]\", \"Eligibility Criterion - Inclusion\"], [\"inclusion\", \"TREE\", \"[]\", \"C25870\", \"Transferase Gene\", \"[Gene or Genome]\", \"[]\", \"[C16612, C21281]\", \"[C21281]\", \"Eligibility Criterion - Inclusion\"], [\"inclusion\", \"TRIAL\", \"[PGR Positive, PR Positive, PR+, Positive]\", \"C15496\", \"Progesterone Receptor Positive\", \"[Laboratory or Test Result]\", \"[]\", \"[C35682, C38349, C101267, C36292, C188928, C20420, C20103, C77140, C16612, C177692, C21295, C54362, C20709, C28656, C16149, C94299, C3367]\", \"[C101267, C16149, C28656]\", \"Eligibility Criterion - Inclusion\"], [\"inclusion\", \"TREE\", \"[ER Alpha Status, ER Status, ER-Alpha Status, ERA Status, ESR Status, ESR1 Status, ESRA Status, ESTRR Status, Estrogen Receptor, Estrogen Receptor 1 Status, Estrogen Receptor Alpha Status, NR3A1 Status, Nuclear Receptor Subfamily 3 Group A Member 1 Status]\", \"C16150\", \"Estrogen Receptor Status\", \"[Laboratory or Test Result]\", \"[]\", \"[C188928, C16612, C20709, C54362, C21295, C20420, C38349, C36292, C77140, C20103, C94299, C3367]\", \"[C188928, C38349]\", \"Eligibility Criterion - Inclusion\"], [\"inclusion\", \"TRIAL\", \"[ER Alpha Positive, ER Positive, ER+, ER-Alpha Positive, ERA Positive, ESR Positive, ESR1 Positive, ESRA Positive, ESTRR Positive, Estrogen Receptor 1 Positive, Estrogen Receptor Alpha Positive, NR3A1 Positive, Nuclear Receptor Subfamily 3 Group A Member 1 Positive, Positive, Positive Estrogen Receptor]\", \"C15492\", \"Estrogen Receptor Positive\", \"[Laboratory or Test Result]\", \"[]\", \"[C35682, C38349, C20103, C36292, C188928, C20420, C16612, C77140, C101267, C177692, C21295, C54362, C28656, C20709, C16150, C94299, C3367]\", \"[C101267, C16150, C38349]\", \"Eligibility Criterion - Inclusion\"], [\"inclusion\", \"TREE\", \"[Clinical Measurement, Diagnostic Test Result]\", \"C77140\", \"Clinical Test Result\", \"[Finding]\", \"[]\", \"[C3367]\", \"[C3367]\", \"Eligibility Criterion - Inclusion\"], [\"inclusion\", \"TREE\", \"[]\", \"C20709\", \"Nuclear Receptor Gene\", \"[Gene or Genome]\", \"[]\", \"[C20420, C16612, C54362, C20103, C21295]\", \"[C20103, C20420]\", \"Eligibility Criterion - Inclusion\"], [\"inclusion\", \"TREE\", \"[]\", \"C101267\", \"Hormone Receptor Positive\", \"[Laboratory or Test Result]\", \"[]\", \"[C35682, C38349, C36292, C188928, C20420, C94299, C77140, C16612, C177692, C21295, C54362, C28656, C20709, C20103, C3367]\", \"[C177692, C188928, C28656, C38349]\", \"Eligibility Criterion - Inclusion\"]]"};
        new ITable(table, dt_args);
    });
</script>
</div>
</div>
</section>
<section id="retrieving-a-trial-by-nct_id-that-has-prior-therapy-records" class="level2">
<h2 class="anchored" data-anchor-id="retrieving-a-trial-by-nct_id-that-has-prior-therapy-records">Retrieving a trial by NCT_ID that has prior therapy records</h2>
<p>The trial NCT02914405 contains prior therapy terms</p>
<div id="3be6980f" class="cell" data-execution_count="4">
<details class="code-fold">
<summary>Code</summary>
<div class="code-copy-outer-scaffold"><div class="sourceCode cell-code" id="cb4"><pre class="sourceCode python code-with-copy"><code class="sourceCode python"><span id="cb4-1"><a href="#cb4-1" aria-hidden="true" tabindex="-1"></a><span class="im">import</span> requests</span>
<span id="cb4-2"><a href="#cb4-2" aria-hidden="true" tabindex="-1"></a><span class="im">import</span> sys</span>
<span id="cb4-3"><a href="#cb4-3" aria-hidden="true" tabindex="-1"></a><span class="im">import</span> json</span>
<span id="cb4-4"><a href="#cb4-4" aria-hidden="true" tabindex="-1"></a><span class="im">import</span> os</span>
<span id="cb4-5"><a href="#cb4-5" aria-hidden="true" tabindex="-1"></a><span class="im">import</span> pandas <span class="im">as</span> pd</span>
<span id="cb4-6"><a href="#cb4-6" aria-hidden="true" tabindex="-1"></a><span class="im">from</span> dotenv <span class="im">import</span> dotenv_values</span>
<span id="cb4-7"><a href="#cb4-7" aria-hidden="true" tabindex="-1"></a><span class="im">import</span> mercury <span class="im">as</span> mr</span>
<span id="cb4-8"><a href="#cb4-8" aria-hidden="true" tabindex="-1"></a><span class="im">import</span> itables</span>
<span id="cb4-9"><a href="#cb4-9" aria-hidden="true" tabindex="-1"></a><span class="im">import</span> time</span>
<span id="cb4-10"><a href="#cb4-10" aria-hidden="true" tabindex="-1"></a><span class="im">import</span> networkx <span class="im">as</span> nx</span>
<span id="cb4-11"><a href="#cb4-11" aria-hidden="true" tabindex="-1"></a><span class="im">import</span> graphviz</span>
<span id="cb4-12"><a href="#cb4-12" aria-hidden="true" tabindex="-1"></a><span class="im">import</span> matplotlib.pyplot <span class="im">as</span> plt</span>
<span id="cb4-13"><a href="#cb4-13" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb4-14"><a href="#cb4-14" aria-hidden="true" tabindex="-1"></a>plt.clf()</span>
<span id="cb4-15"><a href="#cb4-15" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb4-16"><a href="#cb4-16" aria-hidden="true" tabindex="-1"></a>config <span class="op">=</span> dotenv_values(<span class="st">'.env'</span>)</span>
<span id="cb4-17"><a href="#cb4-17" aria-hidden="true" tabindex="-1"></a>CTS_API_KEY<span class="op">=</span>config[<span class="st">'CTS_API_KEY'</span>]</span>
<span id="cb4-18"><a href="#cb4-18" aria-hidden="true" tabindex="-1"></a>cts_api_header <span class="op">=</span> {<span class="st">"x-api-key"</span>: CTS_API_KEY,</span>
<span id="cb4-19"><a href="#cb4-19" aria-hidden="true" tabindex="-1"></a>                  <span class="st">"Content-Type"</span>: <span class="st">"application/json"</span>}</span>
<span id="cb4-20"><a href="#cb4-20" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb4-21"><a href="#cb4-21" aria-hidden="true" tabindex="-1"></a><span class="co"># No 'includes' so get everything </span></span>
<span id="cb4-22"><a href="#cb4-22" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb4-23"><a href="#cb4-23" aria-hidden="true" tabindex="-1"></a>trial_ids <span class="op">=</span> {</span>
<span id="cb4-24"><a href="#cb4-24" aria-hidden="true" tabindex="-1"></a>        <span class="st">'nct_id'</span>: [<span class="st">'NCT02914405'</span>]</span>
<span id="cb4-25"><a href="#cb4-25" aria-hidden="true" tabindex="-1"></a>        }          </span>
<span id="cb4-26"><a href="#cb4-26" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb4-27"><a href="#cb4-27" aria-hidden="true" tabindex="-1"></a>r <span class="op">=</span> requests.post(<span class="st">'https://clinicaltrialsapi.cancer.gov/api/v2/trials'</span>,</span>
<span id="cb4-28"><a href="#cb4-28" aria-hidden="true" tabindex="-1"></a>                  json <span class="op">=</span> trial_ids, headers<span class="op">=</span>cts_api_header)</span>
<span id="cb4-29"><a href="#cb4-29" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb4-30"><a href="#cb4-30" aria-hidden="true" tabindex="-1"></a>j <span class="op">=</span> r.json()  </span>
<span id="cb4-31"><a href="#cb4-31" aria-hidden="true" tabindex="-1"></a>mr.JSON(j) </span>
<span id="cb4-32"><a href="#cb4-32" aria-hidden="true" tabindex="-1"></a>time.sleep(<span class="dv">2</span>)</span>
<span id="cb4-33"><a href="#cb4-33" aria-hidden="true" tabindex="-1"></a>prior_therapy_df <span class="op">=</span> pd.DataFrame(j[<span class="st">'data'</span>][<span class="dv">0</span>][<span class="st">'prior_therapy'</span>])</span>
<span id="cb4-34"><a href="#cb4-34" aria-hidden="true" tabindex="-1"></a>itables.show(prior_therapy_df, column_filters<span class="op">=</span><span class="st">"header"</span>,</span>
<span id="cb4-35"><a href="#cb4-35" aria-hidden="true" tabindex="-1"></a> buttons<span class="op">=</span>[<span class="st">"pageLength"</span>, <span class="st">"copyHtml5"</span>, <span class="st">"csvHtml5"</span>, <span class="st">"excelHtml5"</span>])</span>
<span id="cb4-36"><a href="#cb4-36" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb4-37"><a href="#cb4-37" aria-hidden="true" tabindex="-1"></a><span class="co"># Now set up the graph for display</span></span>
<span id="cb4-38"><a href="#cb4-38" aria-hidden="true" tabindex="-1"></a><span class="co"># set node </span></span>
<span id="cb4-39"><a href="#cb4-39" aria-hidden="true" tabindex="-1"></a>node_label_dict <span class="op">=</span> {}</span>
<span id="cb4-40"><a href="#cb4-40" aria-hidden="true" tabindex="-1"></a>node_color_dict <span class="op">=</span> {}</span>
<span id="cb4-41"><a href="#cb4-41" aria-hidden="true" tabindex="-1"></a>node_size_dict <span class="op">=</span> {}</span>
<span id="cb4-42"><a href="#cb4-42" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb4-43"><a href="#cb4-43" aria-hidden="true" tabindex="-1"></a>G <span class="op">=</span> nx.DiGraph()</span>
<span id="cb4-44"><a href="#cb4-44" aria-hidden="true" tabindex="-1"></a>prior_therapy_df[<span class="st">'node_label'</span>] <span class="op">=</span>  prior_therapy_df[<span class="st">'nci_thesaurus_concept_id'</span>] <span class="op">+</span> <span class="st">'</span><span class="ch">\n</span><span class="st">'</span><span class="op">+</span> prior_therapy_df[<span class="st">'name'</span>]</span>
<span id="cb4-45"><a href="#cb4-45" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb4-46"><a href="#cb4-46" aria-hidden="true" tabindex="-1"></a>trial_pt_df <span class="op">=</span> prior_therapy_df[prior_therapy_df[<span class="st">'inclusion_indicator'</span>] <span class="op">==</span> <span class="st">'TRIAL'</span>]</span>
<span id="cb4-47"><a href="#cb4-47" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb4-48"><a href="#cb4-48" aria-hidden="true" tabindex="-1"></a><span class="cf">for</span> index, pt <span class="kw">in</span> prior_therapy_df.iterrows():</span>
<span id="cb4-49"><a href="#cb4-49" aria-hidden="true" tabindex="-1"></a>    node_label_dict[<span class="bu">str</span>(pt[<span class="st">'nci_thesaurus_concept_id'</span>])] <span class="op">=</span> <span class="bu">str</span>(pt[<span class="st">'node_label'</span>])</span>
<span id="cb4-50"><a href="#cb4-50" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb4-51"><a href="#cb4-51" aria-hidden="true" tabindex="-1"></a>    <span class="cf">if</span> <span class="bu">str</span>(pt[<span class="st">'inclusion_indicator'</span>]) <span class="op">==</span> <span class="st">'TRIAL'</span>:</span>
<span id="cb4-52"><a href="#cb4-52" aria-hidden="true" tabindex="-1"></a>        node_color_dict[<span class="bu">str</span>(pt[<span class="st">'nci_thesaurus_concept_id'</span>])]  <span class="op">=</span> <span class="st">'green'</span></span>
<span id="cb4-53"><a href="#cb4-53" aria-hidden="true" tabindex="-1"></a>        node_size_dict[<span class="bu">str</span>(pt[<span class="st">'nci_thesaurus_concept_id'</span>])]  <span class="op">=</span> <span class="dv">1000</span></span>
<span id="cb4-54"><a href="#cb4-54" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb4-55"><a href="#cb4-55" aria-hidden="true" tabindex="-1"></a>    <span class="cf">else</span>:</span>
<span id="cb4-56"><a href="#cb4-56" aria-hidden="true" tabindex="-1"></a>        node_color_dict[<span class="bu">str</span>(pt[<span class="st">'nci_thesaurus_concept_id'</span>])] <span class="op">=</span> <span class="st">'yellow'</span>  </span>
<span id="cb4-57"><a href="#cb4-57" aria-hidden="true" tabindex="-1"></a>        node_size_dict[<span class="bu">str</span>(pt[<span class="st">'nci_thesaurus_concept_id'</span>])]  <span class="op">=</span> <span class="dv">500</span></span>
<span id="cb4-58"><a href="#cb4-58" aria-hidden="true" tabindex="-1"></a>  </span>
<span id="cb4-59"><a href="#cb4-59" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb4-60"><a href="#cb4-60" aria-hidden="true" tabindex="-1"></a>    G.add_node(<span class="bu">str</span>(pt[<span class="st">'nci_thesaurus_concept_id'</span>]))</span>
<span id="cb4-61"><a href="#cb4-61" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb4-62"><a href="#cb4-62" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb4-63"><a href="#cb4-63" aria-hidden="true" tabindex="-1"></a>    <span class="cf">for</span> p <span class="kw">in</span> pt[<span class="st">'parents'</span>]:</span>
<span id="cb4-64"><a href="#cb4-64" aria-hidden="true" tabindex="-1"></a>        <span class="co">#print('adding edge ',str(pt['nci_thesaurus_concept_id']), str(p) )</span></span>
<span id="cb4-65"><a href="#cb4-65" aria-hidden="true" tabindex="-1"></a>        G.add_edge(<span class="bu">str</span>(pt[<span class="st">'nci_thesaurus_concept_id'</span>]), <span class="bu">str</span>(p))</span>
<span id="cb4-66"><a href="#cb4-66" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb4-67"><a href="#cb4-67" aria-hidden="true" tabindex="-1"></a>color_list <span class="op">=</span> []</span>
<span id="cb4-68"><a href="#cb4-68" aria-hidden="true" tabindex="-1"></a>node_size_list <span class="op">=</span> []</span>
<span id="cb4-69"><a href="#cb4-69" aria-hidden="true" tabindex="-1"></a><span class="cf">for</span> node <span class="kw">in</span> G:</span>
<span id="cb4-70"><a href="#cb4-70" aria-hidden="true" tabindex="-1"></a>    color_list.append(node_color_dict[node])</span>
<span id="cb4-71"><a href="#cb4-71" aria-hidden="true" tabindex="-1"></a>    node_size_list.append(node_size_dict[node])</span>
<span id="cb4-72"><a href="#cb4-72" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb4-73"><a href="#cb4-73" aria-hidden="true" tabindex="-1"></a>pos <span class="op">=</span> nx.nx_pydot.graphviz_layout(G, prog<span class="op">=</span><span class="st">"dot"</span>)</span>
<span id="cb4-74"><a href="#cb4-74" aria-hidden="true" tabindex="-1"></a><span class="co">#pos = nx.spring_layout(G, k=20.0)</span></span>
<span id="cb4-75"><a href="#cb4-75" aria-hidden="true" tabindex="-1"></a>plt.clf()</span>
<span id="cb4-76"><a href="#cb4-76" aria-hidden="true" tabindex="-1"></a>fig <span class="op">=</span> plt.gcf()</span>
<span id="cb4-77"><a href="#cb4-77" aria-hidden="true" tabindex="-1"></a>fig.set_size_inches(<span class="dv">12</span>,<span class="dv">12</span>)</span>
<span id="cb4-78"><a href="#cb4-78" aria-hidden="true" tabindex="-1"></a>nx.draw(G, with_labels<span class="op">=</span><span class="va">True</span>,</span>
<span id="cb4-79"><a href="#cb4-79" aria-hidden="true" tabindex="-1"></a>            labels <span class="op">=</span> node_label_dict,</span>
<span id="cb4-80"><a href="#cb4-80" aria-hidden="true" tabindex="-1"></a>            node_color <span class="op">=</span> color_list,</span>
<span id="cb4-81"><a href="#cb4-81" aria-hidden="true" tabindex="-1"></a>            node_size <span class="op">=</span> node_size_list)</span>
<span id="cb4-82"><a href="#cb4-82" aria-hidden="true" tabindex="-1"></a>plt.show()</span>
<span id="cb4-83"><a href="#cb4-83" aria-hidden="true" tabindex="-1"></a>plt.savefig(<span class="st">'prior_therapy_example.pdf'</span>,dpi<span class="op">=</span><span class="dv">300</span>, <span class="bu">format</span> <span class="op">=</span> <span class="st">'pdf'</span> ) </span></code></pre></div><button title="Copy to Clipboard" class="code-copy-button"><i class="bi"></i></button></div>
</details>
<div class="cell-output cell-output-display">
<style>.renderjson a              { text-decoration: none; }
.renderjson .disclosure    { color: grey; font-size: 125%; }
.renderjson .syntax        { color: grey; }
.renderjson .string        { color: #fe46a5; }
.renderjson .number        { color: #0f9b8e; }
.renderjson .boolean       { color: black; }
.renderjson .key           { color: #2684ff; }
.renderjson .keyword       { color: gray; }
.renderjson .object.syntax { color: gray; }
.renderjson .array.syntax  { color: gray; }</style><div id="a2e5ea1a-fdec-4809-b5b9-40375481b1d2"></div>
</div>
<div class="cell-output cell-output-display">
<script>var renderjson=function(){var t=function(){for(var t=[];arguments.length;)t.push(n(s(Array.prototype.shift.call(arguments)),o(Array.prototype.shift.call(arguments))));return t},n=function(){for(var t=Array.prototype.shift.call(arguments),e=0;e<arguments.length;e++)arguments[e].constructor==Array?n.apply(this,[t].concat(arguments[e])):t.appendChild(arguments[e]);return t},e=function(t,n){return t.insertBefore(n,t.firstChild),t},r=function(t,n){var e=n||Object.keys(t);for(var r in e)if(Object.hasOwnProperty.call(t,e[r]))return!1;return!0},o=function(t){return document.createTextNode(t)},s=function(t){var n=document.createElement("span");return t&&(n.className=t),n},l=function(t,n,e){var r=document.createElement("a");return n&&(r.className=n),r.appendChild(o(t)),r.href="#",r.onclick=function(t){return e(),t&&t.stopPropagation(),!1},r};function a(i,c,u,p,y){var _=u?"":c,f=function(r,a,i,c,u){var f,g=s(c),h=function(){f||n(g.parentNode,f=e(u(),l(y.hide,"disclosure",(function(){f.style.display="none",g.style.display="inline"})))),f.style.display="inline",g.style.display="none"};n(g,l(y.show,"disclosure",h),t(c+" syntax",r),l(a,null,h),t(c+" syntax",i));var d=n(s(),o(_.slice(0,-1)),g);return p>0&&"string"!=c&&h(),d};return null===i?t(null,_,"keyword","null"):void 0===i?t(null,_,"keyword","undefined"):"string"==typeof i&&i.length>y.max_string_length?f('"',i.substr(0,y.max_string_length)+" ...",'"',"string",(function(){return n(s("string"),t(null,_,"string",JSON.stringify(i)))})):"object"!=typeof i||[Number,String,Boolean,Date].indexOf(i.constructor)>=0?t(null,_,typeof i,JSON.stringify(i)):i.constructor==Array?0==i.length?t(null,_,"array syntax","[]"):f("[",y.collapse_msg(i.length),"]","array",(function(){for(var e=n(s("array"),t("array syntax","[",null,"\n")),r=0;r<i.length;r++)n(e,a(y.replacer.call(i,r,i[r]),c+"    ",!1,p-1,y),r!=i.length-1?t("syntax",","):[],o("\n"));return n(e,t(null,c,"array syntax","]")),e})):r(i,y.property_list)?t(null,_,"object syntax","{}"):f("{",y.collapse_msg(Object.keys(i).length),"}","object",(function(){var e=n(s("object"),t("object syntax","{",null,"\n"));for(var r in i)var l=r;var u=y.property_list||Object.keys(i);for(var _ in y.sort_objects&&(u=u.sort()),u){(r=u[_])in i&&n(e,t(null,c+"    ","key",'"'+r+'"',"object syntax",": "),a(y.replacer.call(i,r,i[r]),c+"    ",!0,p-1,y),r!=l?t("syntax",","):[],o("\n"))}return n(e,t(null,c,"object syntax","}")),e}))}var i=function t(e){var r=new Object(t.options);r.replacer="function"==typeof r.replacer?r.replacer:function(t,n){return n};var o=n(document.createElement("pre"),a(e,"",!1,r.show_to_level,r));return o.className="renderjson",o};return i.set_icons=function(t,n){return i.options.show=t,i.options.hide=n,i},i.set_show_to_level=function(t){return i.options.show_to_level="string"==typeof t&&"all"===t.toLowerCase()?Number.MAX_VALUE:t,i},i.set_max_string_length=function(t){return i.options.max_string_length="string"==typeof t&&"none"===t.toLowerCase()?Number.MAX_VALUE:t,i},i.set_sort_objects=function(t){return i.options.sort_objects=t,i},i.set_replacer=function(t){return i.options.replacer=t,i},i.set_collapse_msg=function(t){return i.options.collapse_msg=t,i},i.set_property_list=function(t){return i.options.property_list=t,i},i.set_show_by_default=function(t){return i.options.show_to_level=t?Number.MAX_VALUE:0,i},i.options={},i.set_icons("âŠ•","âŠ–"),i.set_show_by_default(!1),i.set_sort_objects(!1),i.set_max_string_length("none"),i.set_replacer(void 0),i.set_property_list(void 0),i.set_collapse_msg((function(t){return t+" item"+(1==t?"":"s")})),i}(); renderjson.set_show_to_level(1); document.getElementById("a2e5ea1a-fdec-4809-b5b9-40375481b1d2").appendChild(renderjson({"total": 1, "data": [{"other_ids": [{"name": "Study Protocol Other Identifier", "value": "2016-002221-11"}], "amendment_date": null, "keywords": ["131-I-mIBG therapy", "ch14.18/CHO", "Nivolumab", "MiniVan"], "dcp_id": null, "interventional_model": "Single Group", "lead_org": "Southampton General Hospital", "eligibility": {"unstructured": [{"inclusion_indicator": true, "display_order": 0, "description": "At study entry patients must be > 1 year"}, {"inclusion_indicator": true, "display_order": 1, "description": "Relapsed or refractory high risk neuroblastoma (as defined by International Neuroblastoma Risk Group (INRG) criteria)"}, {"inclusion_indicator": true, "display_order": 2, "description": "MIBG avid disease on imaging within 4 weeks to study entry."}, {"inclusion_indicator": true, "display_order": 3, "description": "\u2265 3 months since any myeloablative chemotherapy / stem cell rescue"}, {"inclusion_indicator": true, "display_order": 4, "description": "\u2265 42 days since any other immunotherapy e.g. tumour vaccines. At least 3 half lives since last dose of any monoclonal antibody therapy."}, {"inclusion_indicator": true, "display_order": 5, "description": "Patients must have a performance status greater or equal 60% (Lansky Score or Karnofsky)"}, {"inclusion_indicator": true, "display_order": 6, "description": "Estimated life expectancy \u2265 12 weeks"}, {"inclusion_indicator": true, "display_order": 7, "description": "Adequate bone marrow function: Absolute Neutrophil Count (ANC) >1.0 x 10/L, platelets, 20 x 10/L and haemoglobin > 8.0 g/dL."}, {"inclusion_indicator": true, "display_order": 8, "description": "Adequate renal function: serum creatinine <1.5 mg/dL or a estimated creatinine clearance or radioisotope Glomerular Filtration Rate Study (GFR) of > 60 mL/minute/1.73m2."}, {"inclusion_indicator": true, "display_order": 9, "description": "Adequate cardiac function: shortening fraction of 28 % by echocardiogram."}, {"inclusion_indicator": true, "display_order": 10, "description": "Adequate hepatic function: Alanine transaminase (ALT) or Aspartate transaminase (AST) < 5 x ULN and a total bilirubin < 1.5 x Upper Limit of Normal (ULN)"}, {"inclusion_indicator": true, "display_order": 11, "description": "Adequate lung function: Forced Expiratory Volume in 1 Second (FEV1) and Forced Vital Capacity (FVC) >60% of the predicted by pulmonary function tests. Children unable to do Pulmonary Function Tests (PFTs) should have no dyspnea at rest and a pulse oximetry >94% on room air."}, {"inclusion_indicator": true, "display_order": 12, "description": "Adequate pancreatic function: serum lipase < 1.5 x upper limit normal"}, {"inclusion_indicator": true, "display_order": 13, "description": "Patients may have had prior Central Nervous System (CNS) metastasis at point of entry to study, but patients with mIBG avid parenchymal brain lesions will be excluded. All CNS disease must be treated and stable prior for at least 4 weeks prior to starting trial 131-I mIBG therapy (see section 4). Patients with extra-axial disease (e.g. skull (bone) metastasis that do not invade the dura) may be enrolled providing there is no evidence of brain oedema."}, {"inclusion_indicator": true, "display_order": 14, "description": "Patients must consent to the placement of a central venous line, if one has not already been placed."}, {"inclusion_indicator": true, "display_order": 15, "description": "Patients must have no immediate requirements for palliative chemotherapy, radiotherapy or surgery."}, {"inclusion_indicator": true, "display_order": 16, "description": "Females of childbearing potential must have a negative pregnancy test. Patients of childbearing potential must agree to use an effective birth control method. Female patients who are lactating must agree to stop breast-feeding."}, {"inclusion_indicator": true, "display_order": 17, "description": "Patients with seizure disorders may be enrolled if seizures are well controlled."}, {"inclusion_indicator": true, "display_order": 18, "description": "All patients and/or their parents or legal guardians must sign a written informed consent"}, {"inclusion_indicator": true, "display_order": 19, "description": "All institutional and national requirements for clinical trials must be met."}, {"inclusion_indicator": true, "display_order": 20, "description": "Expression of PD-L1 by tumour is not a pre-requisite"}, {"inclusion_indicator": true, "display_order": 21, "description": "Parents or carers willing and able to comply with radiation safety measures needed for 131-I mIBG administration."}, {"inclusion_indicator": true, "display_order": 22, "description": "Patient must be judged capable of tolerating isolation procedures associated with 131-I-mIBG therapy"}, {"inclusion_indicator": false, "display_order": 23, "description": "Patients who have previously received ch14.18 (CHO or SP2/0) will not be excluded unless they have had severe or life threatening toxicity necessitating withdrawal of treatment previously or if they have a strong/neutralizing Human Antichimeric Antibody (HACA) (\u2265 10 \u03bcg/ml)"}, {"inclusion_indicator": false, "display_order": 24, "description": "Patients who have had previous 131-I mIBG therapy will not be excluded"}, {"inclusion_indicator": false, "display_order": 25, "description": "Patients previously treated with Nivolumab or any other PD-1 or PD-L1 targeting antibodies will be excluded from the study"}, {"inclusion_indicator": false, "display_order": 26, "description": "Previous allogeneic stem cell transplant or solid organ transplant"}, {"inclusion_indicator": false, "display_order": 27, "description": "Patients should be excluded if they have an active, known or suspected autoimmune disease. Subjects are permitted to enroll if they have vitiligo, type I diabetes mellitus, residual hypothyroidism due to autoimmune condition only requiring hormone replacement, psoriasis not requiring systemic treatment, or conditions not expected to recur in the absence of an external trigger"}, {"inclusion_indicator": false, "display_order": 28, "description": "Patients receiving systemic corticosteroids (other than physiological replacement) or other immunosuppressive agents within 14 days prior to study entry"}, {"inclusion_indicator": false, "display_order": 29, "description": "Unable to maintain platelets \u2265 50 x 109/l without transfusion"}, {"inclusion_indicator": false, "display_order": 30, "description": "HIV or Hepatitis B or C infection"}, {"inclusion_indicator": false, "display_order": 31, "description": "Patients with significant intercurrent illnesses and/or any of the following:"}, {"inclusion_indicator": false, "display_order": 32, "description": "Patients with symptoms of congestive heart failure or uncontrolled cardiac rhythm disturbance."}, {"inclusion_indicator": false, "display_order": 33, "description": "Patients with significant psychiatric disabilities or uncontrolled seizure disorders."}, {"inclusion_indicator": false, "display_order": 34, "description": "Patients with active infections."}, {"inclusion_indicator": false, "display_order": 35, "description": "Patients with a clinically significant neurologic deficit or objective peripheral neuropathy (Grade >2) are ineligible."}, {"inclusion_indicator": false, "display_order": 36, "description": "Patients with clinically significant, symptomatic, pleural effusions."}, {"inclusion_indicator": false, "display_order": 37, "description": "Patients who require, or are likely to require, corticosteroid or other immunosuppressive drugs."}], "structured": {"max_age": "99 Years", "max_age_number": 99.0, "min_age_unit": "Years", "max_age_unit": "Years", "max_age_in_years": 99.0, "sex": "ALL", "accepts_healthy_volunteers": true, "min_age": "1 Years", "min_age_number": 1.0, "min_age_in_years": 1.0}}, "sites": [{"org_state_or_province": "WI", "contact_name": "Kenneth Brian De Santes", "contact_phone": null, "recruitment_status_date": "2024-06-28", "org_address_line_2": null, "org_va": false, "org_address_line_1": "4621 Eastpark Boulevard", "org_tty": null, "org_family": "University of Wisconsin Carbone Cancer Center", "org_postal_code": "53718", "contact_email": "kbdesantes@pediatrics.wisc.edu", "recruitment_status": "ACTIVE", "org_city": "Madison", "org_email": "clinicaltrials@cancer.wisc.edu", "org_country": "United States", "org_fax": null, "org_phone": "(800)-622-8922", "org_name": "University of Wisconsin Carbone Cancer Center - Eastpark Medical Center", "org_coordinates": {"lon": -89.2692, "lat": 43.108}}, {"org_state_or_province": "WI", "contact_name": null, "contact_phone": null, "recruitment_status_date": "2024-06-28", "org_address_line_2": null, "org_va": false, "org_address_line_1": "600 Highland Avenue", "org_tty": null, "org_family": "University of Wisconsin Carbone Cancer Center", "org_postal_code": "53792", "contact_email": null, "recruitment_status": "ACTIVE", "org_city": "Madison", "org_email": "clinicaltrials@cancer.wisc.edu", "org_country": "United States", "org_fax": null, "org_phone": "608-262-5223", "org_name": "University of Wisconsin Carbone Cancer Center - University Hospital", "org_coordinates": {"lon": -89.4329, "lat": 43.0769}}], "completion_date_type_code": "ANTICIPATED", "detail_description": null, "official_title": "A Phase I Study of 131-1 MIBG Followed by Nivolumab and Dinutuximab Beta in Children with Relapsed/refractory Neuroblastoma", "_phase_sort_order": 4, "collaborators": [{"name": "Joining Against Cancer in Kids", "functional_role": "LABORATORY"}, {"name": "Solving Kids' Cancer US/EU", "functional_role": "LABORATORY"}, {"name": "The Band of Parents", "functional_role": "LABORATORY"}, {"name": "University College London Hospitals", "functional_role": "LABORATORY"}, {"name": "University Hospital Greifswald", "functional_role": "LABORATORY"}, {"name": "University of Wisconsin Carbone Cancer Center - University Hospital", "functional_role": "LABORATORY"}], "associated_studies": [], "outcome_measures": [{"timeframe": "2 Years", "name": "Anti-tumour response in patients with measureable disease as measured by immunocytology, MIBG, CT and/or MRI in patients receiving 131-I-MIBG, ch14.18/CHO and Nivolumab in patients with relapsed and refractory high risk neuroblastoma", "description": "To document any evidence of efficacy of 131-I-MIBG, ch14.18/CHO and Nivolumab in patients\r\nwith relapsed and refractory high risk neuroblastoma (objective response rate)", "type_code": "SECONDARY"}, {"timeframe": "2 Years", "name": "Anti-tumour response in patients with measureable disease as measured by immunocytology, MIBG, CT and/or MRI in patients receiving 131-I-MIBG, ch14.18/CHO and Nivolumab in patients with relapsed and refractory high risk neuroblastoma", "description": "To document any evidence of efficacy of 131-I-MIBG, ch14.18/CHO and Nivolumab in patients\r\nwith relapsed and refractory high risk neuroblastoma (time to progression)", "type_code": "SECONDARY"}, {"timeframe": "2 Years", "name": "Incidence of Treatment-Emergent Adverse Events [Safety and tolerability] of 131-I-MIBG, ch14.18/CHO and Nivolumab in paediatric patients", "description": "\u2022 To determine the safety and tolerability of the novel combination of 131-I-MIBG,\r\nch14.18/CHO and Nivolumab in paediatric patients, assessed by nature, frequency, severity\r\nand timing of adverse events, including serious adverse events and immune related adverse\r\nevents during administration of ch14.18/CHO", "type_code": "PRIMARY"}, {"timeframe": "2 Years", "name": "KIR/KIR-Ligand genotype, Fc\u03b3R genotype", "description": "To provide descriptive analysis of any associations between KIR/KIR-Ligand genotype, Fc\u03b3R\r\ngenotype and response", "type_code": "SECONDARY"}], "phase": "I", "central_contact": {"phone": null, "name": null, "type": null, "email": null}, "primary_purpose": "TREATMENT", "number_of_arms": 1, "_study_protocol_type_sort_order": 0, "nct_id": "NCT02914405", "biomarkers": [], "classification_code": null, "current_trial_status_date": "2024-12-05", "diseases": [{"inclusion_indicator": "TRIAL", "is_lead_disease": false, "synonyms": [], "nci_thesaurus_concept_id": "C134153", "name": "Refractory Neuroblastoma", "type": ["subtype"], "parents": ["C3270", "C173565"]}, {"inclusion_indicator": "TRIAL", "is_lead_disease": true, "synonyms": ["High Risk Neuroblastoma"], "nci_thesaurus_concept_id": "C150281", "name": "High-Risk Neuroblastoma", "type": ["subtype"], "parents": ["C3270"]}, {"inclusion_indicator": "TRIAL", "is_lead_disease": false, "synonyms": ["Relapsed Neuroblastoma"], "nci_thesaurus_concept_id": "C7837", "name": "Recurrent Neuroblastoma", "type": ["stage"], "parents": ["C3270", "C27295", "C182030"]}, {"inclusion_indicator": "TREE", "is_lead_disease": true, "synonyms": ["embryonal tumor"], "nci_thesaurus_concept_id": "C3264", "name": "Embryonal Neoplasm", "type": ["maintype"], "parents": ["C7062"]}, {"inclusion_indicator": "TREE", "is_lead_disease": true, "synonyms": [], "nci_thesaurus_concept_id": "C7062", "name": "Neoplasm by Special Category", "type": ["subtype"], "parents": ["C3262"]}, {"inclusion_indicator": "TREE", "is_lead_disease": true, "synonyms": [], "nci_thesaurus_concept_id": "C7057", "name": "Disease, Disorder or Finding", "type": ["finding"], "parents": []}, {"inclusion_indicator": "TREE", "is_lead_disease": true, "synonyms": ["Neoplasia", "Neoplasm", "Neoplasm, NOS", "Neoplasms, NOS", "Neoplastic Disease", "Neoplastic Growth", "tumor", "Tumor, NOS"], "nci_thesaurus_concept_id": "C3262", "name": "Other Neoplasm", "type": ["maintype"], "parents": ["C2991"]}, {"inclusion_indicator": "TREE", "is_lead_disease": true, "synonyms": ["Condition", "Diagnosis", "Disease", "Disease or Disorder", "Disease or Disorder, Non-Neoplastic", "disease term", "disease type", "disease_term", "disease_type", "Diseases", "Diseases and Disorders", "Disorder", "Disorders"], "nci_thesaurus_concept_id": "C2991", "name": "Other Disease", "type": ["maintype"], "parents": []}, {"inclusion_indicator": "TREE", "is_lead_disease": true, "synonyms": ["Malignant Neoplasm of Nervous System", "Malignant Neoplasm of the Nervous System", "Malignant Nervous System Tumor", "Malignant Tumor of Nervous System", "Malignant Tumor of the Nervous System", "Nervous System Neoplasms, Malignant"], "nci_thesaurus_concept_id": "C4788", "name": "Malignant Nervous System Neoplasm", "type": ["subtype"], "parents": ["C3268", "C9305"]}, {"inclusion_indicator": "TREE", "is_lead_disease": true, "synonyms": [], "nci_thesaurus_concept_id": "C3263", "name": "Neoplasm by Site", "type": ["subtype"], "parents": ["C3262"]}, {"inclusion_indicator": "TREE", "is_lead_disease": true, "synonyms": ["CA", "Cancer", "Malignancy", "Malignant Growth", "Malignant Neoplastic Disease", "Malignant Tumor", "Neoplasm, malignant", "Tumor, malignant, NOS", "Unclassified tumor, malignant"], "nci_thesaurus_concept_id": "C9305", "name": "Malignant Neoplasm", "type": ["subtype"], "parents": ["C7062"]}, {"inclusion_indicator": "TREE", "is_lead_disease": true, "synonyms": ["Neural Crest Tumor, Malignant", "Neuroblastoma (NBL)", "Neuroblastoma (Schwannian Stroma-Poor)", "NEUROBLASTOMA, MALIGNANT", "Neuroblastoma, NOS"], "nci_thesaurus_concept_id": "C3270", "name": "Neuroblastoma", "type": ["maintype", "subtype"], "parents": ["C6963"]}, {"inclusion_indicator": "TREE", "is_lead_disease": true, "synonyms": ["Neuroectodermal Neoplasm", "Neuroectodermal Tumor", "Neuroepithelioma", "PNET", "PNET, NOS", "Primitive Neuroectodermal Neoplasm", "Primitive Neuroectodermal Tumor", "Primitive neuroectodermal tumor, NOS"], "nci_thesaurus_concept_id": "C3716", "name": "Primitive Neuroectodermal Tumor (PNET)", "type": ["maintype", "subtype"], "parents": ["C3264", "C9305"]}, {"inclusion_indicator": "TREE", "is_lead_disease": true, "synonyms": ["Disorder of Nervous System", "Neurologic Disorder", "Neurological Disorder", "Unspecified Nervous System Problem"], "nci_thesaurus_concept_id": "C26835", "name": "Nervous System Disorder", "type": ["subtype"], "parents": ["C27551"]}, {"inclusion_indicator": "TREE", "is_lead_disease": true, "synonyms": ["Disease by Site"], "nci_thesaurus_concept_id": "C27551", "name": "Disorder by Site", "type": ["subtype"], "parents": ["C2991"]}, {"inclusion_indicator": "TREE", "is_lead_disease": true, "synonyms": ["Neoplasm of Nervous System", "Neoplasm of the Nervous System", "Nervous System Neoplasm", "Nervous System Neoplasms", "Nervous System Tumour", "Tumor of Nervous System", "Tumor of the Nervous System"], "nci_thesaurus_concept_id": "C3268", "name": "Nervous System Tumor", "type": ["maintype"], "parents": ["C3263", "C26835"]}, {"inclusion_indicator": "TREE", "is_lead_disease": true, "synonyms": [], "nci_thesaurus_concept_id": "C6963", "name": "Neuroblastic Tumor", "type": ["subtype"], "parents": ["C3716", "C4788"]}, {"inclusion_indicator": "TREE", "is_lead_disease": false, "synonyms": ["Neoplasm Recurrence", "Recurrence", "Recurrent", "Recurrent Tumor"], "nci_thesaurus_concept_id": "C4798", "name": "Recurrent Neoplasm", "type": ["stage"], "parents": ["C7062"]}, {"inclusion_indicator": "TREE", "is_lead_disease": false, "synonyms": ["clinical resistance", "Refractory Cancer", "resistant cancer"], "nci_thesaurus_concept_id": "C120186", "name": "Refractory Malignant Neoplasm", "type": ["subtype"], "parents": ["C7628", "C9305"]}, {"inclusion_indicator": "TREE", "is_lead_disease": false, "synonyms": ["Refractory Tumor"], "nci_thesaurus_concept_id": "C7628", "name": "Refractory Neoplasm", "type": ["subtype"], "parents": ["C7062"]}, {"inclusion_indicator": "TREE", "is_lead_disease": false, "synonyms": [], "nci_thesaurus_concept_id": "C27295", "name": "Recurrent Primitive Neuroectodermal Tumor", "type": ["stage"], "parents": ["C3716", "C4813"]}, {"inclusion_indicator": "TREE", "is_lead_disease": false, "synonyms": [], "nci_thesaurus_concept_id": "C173565", "name": "Refractory Primitive Neuroectodermal Tumor", "type": ["subtype"], "parents": ["C3716", "C120186"]}, {"inclusion_indicator": "TREE", "is_lead_disease": false, "synonyms": [], "nci_thesaurus_concept_id": "C182030", "name": "Recurrent Nervous System Neoplasm", "type": ["stage"], "parents": ["C3268", "C4798"]}, {"inclusion_indicator": "TREE", "is_lead_disease": false, "synonyms": ["Recurrence", "Recurrent Cancer", "Recurrent Malignant Tumor"], "nci_thesaurus_concept_id": "C4813", "name": "Recurrent Malignant Neoplasm", "type": ["stage"], "parents": ["C4798", "C9305"]}], "_primary_purpose_sort_order": 0, "protocol_id": "RHM CHI0811", "active_sites_count": 2, "lead_org_cancer_center": null, "arms": [{"interventions": [{"inclusion_indicator": "TREE", "synonyms": ["Anti-GD-2 Monoclonal Antibody"], "nci_thesaurus_concept_id": "C155653", "name": "Anti-GD2 Monoclonal Antibody", "description": null, "type": "Biological/Vaccine", "category": "agent category", "parents": ["C20401", "C129822"]}, {"inclusion_indicator": "TREE", "synonyms": ["Pharmaceuticals", "Pharmacologic Agent", "Pharmacological Substance", "Pharmaceutical Agent", "Drug Substance", "Drug", "Agent"], "nci_thesaurus_concept_id": "C1909", "name": "Pharmacologic Substance", "description": null, "type": "Biological/Vaccine", "category": "agent category", "parents": ["C1908"]}, {"inclusion_indicator": "TREE", "synonyms": [], "nci_thesaurus_concept_id": "C141144", "name": "Immune Checkpoint Modulator", "description": null, "type": "Biological/Vaccine", "category": "agent category", "parents": ["C308"]}, {"inclusion_indicator": "TRIAL", "synonyms": ["Opdivo"], "nci_thesaurus_concept_id": "C68814", "name": "Nivolumab", "description": "A fully human monoclonal antibody directed against  the  negative immunoregulatory human cell surface receptor PD-1 (programmed death-1 or programmed cell death-1/PCD-1) with immunopotentiation activity.  Nivolumab binds to and blocks the activation of PD-1, an Ig superfamily transmembrane protein, by its ligands PD-L1 and PD-L2, resulting in the activation of T-cells and cell-mediated  immune responses against tumor cells or pathogens. Activated PD-1 negatively regulates T-cell activation and effector function through the suppression of P13k/Akt pathway activation.  Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)Health professional", "type": "Biological/Vaccine", "category": "agent", "parents": ["C128037", "C129822"]}, {"inclusion_indicator": "TRIAL", "synonyms": ["Unituxin", "Qarziba"], "nci_thesaurus_concept_id": "C1570", "name": "Dinutuximab", "description": "A chimeric mouse/human monoclonal antibody with potential antineoplastic activity. Dinutuximab  binds to the ganglioside GD2 and induces antibody-dependent cell-mediated cytotoxicity and complement-dependent cytotoxicity against GD2-expressing tumor cells.  GD2 is overexpressed in malignant melanoma, neuroblastoma, osteosarcoma, and small cell carcinoma of the lung. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)Health professional", "type": "Biological/Vaccine", "category": "agent", "parents": ["C155653"]}, {"inclusion_indicator": "TREE", "synonyms": ["Programmed Cell Death Protein 1 Inhibitor", "PD-1-targeting Agent", "PD-1 Inhibitor", "Protein PD-1 Inhibitor", "Anti-PD-1 Agent"], "nci_thesaurus_concept_id": "C124946", "name": "PD1 Inhibitor", "description": null, "type": "Biological/Vaccine", "category": "agent category", "parents": ["C143250"]}, {"inclusion_indicator": "TREE", "synonyms": ["Anti-cancer Biological Agent", "Antineoplastic Biological", "Antineoplastic Biotherapeutic", "Anticancer Biological"], "nci_thesaurus_concept_id": "C129821", "name": "Antineoplastic Biological Agent", "description": null, "type": "Biological/Vaccine", "category": "agent category", "parents": ["C307", "C274"]}, {"inclusion_indicator": "TREE", "synonyms": ["Anti-PD-1 Monoclonal Antibody"], "nci_thesaurus_concept_id": "C128037", "name": "Anti-PD1 Monoclonal Antibody", "description": null, "type": "Biological/Vaccine", "category": "agent category", "parents": ["C20401", "C124946"]}, {"inclusion_indicator": "TREE", "synonyms": ["Anti-Cancer Agents", "Anti-Tumor Agents", "Antiproliferative Drugs", "Chemotherapeutic Agents, Neoplastic Disease", "Antineoplastics", "Anti-Tumor Drugs", "Tumor-Specific Treatment Agents", "Cancer Drug", "Antineoplastic Drugs", "Antiproliferative Agents"], "nci_thesaurus_concept_id": "C274", "name": "Antineoplastic Agent", "description": null, "type": "Biological/Vaccine", "category": "agent category", "parents": ["C1909"]}, {"inclusion_indicator": "TREE", "synonyms": [], "nci_thesaurus_concept_id": "C1908", "name": "Drug, Food, Chemical or Biomedical Material", "description": null, "type": "Biological/Vaccine", "category": "agent category", "parents": []}, {"inclusion_indicator": "TREE", "synonyms": [], "nci_thesaurus_concept_id": "C143250", "name": "Immune Checkpoint Inhibitor", "description": null, "type": "Biological/Vaccine", "category": "agent category", "parents": ["C141144"]}, {"inclusion_indicator": "TREE", "synonyms": ["Monoclonal Antibodies", "Monoclonal Antibody"], "nci_thesaurus_concept_id": "C20401", "name": "Monoclonal Antibody Therapy", "description": null, "type": "Biological/Vaccine", "category": "agent category", "parents": ["C307", "C308"]}, {"inclusion_indicator": "TREE", "synonyms": ["Anti-cancer Antibody", "Anticancer Antibody", "Antineoplastic Ab"], "nci_thesaurus_concept_id": "C129822", "name": "Antineoplastic Antibody", "description": null, "type": "Biological/Vaccine", "category": "agent category", "parents": ["C129821"]}, {"inclusion_indicator": "TREE", "synonyms": ["Immunologics", "Biopharmaceuticals", "Biologicals", "Biologics", "Immunologic, Immunochemical", "Biological Products"], "nci_thesaurus_concept_id": "C307", "name": "Biological Agent", "description": null, "type": "Biological/Vaccine", "category": "agent category", "parents": ["C1909"]}, {"inclusion_indicator": "TREE", "synonyms": ["Immunomodulating Agent", "Immune Modulators", "Immune Mediators", "Immunotherapeutic Agent", "Biomodulators", "Immunopotentiators", "Immunomodulatory Agent", "BRM", "Immunomodulators", "Immune Regulators", "Biological Response Modifier", "Immunotherapy Agent"], "nci_thesaurus_concept_id": "C308", "name": "Immunotherapy", "description": null, "type": "Biological/Vaccine", "category": "agent category", "parents": ["C1909"]}], "name": "Arm not specified", "description": null, "type": null}, {"interventions": [], "name": "Treatment", "description": "The dose and schedule of 131-I mIBG will be constant, and the doses of ch14.18/ CHO and\r\nNivolumab determined by cohort:\r\n\r\n  -  Cohort I: 3 mg/kg Nivolumab (100% adult dose). No ch14.18/CHO. (3-6 patients)\r\n\r\n  -  Cohort II: 50mg/m2/cycle ch14.18/CHO (50% established Long Term Intervention (LTI)\r\n     dose) and 3 mg/kg Nivolumab (100% adult dose) (3-6 patients)\r\n\r\n  -  Cohort III: 100mg/m2/cycle ch14.18/CHO (100% established LTI dose) and 3 mg/kg\r\n     Nivolumab (100% adult dose) (initial 3-6 patients, expanded to 15 patient cohort if\r\n     tolerated)", "type": "EXPERIMENTAL"}], "study_model_code": null, "nci_id": "NCI-2019-08425", "why_study_stopped": null, "brief_summary": "Neuroblastoma, the most common extra-cranial solid tumour in children, remains one of the\r\nmajor challenges in paediatric oncology. A promising way to further improve outcome in\r\nthis disease appears to be the development of adjuvant therapeutic strategies. In this\r\nresearch the anti-GD2 antibody, which is a standard treatment, is to be combined with\r\n131-l Metaiodobenzylguanidine (mlBG) and anti-Programmed Cell Death Protein 1 (anti-PD1)\r\nantibody Nivolumab - the investigated drugs - with the aim of generating sustained\r\nanti-neuroblastoma immunity. In particular it will be determined the safety and\r\ntolerability of the novel combination as well as documented any evidence of efficacy in\r\npaediatric patients with relapsed and refractory high risk neuroblastoma.\r\n\r\nThis study is sponsored by the University Hospital Southampton and will take place in 4\r\nhospitals in the United Kingdom, Germany and USA. The estimated duration of the study is\r\n2 years, starting in December 2016.\r\n\r\nThis is an \"adaptive study\". Such design uses accumulating of data from the ongoing trial\r\nto modify aspects of the study (e.g. duration, number of treatments) without undermining\r\nits validity or integrity. There will be 3 cohorts of patients. As safety of Nivolumab is\r\nwell established, Cohort 1 will assess its safety and tolerability in combination with\r\n131-l mlBG. Cohort 2 will then add anti-GD2 to the drug combination, assessing safety and\r\ntolerability. Cohort 3 will escalate all 3 agents to the full 100% dose level to assure\r\nsafety for expanded analyses of clinical and laboratory data at that dose level.\r\n\r\nPatients will initially be recruited into Cohort 1. Patients must have completed at least\r\n12 weeks of trial treatment without reaching a Dose Limiting Toxicity before a patient\r\ncan be recruited to the next cohort.\r\n\r\nA minimum of 3 evaluable patients will be treated in cohorts 1-3. Assuming the full dose\r\ncombination therapy (cohort) is tolerable, 15 evaluable patients will be treated.", "brief_title": "Phase I Study of 131-I MIBG Followed by Nivolumab & Dinutuximab Beta Antibodies in Children with Relapsed/refractory Neuroblastoma", "status_history": [{"status_date": "2024-12-05T00:00:00.000001", "status": "CLOSED_TO_ACCRUAL"}, {"status_date": "2018-05-24T00:00:00", "status": "ACTIVE"}], "study_population_description": null, "sampling_method_code": null, "minimum_target_accrual_number": 44, "prior_therapy": [{"eligibility_criterion": "exclusion", "inclusion_indicator": "TRIAL", "synonyms": ["ABP 206", "BCD-263", "BMS 936558", "BMS-936558", "BMS936558", "CMAB819", "MDX 1106", "MDX-1106", "MDX1106", "NIVO", "Nivolumab Biosimilar ABP 206", "Nivolumab Biosimilar BCD-263", "Nivolumab Biosimilar CMAB819", "ONO 4538", "ONO-4538", "ONO4538", "Opdivo"], "nci_thesaurus_concept_id": "C68814", "name": "Nivolumab", "semantic_types": ["Amino Acid, Peptide, or Protein", "Immunologic Factor", "Pharmacologic Substance"], "branch": "Drug, Food, Chemical or Biomedical Material", "ancestor_ids": ["C124946", "C128037", "C129821", "C129822", "C141144", "C143250", "C1908", "C1909", "C20401", "C274", "C307", "C308"], "parents": ["C128037", "C129822"]}, {"eligibility_criterion": "exclusion", "inclusion_indicator": "TRIAL", "synonyms": ["Allogeneic", "Allogeneic Hematopoietic Cell Transplantation", "Allogeneic Stem Cell Transplantation", "HSC", "HSCT", "Stem Cell Transplantation, Allogeneic"], "nci_thesaurus_concept_id": "C46089", "name": "Allogeneic Hematopoietic Stem Cell Transplantation", "semantic_types": ["Therapeutic or Preventive Procedure"], "branch": "Activity", "ancestor_ids": ["C15329", "C15342", "C15388", "C15431", "C16203", "C165194", "C201922", "C25218", "C43431", "C49165", "C49236"], "parents": ["C15431"]}, {"eligibility_criterion": "exclusion", "inclusion_indicator": "TRIAL", "synonyms": [], "nci_thesaurus_concept_id": "C191377", "name": "Solid Organ Transplantation", "semantic_types": ["Therapeutic or Preventive Procedure"], "branch": "Activity", "ancestor_ids": ["C15289", "C15329", "C15342", "C16203", "C201922", "C25218", "C43431", "C49163", "C49165", "C49236", "C64982"], "parents": ["C15289"]}, {"eligibility_criterion": "exclusion", "inclusion_indicator": "TRIAL", "synonyms": [], "nci_thesaurus_concept_id": "C128057", "name": "Anti-PD-L1 Monoclonal Antibody", "semantic_types": ["Chemical Viewed Functionally", "Pharmacologic Substance"], "branch": "Drug, Food, Chemical or Biomedical Material", "ancestor_ids": ["C141144", "C143250", "C156893", "C1908", "C1909", "C191689", "C20401", "C307", "C308"], "parents": ["C191689", "C20401"]}, {"eligibility_criterion": "exclusion", "inclusion_indicator": "TRIAL", "synonyms": ["Anti-PD-1 Monoclonal Antibody"], "nci_thesaurus_concept_id": "C128037", "name": "Anti-PD1 Monoclonal Antibody", "semantic_types": ["Chemical Viewed Structurally", "Pharmacologic Substance"], "branch": "Drug, Food, Chemical or Biomedical Material", "ancestor_ids": ["C124946", "C141144", "C143250", "C1908", "C1909", "C20401", "C307", "C308"], "parents": ["C124946", "C20401"]}, {"eligibility_criterion": "exclusion", "inclusion_indicator": "TREE", "synonyms": ["Anti-cancer Biological Agent", "Anticancer Biological", "Antineoplastic Biological", "Antineoplastic Biotherapeutic"], "nci_thesaurus_concept_id": "C129821", "name": "Antineoplastic Biological Agent", "semantic_types": ["Pharmacologic Substance"], "branch": "Drug, Food, Chemical or Biomedical Material", "ancestor_ids": ["C1908", "C1909", "C274", "C307"], "parents": ["C274", "C307"]}, {"eligibility_criterion": "exclusion", "inclusion_indicator": "TREE", "synonyms": ["Stem Cell Treatment"], "nci_thesaurus_concept_id": "C165194", "name": "Stem Cell Therapy", "semantic_types": ["Therapeutic or Preventive Procedure"], "branch": "Activity", "ancestor_ids": ["C16203", "C25218", "C43431", "C49236"], "parents": ["C49236"]}, {"eligibility_criterion": "exclusion", "inclusion_indicator": "TREE", "synonyms": [], "nci_thesaurus_concept_id": "C49163", "name": "Surgical Procedure by Site or System", "semantic_types": ["Classification"], "branch": "Activity", "ancestor_ids": ["C15329", "C16203", "C25218", "C43431"], "parents": ["C15329"]}, {"eligibility_criterion": "exclusion", "inclusion_indicator": "TREE", "synonyms": ["Anti-cancer Antibody", "Anticancer Antibody", "Antineoplastic Ab"], "nci_thesaurus_concept_id": "C129822", "name": "Antineoplastic Antibody", "semantic_types": ["Pharmacologic Substance"], "branch": "Drug, Food, Chemical or Biomedical Material", "ancestor_ids": ["C129821", "C1908", "C1909", "C274", "C307"], "parents": ["C129821"]}, {"eligibility_criterion": "exclusion", "inclusion_indicator": "TREE", "synonyms": ["MAb", "MoAB", "Monoclonal Antibodies", "Monoclonal Antibody"], "nci_thesaurus_concept_id": "C20401", "name": "Monoclonal Antibody Therapy", "semantic_types": ["Amino Acid, Peptide, or Protein"], "branch": "Drug, Food, Chemical or Biomedical Material", "ancestor_ids": ["C1908", "C1909", "C307", "C308"], "parents": ["C307", "C308"]}, {"eligibility_criterion": "exclusion", "inclusion_indicator": "TREE", "synonyms": ["any therapy", "any_therapy", "Therapeutic", "Therapeutic Interventions", "Therapeutic Method", "Therapeutic Technique", "Therapy", "TREAT", "Treatment", "treatment or therapy", "treatment_or_therapy", "TX"], "nci_thesaurus_concept_id": "C49236", "name": "Therapeutic Procedure", "semantic_types": ["Therapeutic or Preventive Procedure"], "branch": "Activity", "ancestor_ids": ["C16203", "C25218", "C43431"], "parents": ["C25218"]}, {"eligibility_criterion": "exclusion", "inclusion_indicator": "TREE", "synonyms": ["Clinical Intervention or Procedure", "Intervention", "Intervention Strategies", "Interventional", "Interventional Procedure Type", "interventionDescription", "Procedure", "study intervention", "treatment type", "treatment_type"], "nci_thesaurus_concept_id": "C25218", "name": "Intervention or Procedure", "semantic_types": ["Health Care Activity"], "branch": "Activity", "ancestor_ids": ["C16203", "C43431"], "parents": ["C16203"]}, {"eligibility_criterion": "exclusion", "inclusion_indicator": "TREE", "synonyms": ["Anti-CD274 Agent", "Anti-PD-L1 Agent", "CD274-targeting Agent", "PD-L1-targeting Agent"], "nci_thesaurus_concept_id": "C191689", "name": "PD-L1 Inhibitor", "semantic_types": ["Pharmacologic Substance"], "branch": "Drug, Food, Chemical or Biomedical Material", "ancestor_ids": ["C141144", "C143250", "C156893", "C1908", "C1909", "C308"], "parents": ["C156893"]}, {"eligibility_criterion": "exclusion", "inclusion_indicator": "TREE", "synonyms": ["Anti-PD-1 Agent", "PD-1 Inhibitor", "PD-1-targeting Agent", "Programmed Cell Death Protein 1 Inhibitor", "Protein PD-1 Inhibitor"], "nci_thesaurus_concept_id": "C124946", "name": "PD1 Inhibitor", "semantic_types": ["Chemical Viewed Functionally"], "branch": "Drug, Food, Chemical or Biomedical Material", "ancestor_ids": ["C141144", "C143250", "C1908", "C1909", "C308"], "parents": ["C143250"]}, {"eligibility_criterion": "exclusion", "inclusion_indicator": "TREE", "synonyms": ["General activity"], "nci_thesaurus_concept_id": "C43431", "name": "Activity", "semantic_types": ["Activity"], "branch": "Activity", "ancestor_ids": [], "parents": []}, {"eligibility_criterion": "exclusion", "inclusion_indicator": "TREE", "synonyms": ["PD-1 Ligand-targeting Agent", "PD-1 Ligands Inhibitor"], "nci_thesaurus_concept_id": "C156893", "name": "PD-1 Ligand Inhibitor", "semantic_types": ["Pharmacologic Substance"], "branch": "Drug, Food, Chemical or Biomedical Material", "ancestor_ids": ["C141144", "C143250", "C1908", "C1909", "C308"], "parents": ["C143250"]}, {"eligibility_criterion": "exclusion", "inclusion_indicator": "TREE", "synonyms": ["Biologic", "biologic agent", "Biological Drug", "biological product", "Biological Products", "Biologicals", "Biologics", "Biopharmaceuticals", "Immunologic, Immunochemical", "Immunologics"], "nci_thesaurus_concept_id": "C307", "name": "Biological Agent", "semantic_types": ["Classification"], "branch": "Drug, Food, Chemical or Biomedical Material", "ancestor_ids": ["C1908", "C1909"], "parents": ["C1909"]}, {"eligibility_criterion": "exclusion", "inclusion_indicator": "TREE", "synonyms": [], "nci_thesaurus_concept_id": "C1908", "name": "Drug, Food, Chemical or Biomedical Material", "semantic_types": ["Classification"], "branch": "Drug, Food, Chemical or Biomedical Material", "ancestor_ids": [], "parents": []}, {"eligibility_criterion": "exclusion", "inclusion_indicator": "TREE", "synonyms": [], "nci_thesaurus_concept_id": "C49165", "name": "Surgical Procedure by Method", "semantic_types": ["Classification"], "branch": "Activity", "ancestor_ids": ["C15329", "C16203", "C25218", "C43431"], "parents": ["C15329"]}, {"eligibility_criterion": "exclusion", "inclusion_indicator": "TREE", "synonyms": [], "nci_thesaurus_concept_id": "C64982", "name": "Therapeutic Surgical Procedure", "semantic_types": ["Therapeutic or Preventive Procedure"], "branch": "Activity", "ancestor_ids": ["C15329", "C16203", "C25218", "C43431", "C49236"], "parents": ["C15329", "C49236"]}, {"eligibility_criterion": "exclusion", "inclusion_indicator": "TREE", "synonyms": [], "nci_thesaurus_concept_id": "C141144", "name": "Immune Checkpoint Modulator", "semantic_types": ["Chemical Viewed Functionally"], "branch": "Drug, Food, Chemical or Biomedical Material", "ancestor_ids": ["C1908", "C1909", "C308"], "parents": ["C308"]}, {"eligibility_criterion": "exclusion", "inclusion_indicator": "TREE", "synonyms": ["Anti-Cancer Agents", "Anti-Tumor Agents", "Anti-Tumor Drugs", "antineoplastic", "Antineoplastic Drug", "Antineoplastic Drugs", "ANTINEOPLASTIC_AGENT", "Antineoplastics", "Antiproliferative Agents", "Antiproliferative Drugs", "Cancer Drug", "chemotherapeutic agent", "Chemotherapeutic Agents, Neoplastic Disease", "Tumor-Specific Treatment Agents"], "nci_thesaurus_concept_id": "C274", "name": "Antineoplastic Agent", "semantic_types": ["Chemical Viewed Functionally"], "branch": "Drug, Food, Chemical or Biomedical Material", "ancestor_ids": ["C1908", "C1909"], "parents": ["C1909"]}, {"eligibility_criterion": "exclusion", "inclusion_indicator": "TREE", "synonyms": [], "nci_thesaurus_concept_id": "C16203", "name": "Clinical or Research Activity", "semantic_types": ["Activity"], "branch": "Activity", "ancestor_ids": ["C43431"], "parents": ["C43431"]}, {"eligibility_criterion": "exclusion", "inclusion_indicator": "TREE", "synonyms": ["Agent", "Drug", "Drug Substance", "Pharmaceutical Agent", "Pharmaceuticals", "Pharmacologic Agent", "Pharmacological Substance", "Therapeutic Agent", "therapeutic agents", "therapeutic_agents"], "nci_thesaurus_concept_id": "C1909", "name": "Pharmacologic Substance", "semantic_types": ["Pharmacologic Substance"], "branch": "Drug, Food, Chemical or Biomedical Material", "ancestor_ids": ["C1908"], "parents": ["C1908"]}, {"eligibility_criterion": "exclusion", "inclusion_indicator": "TREE", "synonyms": ["Grafting", "Grafting Procedure", "Surgery, Transplantation", "Transplant", "Transplant Procedure", "Transplantation Surgery"], "nci_thesaurus_concept_id": "C15342", "name": "Transplantation", "semantic_types": ["Therapeutic or Preventive Procedure"], "branch": "Activity", "ancestor_ids": ["C15329", "C16203", "C201922", "C25218", "C43431", "C49165"], "parents": ["C201922"]}, {"eligibility_criterion": "exclusion", "inclusion_indicator": "TREE", "synonyms": ["Biological Response Modifier", "Biomodulators", "BRM", "Immune Mediators", "Immune Modulators", "Immune Regulators", "Immunomodulating Agent", "Immunomodulators", "Immunomodulatory Agent", "Immunopotentiators", "Immunotherapeutic Agent", "Immunotherapeutic Drug", "Immunotherapy Agent"], "nci_thesaurus_concept_id": "C308", "name": "Immunotherapy", "semantic_types": ["Chemical Viewed Functionally"], "branch": "Drug, Food, Chemical or Biomedical Material", "ancestor_ids": ["C1908", "C1909"], "parents": ["C1909"]}, {"eligibility_criterion": "exclusion", "inclusion_indicator": "TREE", "synonyms": ["Infused", "Infusion"], "nci_thesaurus_concept_id": "C15388", "name": "Infusion Procedure", "semantic_types": ["Therapeutic or Preventive Procedure"], "branch": "Activity", "ancestor_ids": ["C16203", "C25218", "C43431", "C49236"], "parents": ["C49236"]}, {"eligibility_criterion": "exclusion", "inclusion_indicator": "TREE", "synonyms": ["Operation", "Surgery", "Surgery Type", "Surgery, NOS", "Surgical", "Surgical Intervention", "Surgical Interventions", "Surgical Procedures", "Surgically", "Type of Surgery"], "nci_thesaurus_concept_id": "C15329", "name": "Surgical Procedure", "semantic_types": ["Health Care Activity"], "branch": "Activity", "ancestor_ids": ["C16203", "C25218", "C43431"], "parents": ["C25218"]}, {"eligibility_criterion": "exclusion", "inclusion_indicator": "TREE", "synonyms": ["Implantation", "Implantation Surgery", "Surgical"], "nci_thesaurus_concept_id": "C201922", "name": "Surgical Implantation", "semantic_types": ["Health Care Activity"], "branch": "Activity", "ancestor_ids": ["C15329", "C16203", "C25218", "C43431", "C49165"], "parents": ["C49165"]}, {"eligibility_criterion": "exclusion", "inclusion_indicator": "TREE", "synonyms": ["HCT", "Hematopoietic Stem Cell Infusion", "HEMATOPOIETIC STEM CELL TRANSPLANT", "Hematopoietic Stem Cell Transplantation", "HSCT", "SCT", "Stem Cell Transplant", "stem cell transplantation", "Stem Cell Transplantation, NOS"], "nci_thesaurus_concept_id": "C15431", "name": "Hematopoietic Cell Transplantation", "semantic_types": ["Therapeutic or Preventive Procedure"], "branch": "Activity", "ancestor_ids": ["C15329", "C15342", "C15388", "C16203", "C165194", "C201922", "C25218", "C43431", "C49165", "C49236"], "parents": ["C15342", "C15388", "C165194"]}, {"eligibility_criterion": "exclusion", "inclusion_indicator": "TREE", "synonyms": ["ICI"], "nci_thesaurus_concept_id": "C143250", "name": "Immune Checkpoint Inhibitor", "semantic_types": ["Chemical Viewed Functionally"], "branch": "Drug, Food, Chemical or Biomedical Material", "ancestor_ids": ["C141144", "C1908", "C1909", "C308"], "parents": ["C141144"]}, {"eligibility_criterion": "exclusion", "inclusion_indicator": "TREE", "synonyms": ["Anatomical Gift", "Clinical, Transplantation, Organ", "Organ Donation", "Organ Donation Procedure", "organ grafting", "Organ Transplants"], "nci_thesaurus_concept_id": "C15289", "name": "Organ Transplantation", "semantic_types": ["Therapeutic or Preventive Procedure"], "branch": "Activity", "ancestor_ids": ["C15329", "C15342", "C16203", "C201922", "C25218", "C43431", "C49163", "C49165", "C49236", "C64982"], "parents": ["C15342", "C49163", "C64982"]}], "_current_trial_status_sort_order": 7, "start_date": "2018-05-24", "record_verification_date": "2024-12-01", "ctep_id": null, "current_trial_status": "Closed to Accrual", "study_model_other_text": null, "masking": {"role_caregiver": null, "masking": null, "role_investigator": null, "role_outcome_assessor": null, "role_subject": null, "allocation_code": "NA"}, "acronym": "MiniVan", "nci_programs": [], "nci_funded": "Indirect", "anatomic_sites": ["Brain and Nervous System"], "ccr_id": null, "start_date_type_code": "ACTUAL", "principal_investigator": null, "study_source": "Externally Peer Reviewed", "completion_date": "2025-07-31", "study_subtype_code": null, "study_protocol_type": "Interventional"}]}))</script>
</div>
<div class="cell-output cell-output-display">
<!--| quarto-html-table-processing: none -->
<table id="itables_1495826d_3f3a_4c40_b381_7aefa97e3f5b"><tbody><tr>
    <td style="vertical-align:middle; text-align:left">
    <a href="https://mwouts.github.io/itables/"><svg class="main-svg" xmlns="http://www.w3.org/2000/svg" xlink="http://www.w3.org/1999/xlink" width="64" viewbox="0 0 500 400" style="font-family: 'Droid Sans', sans-serif;">
    <g style="fill:#d9d7fc">
        <path d="M100,400H500V357H100Z"></path>
        <path d="M100,300H400V257H100Z"></path>
        <path d="M0,200H400V157H0Z"></path>
        <path d="M100,100H500V57H100Z"></path>
        <path d="M100,350H500V307H100Z"></path>
        <path d="M100,250H400V207H100Z"></path>
        <path d="M0,150H400V107H0Z"></path>
        <path d="M100,50H500V7H100Z"></path>
    </g>
    <g style="fill:#1a1366;stroke:#1a1366;">
   <rect x="100" y="7" width="400" height="43">
    <animate attributename="width" values="0;400;0" dur="5s" repeatcount="indefinite"></animate>
      <animate attributename="x" values="100;100;500" dur="5s" repeatcount="indefinite"></animate>
  </rect>
        <rect x="0" y="107" width="400" height="43">
    <animate attributename="width" values="0;400;0" dur="3.5s" repeatcount="indefinite"></animate>
    <animate attributename="x" values="0;0;400" dur="3.5s" repeatcount="indefinite"></animate>
  </rect>
        <rect x="100" y="207" width="300" height="43">
    <animate attributename="width" values="0;300;0" dur="3s" repeatcount="indefinite"></animate>
    <animate attributename="x" values="100;100;400" dur="3s" repeatcount="indefinite"></animate>
  </rect>
        <rect x="100" y="307" width="400" height="43">
    <animate attributename="width" values="0;400;0" dur="4s" repeatcount="indefinite"></animate>
      <animate attributename="x" values="100;100;500" dur="4s" repeatcount="indefinite"></animate>
  </rect>
        <g style="fill:transparent;stroke-width:8; stroke-linejoin:round" rx="5">
            <g transform="translate(45 50) rotate(-45)">
                <circle r="33" cx="0" cy="0"></circle>
                <rect x="-8" y="32" width="16" height="30"></rect>
            </g>

            <g transform="translate(450 152)">
                <polyline points="-15,-20 -35,-20 -35,40 25,40 25,20"></polyline>
                <rect x="-15" y="-40" width="60" height="60"></rect>
            </g>

            <g transform="translate(50 352)">
                <polygon points="-35,-5 0,-40 35,-5"></polygon>
                <polygon points="-35,10 0,45 35,10"></polygon>
            </g>

            <g transform="translate(75 250)">
                <polyline points="-30,30 -60,0 -30,-30"></polyline>
                <polyline points="0,30 -30,0 0,-30"></polyline>
            </g>

            <g transform="translate(425 250) rotate(180)">
                <polyline points="-30,30 -60,0 -30,-30"></polyline>
                <polyline points="0,30 -30,0 0,-30"></polyline>
            </g>
        </g>
    </g>
</svg>
</a>
    Loading ITables v2.5.2 from the internet...
    (need <a href="https://mwouts.github.io/itables/troubleshooting.html">help</a>?)</td>
    </tr></tbody></table>
<link href="https://www.unpkg.com/dt_for_itables@2.4.0/dt_bundle.css" rel="stylesheet">
<script type="module">
    import { ITable, jQuery as $ } from 'https://www.unpkg.com/dt_for_itables@2.4.0/dt_bundle.js';

    document.querySelectorAll("#itables_1495826d_3f3a_4c40_b381_7aefa97e3f5b:not(.dataTable)").forEach(table => {
        if (!(table instanceof HTMLTableElement))
            return;

        let dt_args = {"column_filters": "header", "buttons": ["pageLength", "copyHtml5", "csvHtml5", "excelHtml5"], "layout": {"topStart": "buttons", "topEnd": "search", "bottomStart": "info", "bottomEnd": "paging"}, "order": [], "style": {"table-layout": "auto", "width": "auto", "margin": "auto", "caption-side": "bottom"}, "classes": ["display", "nowrap"], "text_in_header_can_be_selected": true, "table_html": "<table><thead><th>eligibility_criterion</th><th>inclusion_indicator</th><th>synonyms</th><th>nci_thesaurus_concept_id</th><th>name</th><th>semantic_types</th><th>branch</th><th>ancestor_ids</th><th>parents</th></thead></table>", "data_json": "[[\"exclusion\", \"TRIAL\", \"[ABP 206, BCD-263, BMS 936558, BMS-936558, BMS936558, CMAB819, MDX 1106, MDX-1106, MDX1106, NIVO, Nivolumab Biosimilar ABP 206, Nivolumab Biosimilar BCD-263, Nivolumab Biosimilar CMAB819, ONO 4538, ONO-4538, ONO4538, Opdivo]\", \"C68814\", \"Nivolumab\", \"[Amino Acid, Peptide, or Protein, Immunologic Factor, Pharmacologic Substance]\", \"Drug, Food, Chemical or Biomedical Material\", \"[C124946, C128037, C129821, C129822, C141144, C143250, C1908, C1909, C20401, C274, C307, C308]\", \"[C128037, C129822]\"], [\"exclusion\", \"TRIAL\", \"[Allogeneic, Allogeneic Hematopoietic Cell Transplantation, Allogeneic Stem Cell Transplantation, HSC, HSCT, Stem Cell Transplantation, Allogeneic]\", \"C46089\", \"Allogeneic Hematopoietic Stem Cell Transplantation\", \"[Therapeutic or Preventive Procedure]\", \"Activity\", \"[C15329, C15342, C15388, C15431, C16203, C165194, C201922, C25218, C43431, C49165, C49236]\", \"[C15431]\"], [\"exclusion\", \"TRIAL\", \"[]\", \"C191377\", \"Solid Organ Transplantation\", \"[Therapeutic or Preventive Procedure]\", \"Activity\", \"[C15289, C15329, C15342, C16203, C201922, C25218, C43431, C49163, C49165, C49236, C64982]\", \"[C15289]\"], [\"exclusion\", \"TRIAL\", \"[]\", \"C128057\", \"Anti-PD-L1 Monoclonal Antibody\", \"[Chemical Viewed Functionally, Pharmacologic Substance]\", \"Drug, Food, Chemical or Biomedical Material\", \"[C141144, C143250, C156893, C1908, C1909, C191689, C20401, C307, C308]\", \"[C191689, C20401]\"], [\"exclusion\", \"TRIAL\", \"[Anti-PD-1 Monoclonal Antibody]\", \"C128037\", \"Anti-PD1 Monoclonal Antibody\", \"[Chemical Viewed Structurally, Pharmacologic Substance]\", \"Drug, Food, Chemical or Biomedical Material\", \"[C124946, C141144, C143250, C1908, C1909, C20401, C307, C308]\", \"[C124946, C20401]\"], [\"exclusion\", \"TREE\", \"[Anti-cancer Biological Agent, Anticancer Biological, Antineoplastic Biological, Antineoplastic Biotherapeutic]\", \"C129821\", \"Antineoplastic Biological Agent\", \"[Pharmacologic Substance]\", \"Drug, Food, Chemical or Biomedical Material\", \"[C1908, C1909, C274, C307]\", \"[C274, C307]\"], [\"exclusion\", \"TREE\", \"[Stem Cell Treatment]\", \"C165194\", \"Stem Cell Therapy\", \"[Therapeutic or Preventive Procedure]\", \"Activity\", \"[C16203, C25218, C43431, C49236]\", \"[C49236]\"], [\"exclusion\", \"TREE\", \"[]\", \"C49163\", \"Surgical Procedure by Site or System\", \"[Classification]\", \"Activity\", \"[C15329, C16203, C25218, C43431]\", \"[C15329]\"], [\"exclusion\", \"TREE\", \"[Anti-cancer Antibody, Anticancer Antibody, Antineoplastic Ab]\", \"C129822\", \"Antineoplastic Antibody\", \"[Pharmacologic Substance]\", \"Drug, Food, Chemical or Biomedical Material\", \"[C129821, C1908, C1909, C274, C307]\", \"[C129821]\"], [\"exclusion\", \"TREE\", \"[MAb, MoAB, Monoclonal Antibodies, Monoclonal Antibody]\", \"C20401\", \"Monoclonal Antibody Therapy\", \"[Amino Acid, Peptide, or Protein]\", \"Drug, Food, Chemical or Biomedical Material\", \"[C1908, C1909, C307, C308]\", \"[C307, C308]\"], [\"exclusion\", \"TREE\", \"[any therapy, any_therapy, Therapeutic, Therapeutic Interventions, Therapeutic Method, Therapeutic Technique, Therapy, TREAT, Treatment, treatment or therapy, treatment_or_therapy, TX]\", \"C49236\", \"Therapeutic Procedure\", \"[Therapeutic or Preventive Procedure]\", \"Activity\", \"[C16203, C25218, C43431]\", \"[C25218]\"], [\"exclusion\", \"TREE\", \"[Clinical Intervention or Procedure, Intervention, Intervention Strategies, Interventional, Interventional Procedure Type, interventionDescription, Procedure, study intervention, treatment type, treatment_type]\", \"C25218\", \"Intervention or Procedure\", \"[Health Care Activity]\", \"Activity\", \"[C16203, C43431]\", \"[C16203]\"], [\"exclusion\", \"TREE\", \"[Anti-CD274 Agent, Anti-PD-L1 Agent, CD274-targeting Agent, PD-L1-targeting Agent]\", \"C191689\", \"PD-L1 Inhibitor\", \"[Pharmacologic Substance]\", \"Drug, Food, Chemical or Biomedical Material\", \"[C141144, C143250, C156893, C1908, C1909, C308]\", \"[C156893]\"], [\"exclusion\", \"TREE\", \"[Anti-PD-1 Agent, PD-1 Inhibitor, PD-1-targeting Agent, Programmed Cell Death Protein 1 Inhibitor, Protein PD-1 Inhibitor]\", \"C124946\", \"PD1 Inhibitor\", \"[Chemical Viewed Functionally]\", \"Drug, Food, Chemical or Biomedical Material\", \"[C141144, C143250, C1908, C1909, C308]\", \"[C143250]\"], [\"exclusion\", \"TREE\", \"[General activity]\", \"C43431\", \"Activity\", \"[Activity]\", \"Activity\", \"[]\", \"[]\"], [\"exclusion\", \"TREE\", \"[PD-1 Ligand-targeting Agent, PD-1 Ligands Inhibitor]\", \"C156893\", \"PD-1 Ligand Inhibitor\", \"[Pharmacologic Substance]\", \"Drug, Food, Chemical or Biomedical Material\", \"[C141144, C143250, C1908, C1909, C308]\", \"[C143250]\"], [\"exclusion\", \"TREE\", \"[Biologic, biologic agent, Biological Drug, biological product, Biological Products, Biologicals, Biologics, Biopharmaceuticals, Immunologic, Immunochemical, Immunologics]\", \"C307\", \"Biological Agent\", \"[Classification]\", \"Drug, Food, Chemical or Biomedical Material\", \"[C1908, C1909]\", \"[C1909]\"], [\"exclusion\", \"TREE\", \"[]\", \"C1908\", \"Drug, Food, Chemical or Biomedical Material\", \"[Classification]\", \"Drug, Food, Chemical or Biomedical Material\", \"[]\", \"[]\"], [\"exclusion\", \"TREE\", \"[]\", \"C49165\", \"Surgical Procedure by Method\", \"[Classification]\", \"Activity\", \"[C15329, C16203, C25218, C43431]\", \"[C15329]\"], [\"exclusion\", \"TREE\", \"[]\", \"C64982\", \"Therapeutic Surgical Procedure\", \"[Therapeutic or Preventive Procedure]\", \"Activity\", \"[C15329, C16203, C25218, C43431, C49236]\", \"[C15329, C49236]\"], [\"exclusion\", \"TREE\", \"[]\", \"C141144\", \"Immune Checkpoint Modulator\", \"[Chemical Viewed Functionally]\", \"Drug, Food, Chemical or Biomedical Material\", \"[C1908, C1909, C308]\", \"[C308]\"], [\"exclusion\", \"TREE\", \"[Anti-Cancer Agents, Anti-Tumor Agents, Anti-Tumor Drugs, antineoplastic, Antineoplastic Drug, Antineoplastic Drugs, ANTINEOPLASTIC_AGENT, Antineoplastics, Antiproliferative Agents, Antiproliferative Drugs, Cancer Drug, chemotherapeutic agent, Chemotherapeutic Agents, Neoplastic Disease, Tumor-Specific Treatment Agents]\", \"C274\", \"Antineoplastic Agent\", \"[Chemical Viewed Functionally]\", \"Drug, Food, Chemical or Biomedical Material\", \"[C1908, C1909]\", \"[C1909]\"], [\"exclusion\", \"TREE\", \"[]\", \"C16203\", \"Clinical or Research Activity\", \"[Activity]\", \"Activity\", \"[C43431]\", \"[C43431]\"], [\"exclusion\", \"TREE\", \"[Agent, Drug, Drug Substance, Pharmaceutical Agent, Pharmaceuticals, Pharmacologic Agent, Pharmacological Substance, Therapeutic Agent, therapeutic agents, therapeutic_agents]\", \"C1909\", \"Pharmacologic Substance\", \"[Pharmacologic Substance]\", \"Drug, Food, Chemical or Biomedical Material\", \"[C1908]\", \"[C1908]\"], [\"exclusion\", \"TREE\", \"[Grafting, Grafting Procedure, Surgery, Transplantation, Transplant, Transplant Procedure, Transplantation Surgery]\", \"C15342\", \"Transplantation\", \"[Therapeutic or Preventive Procedure]\", \"Activity\", \"[C15329, C16203, C201922, C25218, C43431, C49165]\", \"[C201922]\"], [\"exclusion\", \"TREE\", \"[Biological Response Modifier, Biomodulators, BRM, Immune Mediators, Immune Modulators, Immune Regulators, Immunomodulating Agent, Immunomodulators, Immunomodulatory Agent, Immunopotentiators, Immunotherapeutic Agent, Immunotherapeutic Drug, Immunotherapy Agent]\", \"C308\", \"Immunotherapy\", \"[Chemical Viewed Functionally]\", \"Drug, Food, Chemical or Biomedical Material\", \"[C1908, C1909]\", \"[C1909]\"], [\"exclusion\", \"TREE\", \"[Infused, Infusion]\", \"C15388\", \"Infusion Procedure\", \"[Therapeutic or Preventive Procedure]\", \"Activity\", \"[C16203, C25218, C43431, C49236]\", \"[C49236]\"], [\"exclusion\", \"TREE\", \"[Operation, Surgery, Surgery Type, Surgery, NOS, Surgical, Surgical Intervention, Surgical Interventions, Surgical Procedures, Surgically, Type of Surgery]\", \"C15329\", \"Surgical Procedure\", \"[Health Care Activity]\", \"Activity\", \"[C16203, C25218, C43431]\", \"[C25218]\"], [\"exclusion\", \"TREE\", \"[Implantation, Implantation Surgery, Surgical]\", \"C201922\", \"Surgical Implantation\", \"[Health Care Activity]\", \"Activity\", \"[C15329, C16203, C25218, C43431, C49165]\", \"[C49165]\"], [\"exclusion\", \"TREE\", \"[HCT, Hematopoietic Stem Cell Infusion, HEMATOPOIETIC STEM CELL TRANSPLANT, Hematopoietic Stem Cell Transplantation, HSCT, SCT, Stem Cell Transplant, stem cell transplantation, Stem Cell Transplantation, NOS]\", \"C15431\", \"Hematopoietic Cell Transplantation\", \"[Therapeutic or Preventive Procedure]\", \"Activity\", \"[C15329, C15342, C15388, C16203, C165194, C201922, C25218, C43431, C49165, C49236]\", \"[C15342, C15388, C165194]\"], [\"exclusion\", \"TREE\", \"[ICI]\", \"C143250\", \"Immune Checkpoint Inhibitor\", \"[Chemical Viewed Functionally]\", \"Drug, Food, Chemical or Biomedical Material\", \"[C141144, C1908, C1909, C308]\", \"[C141144]\"], [\"exclusion\", \"TREE\", \"[Anatomical Gift, Clinical, Transplantation, Organ, Organ Donation, Organ Donation Procedure, organ grafting, Organ Transplants]\", \"C15289\", \"Organ Transplantation\", \"[Therapeutic or Preventive Procedure]\", \"Activity\", \"[C15329, C15342, C16203, C201922, C25218, C43431, C49163, C49165, C49236, C64982]\", \"[C15342, C49163, C64982]\"]]"};
        new ITable(table, dt_args);
    });
</script>
</div>
<div class="cell-output cell-output-display">
<div>
<figure class="figure">
<p><img src="demo_files/figure-html/cell-5-output-4.png" width="1171" height="1171" class="figure-img"></p>
</figure>
</div>
</div>
<div class="cell-output cell-output-display">
<pre><code>&lt;Figure size 672x480 with 0 Axes&gt;</code></pre>
</div>
</div>
</section>
<section id="retrieving-several-trials-by-nct_id" class="level2">
<h2 class="anchored" data-anchor-id="retrieving-several-trials-by-nct_id">Retrieving several trials by NCT_ID</h2>
<p>Let us now retrieve the information for three trials: NCT05183035,NCT05188170,NCT02914405</p>
<div id="8844cf9e" class="cell" data-execution_count="5">
<details class="code-fold">
<summary>Code</summary>
<div class="code-copy-outer-scaffold"><div class="sourceCode cell-code" id="cb6"><pre class="sourceCode python code-with-copy"><code class="sourceCode python"><span id="cb6-1"><a href="#cb6-1" aria-hidden="true" tabindex="-1"></a><span class="im">import</span> requests</span>
<span id="cb6-2"><a href="#cb6-2" aria-hidden="true" tabindex="-1"></a><span class="im">import</span> sys</span>
<span id="cb6-3"><a href="#cb6-3" aria-hidden="true" tabindex="-1"></a><span class="im">import</span> json</span>
<span id="cb6-4"><a href="#cb6-4" aria-hidden="true" tabindex="-1"></a><span class="im">import</span> os</span>
<span id="cb6-5"><a href="#cb6-5" aria-hidden="true" tabindex="-1"></a><span class="im">import</span> pandas <span class="im">as</span> pd</span>
<span id="cb6-6"><a href="#cb6-6" aria-hidden="true" tabindex="-1"></a><span class="im">from</span> dotenv <span class="im">import</span> dotenv_values</span>
<span id="cb6-7"><a href="#cb6-7" aria-hidden="true" tabindex="-1"></a><span class="im">import</span> mercury <span class="im">as</span> mr</span>
<span id="cb6-8"><a href="#cb6-8" aria-hidden="true" tabindex="-1"></a><span class="im">import</span> itables</span>
<span id="cb6-9"><a href="#cb6-9" aria-hidden="true" tabindex="-1"></a><span class="im">import</span> time</span>
<span id="cb6-10"><a href="#cb6-10" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb6-11"><a href="#cb6-11" aria-hidden="true" tabindex="-1"></a>config <span class="op">=</span> dotenv_values(<span class="st">'.env'</span>)</span>
<span id="cb6-12"><a href="#cb6-12" aria-hidden="true" tabindex="-1"></a>CTS_API_KEY<span class="op">=</span>config[<span class="st">'CTS_API_KEY'</span>]</span>
<span id="cb6-13"><a href="#cb6-13" aria-hidden="true" tabindex="-1"></a>cts_api_header <span class="op">=</span> {<span class="st">"x-api-key"</span>: CTS_API_KEY,</span>
<span id="cb6-14"><a href="#cb6-14" aria-hidden="true" tabindex="-1"></a>                  <span class="st">"Content-Type"</span>: <span class="st">"application/json"</span>}</span>
<span id="cb6-15"><a href="#cb6-15" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb6-16"><a href="#cb6-16" aria-hidden="true" tabindex="-1"></a><span class="co"># No 'includes' so get everything </span></span>
<span id="cb6-17"><a href="#cb6-17" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb6-18"><a href="#cb6-18" aria-hidden="true" tabindex="-1"></a>trial_ids <span class="op">=</span> {</span>
<span id="cb6-19"><a href="#cb6-19" aria-hidden="true" tabindex="-1"></a>        <span class="st">'nct_id'</span>: [<span class="st">'NCT05183035'</span>,<span class="st">'NCT05188170'</span>,<span class="st">'NCT02914405'</span>]</span>
<span id="cb6-20"><a href="#cb6-20" aria-hidden="true" tabindex="-1"></a>        }          </span>
<span id="cb6-21"><a href="#cb6-21" aria-hidden="true" tabindex="-1"></a>r <span class="op">=</span> requests.post(<span class="st">'https://clinicaltrialsapi.cancer.gov/api/v2/trials'</span>,</span>
<span id="cb6-22"><a href="#cb6-22" aria-hidden="true" tabindex="-1"></a>                  json <span class="op">=</span> trial_ids, headers<span class="op">=</span>cts_api_header)</span>
<span id="cb6-23"><a href="#cb6-23" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb6-24"><a href="#cb6-24" aria-hidden="true" tabindex="-1"></a>j <span class="op">=</span> r.json()  </span>
<span id="cb6-25"><a href="#cb6-25" aria-hidden="true" tabindex="-1"></a>mr.JSON(j) </span>
<span id="cb6-26"><a href="#cb6-26" aria-hidden="true" tabindex="-1"></a>time.sleep(<span class="dv">2</span>)</span>
<span id="cb6-27"><a href="#cb6-27" aria-hidden="true" tabindex="-1"></a><span class="co">#diseases_df = pd.DataFrame(j['data'][0]['diseases'])</span></span>
<span id="cb6-28"><a href="#cb6-28" aria-hidden="true" tabindex="-1"></a><span class="co">#itables.show(diseases_df, column_filters="header",</span></span>
<span id="cb6-29"><a href="#cb6-29" aria-hidden="true" tabindex="-1"></a><span class="co"># buttons=["pageLength", "copyHtml5", "csvHtml5", "excelHtml5"])</span></span></code></pre></div><button title="Copy to Clipboard" class="code-copy-button"><i class="bi"></i></button></div>
</details>
<div class="cell-output cell-output-display">
<style>.renderjson a              { text-decoration: none; }
.renderjson .disclosure    { color: grey; font-size: 125%; }
.renderjson .syntax        { color: grey; }
.renderjson .string        { color: #fe46a5; }
.renderjson .number        { color: #0f9b8e; }
.renderjson .boolean       { color: black; }
.renderjson .key           { color: #2684ff; }
.renderjson .keyword       { color: gray; }
.renderjson .object.syntax { color: gray; }
.renderjson .array.syntax  { color: gray; }</style><div id="808cf836-725a-4869-8131-57cd777dfb40"></div>
</div>
<div class="cell-output cell-output-display">
<script>var renderjson=function(){var t=function(){for(var t=[];arguments.length;)t.push(n(s(Array.prototype.shift.call(arguments)),o(Array.prototype.shift.call(arguments))));return t},n=function(){for(var t=Array.prototype.shift.call(arguments),e=0;e<arguments.length;e++)arguments[e].constructor==Array?n.apply(this,[t].concat(arguments[e])):t.appendChild(arguments[e]);return t},e=function(t,n){return t.insertBefore(n,t.firstChild),t},r=function(t,n){var e=n||Object.keys(t);for(var r in e)if(Object.hasOwnProperty.call(t,e[r]))return!1;return!0},o=function(t){return document.createTextNode(t)},s=function(t){var n=document.createElement("span");return t&&(n.className=t),n},l=function(t,n,e){var r=document.createElement("a");return n&&(r.className=n),r.appendChild(o(t)),r.href="#",r.onclick=function(t){return e(),t&&t.stopPropagation(),!1},r};function a(i,c,u,p,y){var _=u?"":c,f=function(r,a,i,c,u){var f,g=s(c),h=function(){f||n(g.parentNode,f=e(u(),l(y.hide,"disclosure",(function(){f.style.display="none",g.style.display="inline"})))),f.style.display="inline",g.style.display="none"};n(g,l(y.show,"disclosure",h),t(c+" syntax",r),l(a,null,h),t(c+" syntax",i));var d=n(s(),o(_.slice(0,-1)),g);return p>0&&"string"!=c&&h(),d};return null===i?t(null,_,"keyword","null"):void 0===i?t(null,_,"keyword","undefined"):"string"==typeof i&&i.length>y.max_string_length?f('"',i.substr(0,y.max_string_length)+" ...",'"',"string",(function(){return n(s("string"),t(null,_,"string",JSON.stringify(i)))})):"object"!=typeof i||[Number,String,Boolean,Date].indexOf(i.constructor)>=0?t(null,_,typeof i,JSON.stringify(i)):i.constructor==Array?0==i.length?t(null,_,"array syntax","[]"):f("[",y.collapse_msg(i.length),"]","array",(function(){for(var e=n(s("array"),t("array syntax","[",null,"\n")),r=0;r<i.length;r++)n(e,a(y.replacer.call(i,r,i[r]),c+"    ",!1,p-1,y),r!=i.length-1?t("syntax",","):[],o("\n"));return n(e,t(null,c,"array syntax","]")),e})):r(i,y.property_list)?t(null,_,"object syntax","{}"):f("{",y.collapse_msg(Object.keys(i).length),"}","object",(function(){var e=n(s("object"),t("object syntax","{",null,"\n"));for(var r in i)var l=r;var u=y.property_list||Object.keys(i);for(var _ in y.sort_objects&&(u=u.sort()),u){(r=u[_])in i&&n(e,t(null,c+"    ","key",'"'+r+'"',"object syntax",": "),a(y.replacer.call(i,r,i[r]),c+"    ",!0,p-1,y),r!=l?t("syntax",","):[],o("\n"))}return n(e,t(null,c,"object syntax","}")),e}))}var i=function t(e){var r=new Object(t.options);r.replacer="function"==typeof r.replacer?r.replacer:function(t,n){return n};var o=n(document.createElement("pre"),a(e,"",!1,r.show_to_level,r));return o.className="renderjson",o};return i.set_icons=function(t,n){return i.options.show=t,i.options.hide=n,i},i.set_show_to_level=function(t){return i.options.show_to_level="string"==typeof t&&"all"===t.toLowerCase()?Number.MAX_VALUE:t,i},i.set_max_string_length=function(t){return i.options.max_string_length="string"==typeof t&&"none"===t.toLowerCase()?Number.MAX_VALUE:t,i},i.set_sort_objects=function(t){return i.options.sort_objects=t,i},i.set_replacer=function(t){return i.options.replacer=t,i},i.set_collapse_msg=function(t){return i.options.collapse_msg=t,i},i.set_property_list=function(t){return i.options.property_list=t,i},i.set_show_by_default=function(t){return i.options.show_to_level=t?Number.MAX_VALUE:0,i},i.options={},i.set_icons("âŠ•","âŠ–"),i.set_show_by_default(!1),i.set_sort_objects(!1),i.set_max_string_length("none"),i.set_replacer(void 0),i.set_property_list(void 0),i.set_collapse_msg((function(t){return t+" item"+(1==t?"":"s")})),i}(); renderjson.set_show_to_level(1); document.getElementById("808cf836-725a-4869-8131-57cd777dfb40").appendChild(renderjson({"total": 3, "data": [{"other_ids": [{"name": "Study Protocol Other Identifier", "value": "2021-003212-11"}, {"name": "Study Protocol Other Identifier", "value": "2023-510160-12-00"}], "amendment_date": null, "keywords": ["Venetoclax", "Gemtuzumab Ozogamicin", "Fludarabine", "Cytarabine", "Relapsed refractory", "Azacitidine"], "dcp_id": null, "interventional_model": "Parallel", "lead_org": "LLS PedAL Initiative, LLC", "eligibility": {"unstructured": [{"inclusion_indicator": true, "display_order": 0, "description": "Participants must have enrolled on APAL2020SC, NCT Number: NCT04726241 prior to enrollment on ITCC-101/APAL2020D. (This is only applicable for participants in USA/Canada/Australia/New Zealand sites/LLS territory)."}, {"inclusion_indicator": true, "display_order": 1, "description": "Participants must be \u2265 29 days of age and \u2264 21 years of age at enrollment."}, {"inclusion_indicator": true, "display_order": 2, "description": "Participants must have one of the following:"}, {"inclusion_indicator": true, "display_order": 3, "description": "Children, adolescents, and young adults with AML without demonstrated FLT3/internal tandem duplication (ITD) mutation. Ideally, the status of the mutation needs to be proven in the current relapse. Nevertheless, patients with previous FLT3/ITD negative test from prior lines can be included based on local results in order to not delay the start of treatment."}, {"inclusion_indicator": true, "display_order": 4, "description": "And participants must have AML which is either:"}, {"inclusion_indicator": true, "display_order": 5, "description": "Untreated second relapse, in participants who are sufficiently fit to undergo another round of intensive chemotherapy, or"}, {"inclusion_indicator": true, "display_order": 6, "description": "Untreated first relapse, in participants who cannot tolerate additional anthracycline containing chemotherapy per investigator discretion."}, {"inclusion_indicator": true, "display_order": 7, "description": "Participants must have a performance status corresponding to Eastern Cooperative Oncology Group (ECOG) scores of 0, 1 or 2 (\u2265 50% Lansky or Karnofsky score)."}, {"inclusion_indicator": true, "display_order": 8, "description": "Participants must have fully recovered from the acute toxic effects of all prior anti-cancer therapy and must meet the following minimum duration from prior anti-cancer directed therapy prior to start of protocol treatment:"}, {"inclusion_indicator": true, "display_order": 9, "description": "Cytotoxic chemotherapy: Must not have received cytotoxic chemotherapy within 14 days prior to start of protocol treatment, except for corticosteroids, low dose cytarabine or hydroxyurea that can be given up to 24 hours prior to start of protocol treatment."}, {"inclusion_indicator": true, "display_order": 10, "description": "Intrathecal cytotoxic therapy: No wash-out time is required for participants having received any combination of intrathecal cytarabine, methotrexate, and/or hydrocortisone."}, {"inclusion_indicator": true, "display_order": 11, "description": "Antibodies: \u2265 21 days must have elapsed from infusion of last dose of an antibody-drug conjugate before start of protocol treatment. For unmodified antibodies or T cell engaging antibodies, 2 half-lives must have elapsed before start of protocol treatment. Any toxicity related to prior antibody therapy must be recovered to Grade \u2264 1."}, {"inclusion_indicator": true, "display_order": 12, "description": "Interleukins, Interferons and Cytokines (other than Hematopoietic Growth Factors): \u2265 21 days after the completion of interleukins, interferon or cytokines (other than Hematopoietic Growth Factors) before start of protocol treatment."}, {"inclusion_indicator": true, "display_order": 13, "description": "Hematopoietic growth factors: \u2265 14 days after the last dose of a long-acting growth factor (e.g., pegfilgrastim) or \u22657 days for short-acting growth factor before start of protocol treatment."}, {"inclusion_indicator": true, "display_order": 14, "description": "Radiation therapy (RT) (before start of protocol treatment):"}, {"inclusion_indicator": true, "display_order": 15, "description": "\u2265 14 days have elapsed for local palliative RT (small port);"}, {"inclusion_indicator": true, "display_order": 16, "description": "\u2265 84 days must have elapsed if prior craniospinal RT or if \u2265 50% radiation of pelvis;"}, {"inclusion_indicator": true, "display_order": 17, "description": "\u2265 42 days must have elapsed if other substantial bone marrow (BM) radiation."}, {"inclusion_indicator": true, "display_order": 18, "description": "Stem Cell Infusions (before start of protocol treatment):"}, {"inclusion_indicator": true, "display_order": 19, "description": "\u2265 84 days since allogeneic (non-autologous) bone marrow or stem cell transplant (with or without total body irradiation [TBI]) or boost infusion (any stem cell product; not including donor lymphocyte infusion [DLI]);"}, {"inclusion_indicator": true, "display_order": 20, "description": "No evidence of active graft versus host disease (GVHD)."}, {"inclusion_indicator": true, "display_order": 21, "description": "Participants who are receiving cyclosporine, tacrolimus or other agents to treat or prevent either graft-versus-host disease post bone marrow transplant or organ rejection post-transplant are not eligible for this trial. Participants must be off medications to treat or prevent either graft-versus-host disease post bone marrow transplant or organ rejection post-transplant for at least 14 days prior to enrollment."}, {"inclusion_indicator": true, "display_order": 22, "description": "Cellular Therapy: \u2265 42 days after the completion of donor lymphocyte infusion (DLI) or any type of cellular therapy (e.g., modified T cells, natural killer [NK] cells, dendritic cells, etc.) before start of protocol treatment."}, {"inclusion_indicator": true, "display_order": 23, "description": "Participants with prior exposure to venetoclax are eligible in this trial."}, {"inclusion_indicator": true, "display_order": 24, "description": "Adequate organ function:"}, {"inclusion_indicator": true, "display_order": 25, "description": "Adequate Renal Function defined as:"}, {"inclusion_indicator": true, "display_order": 26, "description": "Creatinine clearance or radioisotope glomerular filtration rate (GFR) \u2265 60ml/min/1.73 m^2, or"}, {"inclusion_indicator": true, "display_order": 27, "description": "Normal serum creatinine based on age/sex"}, {"inclusion_indicator": true, "display_order": 28, "description": "Adequate Liver Function defined as:"}, {"inclusion_indicator": true, "display_order": 29, "description": "Direct bilirubin < 1.5 x upper limit of normal (ULN), and"}, {"inclusion_indicator": true, "display_order": 30, "description": "Alkaline phosphatase \u2264 2.5 x ULN, and"}, {"inclusion_indicator": true, "display_order": 31, "description": "Serum glutamic pyruvic transaminase (SGPT) alanine aminotransferase (ALT) \u2264 2.5 x ULN. If higher transaminases outside these ranges (up to 5x ULN) are due to a radiographically identifiable leukemia infiltrate, the participant will remain eligible. Transaminase elevation up to 5x ULN is also allowed in case of steatosis on echography."}, {"inclusion_indicator": true, "display_order": 32, "description": "Cardiac performance: Minimum cardiac function defined as:"}, {"inclusion_indicator": true, "display_order": 33, "description": "No history of congestive heart failure in need of medical treatment"}, {"inclusion_indicator": true, "display_order": 34, "description": "No pre-treatment diminished left ventricular function on echocardiography (shortening fraction [SF] < 25% or ejection fraction [EF] < 40%)"}, {"inclusion_indicator": true, "display_order": 35, "description": "No signs of congestive heart failure at presentation of relapse."}, {"inclusion_indicator": true, "display_order": 36, "description": "Participant, parent or guardian must sign and date informed consent and pediatric assent (when required), prior to the initiation of screening or study specific procedures, according to local law and legislation."}, {"inclusion_indicator": false, "display_order": 37, "description": "Participants who in the opinion of the investigator may not be able to comply with the study requirements of the study, are not eligible."}, {"inclusion_indicator": false, "display_order": 38, "description": "Participants with Down syndrome."}, {"inclusion_indicator": false, "display_order": 39, "description": "Participants with Acute promyelocytic leukemia (APL) or Juvenile myelomonocytic leukemia (JMML)."}, {"inclusion_indicator": false, "display_order": 40, "description": "Participants with isolated CNS3 disease or symptomatic CNS3 disease."}, {"inclusion_indicator": false, "display_order": 41, "description": "Participants with malabsorption syndrome or any other condition that precludes enteral administration of venetoclax."}, {"inclusion_indicator": false, "display_order": 42, "description": "Participants who are currently receiving an investigational drug other than those specified for this study."}, {"inclusion_indicator": false, "display_order": 43, "description": "Participants with Fanconi anemia, Kostmann syndrome, Shwachman syndrome or any other known congenital bone marrow failure syndrome."}, {"inclusion_indicator": false, "display_order": 44, "description": "Participants with known prior allergy to any of the medications used in protocol therapy."}, {"inclusion_indicator": false, "display_order": 45, "description": "Participants with documented active, uncontrolled infection at the time of study entry."}, {"inclusion_indicator": false, "display_order": 46, "description": "Known hepatitis C virus (HCV), hepatitis B virus (HBV) (known positive hepatitis B virus (HBV) surface antigen (HBsAg) results), or human immunodeficiency virus (HIV) infection."}, {"inclusion_indicator": false, "display_order": 47, "description": "Concomitant Medications"}, {"inclusion_indicator": false, "display_order": 48, "description": "Participants who have received strong and moderate CYP3A inducers such as rifampin, carbamazepine, phenytoin, and St. John's wort within 7 days of the start of study treatment."}, {"inclusion_indicator": false, "display_order": 49, "description": "Participants who have consumed grapefruit, grapefruit products, Seville oranges (including marmalade containing Seville oranges) or starfruit within 3 days of the start of study treatment."}, {"inclusion_indicator": false, "display_order": 50, "description": "Participants who have hypersensitivity to the active substance or to any of the excipients listed in summary of product characteristics (SPC)."}, {"inclusion_indicator": false, "display_order": 51, "description": "Pregnancy or Breast-Feeding:"}, {"inclusion_indicator": false, "display_order": 52, "description": "Participants who are pregnant or breast-feeding."}, {"inclusion_indicator": false, "display_order": 53, "description": "Participants of reproductive potential may not participate unless they have agreed to use a highly effective contraceptive method per Clinical Trial Facilitation Group (CTFG) guidelines for the duration of study therapy and at least 30 days after last dose of venetoclax, or 7 months after gemtuzumab ozogamicin treatment, or for 6 months after the completion of all study therapy, whichever is longer."}, {"inclusion_indicator": false, "display_order": 54, "description": "Male participants must use a condom during intercourse and agree not to father a child or donate sperm during therapy and for the duration of study therapy and at least 30 days after last dose of venetoclax or 4 months after last dose of gemtuzumab ozogamicin, 6 months from the last dose of cytarabine, or 90-days after last exposure to any other chemotherapy, whichever is longer. Additional criteria to receive a gemtuzumab ozogamicin infusion: Gemtuzumab ozogamicin should not be given:"}, {"inclusion_indicator": false, "display_order": 55, "description": "to participants with history of veno-occlusive disease (VOD)/Sinusoidal obstruction syndrome (SOS) grade 3 or 4"}, {"inclusion_indicator": false, "display_order": 56, "description": "to participants with CD33 negative leukemic blasts (determined at local lab) Note that these participants are eligible for the study but will not be treated with\r\ngemtuzumab ozogamicin."}], "structured": {"max_age": "21 Years", "max_age_number": 21.0, "min_age_unit": "Days", "max_age_unit": "Years", "max_age_in_years": 21.0, "sex": "ALL", "accepts_healthy_volunteers": false, "min_age": "29 Days", "min_age_number": 29.0, "min_age_in_years": 0.07945205479452055}}, "sites": [{"org_state_or_province": "CO", "contact_name": "Barbara J. Shepperd", "contact_phone": "720-777-6819", "recruitment_status_date": "2023-08-18", "org_address_line_2": null, "org_va": false, "org_address_line_1": "12605 East 16th Avenue", "org_tty": null, "org_family": "University of Colorado Cancer Center", "org_postal_code": "80045", "contact_email": "Barbara.shepperd@childrenscolorado.org", "recruitment_status": "ACTIVE", "org_city": "Aurora", "org_email": null, "org_country": "United States", "org_fax": null, "org_phone": "720-848-0650", "org_name": "UCHealth University of Colorado Hospital", "org_coordinates": {"lon": -104.837, "lat": 39.7462}}, {"org_state_or_province": "CA", "contact_name": "UCSF Clinical Trials", "contact_phone": "877-827-3222", "recruitment_status_date": "2023-01-12", "org_address_line_2": "Floor 6", "org_va": false, "org_address_line_1": "490 Illinois Street", "org_tty": null, "org_family": "UCSF Helen Diller Family Comprehensive Cancer Center", "org_postal_code": "94143", "contact_email": "cancertrials@ucsf.edu", "recruitment_status": "ACTIVE", "org_city": "San Francisco", "org_email": null, "org_country": "United States", "org_fax": null, "org_phone": "877-827-3222", "org_name": "University of California San Francisco", "org_coordinates": {"lon": -122.4584, "lat": 37.7616}}, {"org_state_or_province": "MN", "contact_name": null, "contact_phone": null, "recruitment_status_date": "2023-07-12", "org_address_line_2": null, "org_va": false, "org_address_line_1": "420 Delaware Street Southeast", "org_tty": null, "org_family": "Masonic Cancer Center", "org_postal_code": "55455", "contact_email": null, "recruitment_status": "ACTIVE", "org_city": "Minneapolis", "org_email": null, "org_country": "United States", "org_fax": null, "org_phone": "612-624-2620", "org_name": "University of Minnesota/Masonic Cancer Center", "org_coordinates": {"lon": -93.2319, "lat": 44.974}}, {"org_state_or_province": "MA", "contact_name": null, "contact_phone": null, "recruitment_status_date": "2023-09-15", "org_address_line_2": null, "org_va": false, "org_address_line_1": "450 Brookline Avenue", "org_tty": null, "org_family": "Dana-Farber/Harvard Cancer Center", "org_postal_code": "02215", "contact_email": null, "recruitment_status": "ACTIVE", "org_city": "Boston", "org_email": null, "org_country": "United States", "org_fax": null, "org_phone": "617-632-3000", "org_name": "Dana-Farber Cancer Institute", "org_coordinates": {"lon": -71.1025, "lat": 42.3469}}, {"org_state_or_province": "NY", "contact_name": null, "contact_phone": null, "recruitment_status_date": "2023-03-05", "org_address_line_2": null, "org_va": false, "org_address_line_1": "630 West 168th Street", "org_tty": null, "org_family": "Herbert Irving Comprehensive Cancer Center", "org_postal_code": "10032", "contact_email": null, "recruitment_status": "ACTIVE", "org_city": "New York", "org_email": "cancerclinicaltrials@cumc.columbia.edu", "org_country": "United States", "org_fax": null, "org_phone": "212-305-8615", "org_name": "NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center", "org_coordinates": {"lon": -73.9425, "lat": 40.839}}, {"org_state_or_province": "TX", "contact_name": null, "contact_phone": null, "recruitment_status_date": "2023-05-22", "org_address_line_2": null, "org_va": false, "org_address_line_1": "6621 Fannin Street", "org_tty": null, "org_family": "Dan L Duncan Comprehensive Cancer Center", "org_postal_code": "77030", "contact_email": null, "recruitment_status": "ACTIVE", "org_city": "Houston", "org_email": null, "org_country": "United States", "org_fax": null, "org_phone": "832-824-1000", "org_name": "Texas Children's Hospital", "org_coordinates": {"lon": -95.4026, "lat": 29.7059}}, {"org_state_or_province": "IA", "contact_name": null, "contact_phone": null, "recruitment_status_date": "2023-04-20", "org_address_line_2": null, "org_va": false, "org_address_line_1": "200 Hawkins Drive", "org_tty": null, "org_family": "Holden Comprehensive Cancer Center", "org_postal_code": "52242", "contact_email": null, "recruitment_status": "ACTIVE", "org_city": "Iowa City", "org_email": null, "org_country": "United States", "org_fax": null, "org_phone": "800-237-1225", "org_name": "University of Iowa/Holden Comprehensive Cancer Center", "org_coordinates": {"lon": -91.5469, "lat": 41.6596}}, {"org_state_or_province": "UT", "contact_name": null, "contact_phone": null, "recruitment_status_date": "2023-02-09", "org_address_line_2": null, "org_va": false, "org_address_line_1": "100 North Mario Capecchi Drive", "org_tty": null, "org_family": "Huntsman Cancer Institute", "org_postal_code": "84113", "contact_email": null, "recruitment_status": "ACTIVE", "org_city": "Salt Lake City", "org_email": null, "org_country": "United States", "org_fax": null, "org_phone": "801-585-5270", "org_name": "Primary Children's Hospital", "org_coordinates": {"lon": -111.833, "lat": 40.7638}}, {"org_state_or_province": "MI", "contact_name": null, "contact_phone": null, "recruitment_status_date": "2025-04-28", "org_address_line_2": null, "org_va": false, "org_address_line_1": "1500 East Medical Center Drive", "org_tty": null, "org_family": "University of Michigan Rogel Cancer Center", "org_postal_code": "48109", "contact_email": null, "recruitment_status": "APPROVED", "org_city": "Ann Arbor", "org_email": null, "org_country": "United States", "org_fax": null, "org_phone": "800-865-1125", "org_name": "University of Michigan Comprehensive Cancer Center", "org_coordinates": {"lon": -83.7144, "lat": 42.2909}}, {"org_state_or_province": "OR", "contact_name": null, "contact_phone": null, "recruitment_status_date": "2023-09-05", "org_address_line_2": null, "org_va": false, "org_address_line_1": "3181 SW Sam Jackson Pk. Rd", "org_tty": null, "org_family": "OHSU Knight Cancer Institute", "org_postal_code": "97239", "contact_email": null, "recruitment_status": "ACTIVE", "org_city": "Portland", "org_email": "cancer@ohsu.edu", "org_country": "United States", "org_fax": null, "org_phone": "503-494-1080", "org_name": "OHSU Knight Cancer Institute", "org_coordinates": {"lon": -122.6915, "lat": 45.4923}}, {"org_state_or_province": "TX", "contact_name": null, "contact_phone": null, "recruitment_status_date": "2023-08-01", "org_address_line_2": null, "org_va": false, "org_address_line_1": "5323 Harry Hines Boulevard", "org_tty": null, "org_family": "Harold C. Simmons Comprehensive Cancer Center", "org_postal_code": "75390", "contact_email": null, "recruitment_status": "ACTIVE", "org_city": "Dallas", "org_email": "canceranswerline@UTSouthwestern.edu", "org_country": "United States", "org_fax": null, "org_phone": "214-648-7097", "org_name": "UT Southwestern/Simmons Cancer Center-Dallas", "org_coordinates": {"lon": -96.7016, "lat": 32.8432}}, {"org_state_or_province": "TN", "contact_name": null, "contact_phone": null, "recruitment_status_date": "2023-03-16", "org_address_line_2": null, "org_va": false, "org_address_line_1": "2200 Pierce Avenue", "org_tty": null, "org_family": "Vanderbilt-Ingram Cancer Center", "org_postal_code": "37232", "contact_email": null, "recruitment_status": "ACTIVE", "org_city": "Nashville", "org_email": null, "org_country": "United States", "org_fax": null, "org_phone": "877-936-8422", "org_name": "Vanderbilt University/Ingram Cancer Center", "org_coordinates": {"lon": -86.8096, "lat": 36.1437}}, {"org_state_or_province": "GA", "contact_name": null, "contact_phone": null, "recruitment_status_date": "2023-11-10", "org_address_line_2": null, "org_va": false, "org_address_line_1": "2220 North Druid Hills Road", "org_tty": null, "org_family": "Winship Cancer Institute of Emory University", "org_postal_code": "30329", "contact_email": null, "recruitment_status": "ACTIVE", "org_city": "Atlanta", "org_email": "Olivia.Floyd@choa.org", "org_country": "United States", "org_fax": null, "org_phone": "888-785-1112", "org_name": "Children's Healthcare of Atlanta - Arthur M Blank Hospital", "org_coordinates": {"lon": -84.323, "lat": 33.8247}}, {"org_state_or_province": "CT", "contact_name": null, "contact_phone": null, "recruitment_status_date": "2023-10-02", "org_address_line_2": "Suite 203", "org_va": false, "org_address_line_1": "5520 Park Avenue", "org_tty": null, "org_family": "Yale Cancer Center", "org_postal_code": "06611", "contact_email": null, "recruitment_status": "ACTIVE", "org_city": "Trumbull", "org_email": "canceranswers@yale.edu", "org_country": "United States", "org_fax": "203-502-8409", "org_phone": "203-502-8400", "org_name": "Smilow Cancer Hospital Care Center-Trumbull", "org_coordinates": {"lon": -73.2099, "lat": 41.2599}}, {"org_state_or_province": "CT", "contact_name": null, "contact_phone": null, "recruitment_status_date": "2023-10-02", "org_address_line_2": null, "org_va": false, "org_address_line_1": "333 Cedar Street", "org_tty": null, "org_family": "Yale Cancer Center", "org_postal_code": "06520", "contact_email": null, "recruitment_status": "ACTIVE", "org_city": "New Haven", "org_email": "canceranswers@yale.edu", "org_country": "United States", "org_fax": null, "org_phone": "203-785-5702", "org_name": "Yale University", "org_coordinates": {"lon": -72.9291, "lat": 41.31}}, {"org_state_or_province": "NY", "contact_name": null, "contact_phone": null, "recruitment_status_date": "2023-01-03", "org_address_line_2": null, "org_va": false, "org_address_line_1": "1275 York Avenue", "org_tty": null, "org_family": "Memorial Sloan Kettering Cancer Center", "org_postal_code": "10065", "contact_email": null, "recruitment_status": "ACTIVE", "org_city": "New York", "org_email": null, "org_country": "United States", "org_fax": null, "org_phone": "212-639-2000", "org_name": "Memorial Sloan Kettering Cancer Center", "org_coordinates": {"lon": -73.9624, "lat": 40.7656}}, {"org_state_or_province": "WA", "contact_name": null, "contact_phone": null, "recruitment_status_date": "2023-09-08", "org_address_line_2": null, "org_va": false, "org_address_line_1": "1100 Fairview Avenue North", "org_tty": null, "org_family": "Fred Hutch/University of Washington/Seattle Children's Cancer Consortium", "org_postal_code": "98109", "contact_email": null, "recruitment_status": "ACTIVE", "org_city": "Seattle", "org_email": "CRScustomerservice@fredhutch.org", "org_country": "United States", "org_fax": null, "org_phone": "206-667-4520", "org_name": "Fred Hutch/University of Washington/Seattle Children's Cancer Consortium", "org_coordinates": {"lon": -122.3461, "lat": 47.6307}}, {"org_state_or_province": "MO", "contact_name": null, "contact_phone": null, "recruitment_status_date": "2022-09-15", "org_address_line_2": null, "org_va": false, "org_address_line_1": "2401 Gillham Road", "org_tty": null, "org_family": "University of Kansas Cancer Center", "org_postal_code": "64108", "contact_email": null, "recruitment_status": "ACTIVE", "org_city": "Kansas City", "org_email": "rryan@cmh.edu", "org_country": "United States", "org_fax": null, "org_phone": "816-234-3000", "org_name": "Children's Mercy Hospitals and Clinics", "org_coordinates": {"lon": -94.5849, "lat": 39.084}}, {"org_state_or_province": "IL", "contact_name": null, "contact_phone": null, "recruitment_status_date": "2023-05-17", "org_address_line_2": null, "org_va": false, "org_address_line_1": "5841 South Maryland Avenue", "org_tty": null, "org_family": "University of Chicago Comprehensive Cancer Center", "org_postal_code": "60637", "contact_email": null, "recruitment_status": "ACTIVE", "org_city": "Chicago", "org_email": "cancerclinicaltrials@bsd.uchicago.edu", "org_country": "United States", "org_fax": "773-702-9311", "org_phone": "773-834-7424\r773-702-6180", "org_name": "University of Chicago Comprehensive Cancer Center", "org_coordinates": {"lon": -87.6021, "lat": 41.781}}, {"org_state_or_province": "MO", "contact_name": null, "contact_phone": null, "recruitment_status_date": "2023-04-24", "org_address_line_2": null, "org_va": false, "org_address_line_1": "4921 Parkview Place", "org_tty": null, "org_family": "Alvin J. Siteman Cancer Center", "org_postal_code": "63110", "contact_email": null, "recruitment_status": "ACTIVE", "org_city": "Saint Louis", "org_email": null, "org_country": "United States", "org_fax": null, "org_phone": "314-747-7236", "org_name": "Siteman Cancer Center at Washington University", "org_coordinates": {"lon": -90.267, "lat": 38.6267}}, {"org_state_or_province": "MA", "contact_name": null, "contact_phone": null, "recruitment_status_date": "2023-09-15", "org_address_line_2": null, "org_va": false, "org_address_line_1": "300 Longwood Avenue", "org_tty": "617-730-0152", "org_family": "Dana-Farber/Harvard Cancer Center", "org_postal_code": "02115", "contact_email": null, "recruitment_status": "ACTIVE", "org_city": "Boston", "org_email": null, "org_country": "United States", "org_fax": null, "org_phone": "617-355-6000", "org_name": "Boston Children's Hospital", "org_coordinates": {"lon": -71.0948, "lat": 42.341}}, {"org_state_or_province": "IL", "contact_name": null, "contact_phone": null, "recruitment_status_date": "2023-08-23", "org_address_line_2": null, "org_va": false, "org_address_line_1": "225 East Chicago Avenue", "org_tty": null, "org_family": "Robert H. Lurie Comprehensive Cancer Center", "org_postal_code": "60611", "contact_email": null, "recruitment_status": "ACTIVE", "org_city": "Chicago", "org_email": null, "org_country": "United States", "org_fax": null, "org_phone": "312-227-4000", "org_name": "Lurie Children's Hospital-Chicago", "org_coordinates": {"lon": -87.6187, "lat": 41.8946}}, {"org_state_or_province": "TN", "contact_name": null, "contact_phone": null, "recruitment_status_date": "2022-11-01", "org_address_line_2": null, "org_va": false, "org_address_line_1": "262 Danny Thomas Place", "org_tty": null, "org_family": "St. Jude Children's Research Hospital", "org_postal_code": "38105", "contact_email": null, "recruitment_status": "ACTIVE", "org_city": "Memphis", "org_email": "referralinfo@stjude.org", "org_country": "United States", "org_fax": null, "org_phone": "866-278-5833\r901-595-4357", "org_name": "Saint Jude Children's Research Hospital", "org_coordinates": {"lon": -90.0341, "lat": 35.1506}}, {"org_state_or_province": "PA", "contact_name": null, "contact_phone": null, "recruitment_status_date": "2023-06-20", "org_address_line_2": null, "org_va": false, "org_address_line_1": "3401 Civic Center Boulevard", "org_tty": null, "org_family": "Abramson Cancer Center", "org_postal_code": "19104", "contact_email": null, "recruitment_status": "ACTIVE", "org_city": "Philadelphia", "org_email": "CancerTrials@email.chop.edu", "org_country": "United States", "org_fax": null, "org_phone": "215-590-2810", "org_name": "Children's Hospital of Philadelphia", "org_coordinates": {"lon": -75.1995, "lat": 39.9616}}], "completion_date_type_code": "ANTICIPATED", "detail_description": "Relapse of AML is driven by chemotherapy resistant stem cells. One mechanism of\r\nchemotherapeutic resistance in AML is the overexpression of the protein B-cell lymphoma 2\r\n(BCL-2), an anti-apoptotic protein which sequesters intracellular activators of\r\napoptosis. Venetoclax is a selective, potent, orally bioavailable, small molecule\r\ninhibitor of BCL-2 that restores programmed cell death in cancer cells.\r\n\r\nThis is a trial for children, adolescents and young adults with 2nd relapsed AML or 1st\r\nrelapsed AML unable to receive additional anthracycline.\r\n\r\nThis is randomized trial of venetoclax in combination with intensive chemotherapy\r\n(fludarabine/cytarabine/gemtuzumab ozogamicin) for the first two cycles (42-day-cycles)\r\nthat would inform and evaluate if this agent is an effective option for this population\r\nto improve its poor prognosis. Participants can receive up to two cycles of induction\r\nchemotherapy before hematopoietic stem cell transplantation (HSCT). If participants who\r\nhave perceived clinical benefit cannot be transplanted after the 2 cycles, maintenance\r\ntreatment may be given at the discretion of the investigator. In Arm B (experimental\r\narm), participants can continue venetoclax if they have perceived clinical benefit, and\r\nmaintenance therapy will combine venetoclax with azacitidine for a maximum of 24 cycles.\r\nIn Arm A (control arm), participants will receive azacitidine in monotherapy. Maintenance\r\nis continued until clinical progression or unacceptable toxicity with a maximum of 24\r\ncycles.", "official_title": "A Randomized Phase 3 Trial of Fludarabine/Cytarabine/Gemtuzumab Ozogamicin With or Without Venetoclax in Children With Relapsed AML", "_phase_sort_order": 0, "collaborators": [{"name": "Abbvie", "functional_role": "LABORATORY"}, {"name": "EuPAL", "functional_role": "LABORATORY"}, {"name": "Genentech Inc.", "functional_role": "LABORATORY"}, {"name": "Princess Maxima Center for Pediatric Oncology (European Sponsor)", "functional_role": "LABORATORY"}], "associated_studies": [], "outcome_measures": [{"timeframe": "Pre-dose, 2, 4, 6, 8, and 24 hours post-dose on Cycle 1 Day 8 and Day 13 (cycle is 42 days); once on follow-up visits of Cycle 2 between Day 5 and Day 21", "name": "Area Under the Plasma Concentration-time Curve Over a 24-hour Dose Interval (AUC0-24)", "description": null, "type_code": "SECONDARY"}, {"timeframe": "Up to 5 years", "name": "Cumulative Incidence of Relapse (CIR)", "description": null, "type_code": "SECONDARY"}, {"timeframe": "Up to 5 years", "name": "Disease-related Mortality", "description": null, "type_code": "SECONDARY"}, {"timeframe": "Up to 5 years", "name": "Duration of Response (DOR)", "description": null, "type_code": "SECONDARY"}, {"timeframe": "Up to 5 years", "name": "Flow-based Event Free Survival (EFS)", "description": null, "type_code": "SECONDARY"}, {"timeframe": "Up to Day 84", "name": "Flow-based Overall Response Rate (ORR)", "description": null, "type_code": "SECONDARY"}, {"timeframe": "Up to 5 years", "name": "Hematopoietic Stem Cell Transplantation (HSCT) Rate", "description": null, "type_code": "SECONDARY"}, {"timeframe": "Pre-dose, 2, 4, 6, 8, and 24 hours post-dose on Cycle 1 Day 8 and Day 13 (cycle is 42 days); once on follow-up visits of Cycle 2 between Day 5 and Day 21", "name": "Maximum Observed Plasma Concentration (Cmax) of Venetoclax", "description": null, "type_code": "SECONDARY"}, {"timeframe": "Up to Day 84", "name": "Morphological Overall Response Rate (ORR)", "description": null, "type_code": "SECONDARY"}, {"timeframe": "Up to 5 years", "name": "Morphology Event Free Survival (EFS)", "description": null, "type_code": "SECONDARY"}, {"timeframe": "Up to 5 years", "name": "Non-disease-related Mortality", "description": null, "type_code": "SECONDARY"}, {"timeframe": "Up to 5 years", "name": "Number of Participants That Are Pediatric Minimal Residual Disease (Ped-MRD) Negative with Complete Remission (CR), Partial Complete Remission (CRp), or Complete Remission with Incomplete Hematologic Recovery (CRi)", "description": null, "type_code": "SECONDARY"}, {"timeframe": "Up to 5 years", "name": "Number of Participants with Adverse Events (AEs)", "description": null, "type_code": "SECONDARY"}, {"timeframe": "Up to 5 years", "name": "Number of Participants with International Working Group Complete Response (IWG-CR)", "description": null, "type_code": "SECONDARY"}, {"timeframe": "Up to 5 years", "name": "Overall Survival (OS)", "description": null, "type_code": "PRIMARY"}, {"timeframe": "Pre-dose, 2, 4, 6, 8, and 24 hours post-dose on Cycle 1 Day 8 and Day 13 (cycle is 42 days); once on follow-up visits of Cycle 2 between Day 5 and Day 21", "name": "Time to Maximum Observed Plasma Concentration (Tmax) of Venetoclax", "description": null, "type_code": "SECONDARY"}], "phase": "III", "central_contact": {"phone": null, "name": null, "type": null, "email": null}, "primary_purpose": "TREATMENT", "number_of_arms": 2, "_study_protocol_type_sort_order": 0, "nct_id": "NCT05183035", "biomarkers": [{"eligibility_criterion": "inclusion", "inclusion_indicator": "TREE", "synonyms": ["FLT3", "FMS-Related Tyrosine Kinase 3 Gene"], "nci_thesaurus_concept_id": "C24399", "name": "FLT3 Gene", "semantic_types": ["Gene or Genome"], "type": ["reference_gene"], "ancestors": ["C16612", "C25872", "C21295", "C21281", "C20719", "C25870", "C25871", "C20103", "C26131"], "parents": ["C20719", "C26131"], "assay_purpose": "Eligibility Criterion - Inclusion"}, {"eligibility_criterion": "inclusion", "inclusion_indicator": "TREE", "synonyms": [], "nci_thesaurus_concept_id": "C21295", "name": "Ligand Binding Protein Gene", "semantic_types": ["Gene or Genome"], "type": [], "ancestors": ["C16612"], "parents": ["C16612"], "assay_purpose": "Eligibility Criterion - Inclusion"}, {"eligibility_criterion": "inclusion", "inclusion_indicator": "TREE", "synonyms": [], "nci_thesaurus_concept_id": "C20103", "name": "Receptor Gene", "semantic_types": ["Gene or Genome"], "type": [], "ancestors": ["C21295", "C16612"], "parents": ["C21295"], "assay_purpose": "Eligibility Criterion - Inclusion"}, {"eligibility_criterion": "inclusion", "inclusion_indicator": "TREE", "synonyms": ["Gene Mutant Negative", "Gene Mutation Negative", "Gene Mutation Not Detected", "Gene Variation Negative", "Gene Variation Not Detected", "Not Mutated"], "nci_thesaurus_concept_id": "C177687", "name": "Gene Variant Negative", "semantic_types": ["Laboratory or Test Result"], "type": [], "ancestors": ["C35681", "C77140", "C3367", "C36292", "C103223"], "parents": ["C103223", "C35681"], "assay_purpose": "Eligibility Criterion - Inclusion"}, {"eligibility_criterion": "inclusion", "inclusion_indicator": "TREE", "synonyms": [], "nci_thesaurus_concept_id": "C25872", "name": "Kinase Family Gene", "semantic_types": ["Gene or Genome"], "type": [], "ancestors": ["C25871", "C16612", "C21281", "C25870"], "parents": ["C25871"], "assay_purpose": "Eligibility Criterion - Inclusion"}, {"eligibility_criterion": "inclusion", "inclusion_indicator": "TREE", "synonyms": [], "nci_thesaurus_concept_id": "C25871", "name": "Phosphotransferase Gene", "semantic_types": ["Gene or Genome"], "type": [], "ancestors": ["C16612", "C21281", "C25870"], "parents": ["C25870"], "assay_purpose": "Eligibility Criterion - Inclusion"}, {"eligibility_criterion": "inclusion", "inclusion_indicator": "TREE", "synonyms": ["Proto-Oncogene, Growth Factor Receptor Gene"], "nci_thesaurus_concept_id": "C26131", "name": "Growth Factor Receptor Gene", "semantic_types": ["Gene or Genome"], "type": [], "ancestors": ["C16612", "C20103", "C21295"], "parents": ["C20103"], "assay_purpose": "Eligibility Criterion - Inclusion"}, {"eligibility_criterion": "inclusion", "inclusion_indicator": "TREE", "synonyms": ["Observable Entity"], "nci_thesaurus_concept_id": "C3367", "name": "Finding", "semantic_types": ["Finding"], "type": ["branch"], "ancestors": [], "parents": [], "assay_purpose": "Eligibility Criterion - Inclusion"}, {"eligibility_criterion": "inclusion", "inclusion_indicator": "TREE", "synonyms": ["Clinical Measurement", "Diagnostic Test Result"], "nci_thesaurus_concept_id": "C77140", "name": "Clinical Test Result", "semantic_types": ["Finding"], "type": [], "ancestors": ["C3367"], "parents": ["C3367"], "assay_purpose": "Eligibility Criterion - Inclusion"}, {"eligibility_criterion": "inclusion", "inclusion_indicator": "TREE", "synonyms": [], "nci_thesaurus_concept_id": "C103223", "name": "Genetic Finding", "semantic_types": ["Laboratory or Test Result"], "type": [], "ancestors": ["C77140", "C3367", "C36292"], "parents": ["C36292"], "assay_purpose": "Eligibility Criterion - Inclusion"}, {"eligibility_criterion": "inclusion", "inclusion_indicator": "TREE", "synonyms": ["Negative"], "nci_thesaurus_concept_id": "C35681", "name": "Negative Test Result", "semantic_types": ["Finding"], "type": [], "ancestors": ["C77140", "C3367"], "parents": ["C77140"], "assay_purpose": "Eligibility Criterion - Inclusion"}, {"eligibility_criterion": "inclusion", "inclusion_indicator": "TREE", "synonyms": ["LAB_RESULT", "Lab Findings", "Lab Value", "Laboratory Finding", "Laboratory Report", "Labs", "Test Result", "test_result"], "nci_thesaurus_concept_id": "C36292", "name": "Laboratory Test Result", "semantic_types": ["Laboratory or Test Result"], "type": [], "ancestors": ["C3367", "C77140"], "parents": ["C77140"], "assay_purpose": "Eligibility Criterion - Inclusion"}, {"eligibility_criterion": "inclusion", "inclusion_indicator": "TREE", "synonyms": ["Genes"], "nci_thesaurus_concept_id": "C16612", "name": "Gene", "semantic_types": ["Gene or Genome"], "type": ["branch"], "ancestors": [], "parents": [], "assay_purpose": "Eligibility Criterion - Inclusion"}, {"eligibility_criterion": "inclusion", "inclusion_indicator": "TREE", "synonyms": [], "nci_thesaurus_concept_id": "C25870", "name": "Transferase Gene", "semantic_types": ["Gene or Genome"], "type": [], "ancestors": ["C16612", "C21281"], "parents": ["C21281"], "assay_purpose": "Eligibility Criterion - Inclusion"}, {"eligibility_criterion": "inclusion", "inclusion_indicator": "TREE", "synonyms": ["RTK Family Gene"], "nci_thesaurus_concept_id": "C20719", "name": "Receptor Tyrosine Kinase Gene", "semantic_types": ["Gene or Genome"], "type": [], "ancestors": ["C25870", "C25872", "C21295", "C20103", "C25871", "C16612", "C21281"], "parents": ["C20103", "C25872"], "assay_purpose": "Eligibility Criterion - Inclusion"}, {"eligibility_criterion": "inclusion", "inclusion_indicator": "TREE", "synonyms": [], "nci_thesaurus_concept_id": "C21281", "name": "Enzyme Gene", "semantic_types": ["Gene or Genome"], "type": [], "ancestors": ["C16612"], "parents": ["C16612"], "assay_purpose": "Eligibility Criterion - Inclusion"}, {"eligibility_criterion": "inclusion", "inclusion_indicator": "TRIAL", "synonyms": ["FLT3-ITD Mutation Negative", "FLT3-ITD Negative", "FLT3/ITD Mutation Negative", "FLT3/ITD Negative"], "nci_thesaurus_concept_id": "C150625", "name": "FLT3 Internal Tandem Duplication Negative", "semantic_types": ["Laboratory or Test Result"], "type": [], "ancestors": ["C25872", "C35681", "C21295", "C103223", "C25870", "C21281", "C16612", "C26131", "C24399", "C25871", "C20103", "C36292", "C77140", "C20719", "C177687", "C3367"], "parents": ["C177687", "C24399"], "assay_purpose": "Eligibility Criterion - Inclusion"}], "classification_code": null, "current_trial_status_date": "2022-08-01", "diseases": [{"inclusion_indicator": "TRIAL", "is_lead_disease": true, "synonyms": ["Recurrent Childhood Acute Myeloblastic Leukemia", "Recurrent Childhood Acute Myelogenous Leukemia", "Recurrent Childhood Acute Myeloid Leukemia", "Recurrent Childhood Acute Non-Lymphocytic Leukemia", "Recurrent Childhood AML", "Recurrent Pediatric Acute Myeloblastic Leukemia", "Recurrent Pediatric Acute Myelogenous Leukemia", "Recurrent Pediatric Acute Myeloid Leukemia", "Recurrent Pediatric AML", "Relapsed Childhood Acute Myeloblastic Leukemia", "Relapsed Childhood Acute Myelogenous Leukemia", "Relapsed Childhood Acute Myeloid Leukemia", "Relapsed Childhood AML", "Relapsed Pediatric Acute Myeloblastic Leukemia", "Relapsed Pediatric Acute Myelogenous Leukemia", "Relapsed Pediatric Acute Myeloid Leukemia", "Relapsed Pediatric AML"], "nci_thesaurus_concept_id": "C9068", "name": "Recurrent Acute Myeloid Leukemia (AML)", "type": ["stage"], "parents": ["C148427", "C212203", "C9160"]}, {"inclusion_indicator": "TREE", "is_lead_disease": true, "synonyms": ["Childhood Neoplasm", "Childhood Tumor", "Pediatric Neoplasm", "Pediatric Tumor"], "nci_thesaurus_concept_id": "C6283", "name": "Neoplasm", "type": ["subtype"], "parents": ["C89328", "C7062"]}, {"inclusion_indicator": "TREE", "is_lead_disease": true, "synonyms": ["Recurrent Hematologic Cancer", "Recurrent Hematologic Malignancy", "Relapsed Hematologic Cancer", "Relapsed Hematologic Malignancy"], "nci_thesaurus_concept_id": "C27358", "name": "Recurrent Hematopoietic and Lymphoid Cell Neoplasm", "type": ["stage"], "parents": ["C27134", "C4813"]}, {"inclusion_indicator": "TREE", "is_lead_disease": true, "synonyms": ["Acute Granulocytic Leukemia", "Acute Myeloblastic Leukemia", "Acute Myelocytic Leukemia", "Acute Myelogenous Leukemia", "Acute Myelogenous Leukemias", "Acute Myeloid Leukemia", "Acute Nonlymphocytic Leukemia", "AML", "AML - Acute Myeloid Leukemia", "ANLL", "Hematopoeitic - Acute Myleogenous Leukemia (AML)"], "nci_thesaurus_concept_id": "C3171", "name": "Acute Myeloid Leukemia (AML)", "type": ["maintype", "subtype"], "parents": ["C9300", "C3172"]}, {"inclusion_indicator": "TREE", "is_lead_disease": true, "synonyms": ["CA", "Cancer", "Malignancy", "Malignant Growth", "Malignant Neoplastic Disease", "Malignant Tumor", "Neoplasm, malignant", "Tumor, malignant, NOS", "Unclassified tumor, malignant"], "nci_thesaurus_concept_id": "C9305", "name": "Malignant Neoplasm", "type": ["subtype"], "parents": ["C7062"]}, {"inclusion_indicator": "TREE", "is_lead_disease": true, "synonyms": ["Childhood Leukemia"], "nci_thesaurus_concept_id": "C4989", "name": "Leukemia", "type": ["subtype"], "parents": ["C3161", "C9431", "C4005"]}, {"inclusion_indicator": "TREE", "is_lead_disease": true, "synonyms": ["Bone Marrow Tumor", "Neoplasm of Bone Marrow"], "nci_thesaurus_concept_id": "C35370", "name": "Bone Marrow Neoplasm", "type": ["subtype"], "parents": ["C35813", "C34433"]}, {"inclusion_indicator": "TREE", "is_lead_disease": true, "synonyms": ["Recurrence", "Recurrent Cancer", "Recurrent Malignant Tumor"], "nci_thesaurus_concept_id": "C4813", "name": "Recurrent Malignant Neoplasm", "type": ["stage"], "parents": ["C4798", "C9305"]}, {"inclusion_indicator": "TREE", "is_lead_disease": true, "synonyms": ["Hematologic Cancer", "Hematologic Neoplasm", "Hematological Neoplasm", "Hematopoietic and Lymphoid Neoplasm", "Hematopoietic malignancy, NOS", "Hematopoietic Neoplasm", "Hematopoietic Neoplasms Including Lymphomas", "HEMOLYMPHORETICULAR TUMOR, MALIGNANT", "Malignant Hematologic Neoplasm", "Malignant Hematopoietic Neoplasm", "Malignant neoplasm of lymphoid, hematopoietic and related tissue, unspecified"], "nci_thesaurus_concept_id": "C27134", "name": "Hematopoietic and Lymphoid Cell Neoplasm", "type": ["maintype"], "parents": ["C35813", "C26323", "C4741"]}, {"inclusion_indicator": "TREE", "is_lead_disease": true, "synonyms": [], "nci_thesaurus_concept_id": "C7062", "name": "Neoplasm by Special Category", "type": ["subtype"], "parents": ["C3262"]}, {"inclusion_indicator": "TREE", "is_lead_disease": true, "synonyms": ["Childhood Hematopoietic and Lymphoid Cell Neoplasm", "Childhood Hematopoietic Neoplasm", "Pediatric Hematopoietic and Lymphoid Cell Neoplasm"], "nci_thesaurus_concept_id": "C9431", "name": "Hematopoietic Neoplasm", "type": ["subtype"], "parents": ["C208293", "C27134"]}, {"inclusion_indicator": "TREE", "is_lead_disease": true, "synonyms": ["Leukemia, unspecified, in relapse"], "nci_thesaurus_concept_id": "C148425", "name": "Recurrent Leukemia", "type": ["stage"], "parents": ["C3161", "C27358"]}, {"inclusion_indicator": "TREE", "is_lead_disease": true, "synonyms": ["Blood Disease", "Blood Disorder", "Hematologic and Lymphocytic Disorder", "Hematologic and Lymphoid Cell Disorder", "Hematologic Disorder", "Hematological Disorder"], "nci_thesaurus_concept_id": "C26323", "name": "Hematopoietic and Lymphoid Cell Disorder", "type": ["subtype"], "parents": ["C35814"]}, {"inclusion_indicator": "TREE", "is_lead_disease": true, "synonyms": ["Hematopoietic and Lymphoid System Disorder"], "nci_thesaurus_concept_id": "C35814", "name": "Hematopoietic and Lymphatic System Disorder", "type": ["subtype"], "parents": ["C27551"]}, {"inclusion_indicator": "TREE", "is_lead_disease": true, "synonyms": ["Condition", "Diagnosis", "Disease", "Disease or Disorder", "Disease or Disorder, Non-Neoplastic", "disease term", "disease type", "disease_term", "disease_type", "Diseases", "Diseases and Disorders", "Disorder", "Disorders"], "nci_thesaurus_concept_id": "C2991", "name": "Other Disease", "type": ["maintype"], "parents": []}, {"inclusion_indicator": "TREE", "is_lead_disease": true, "synonyms": ["Myeloid leukemia, unspecified in relapse"], "nci_thesaurus_concept_id": "C193431", "name": "Recurrent Myeloid Leukemia", "type": ["stage"], "parents": ["C3172", "C172132", "C148425"]}, {"inclusion_indicator": "TREE", "is_lead_disease": true, "synonyms": ["Neoplasia", "Neoplasm", "Neoplasm, NOS", "Neoplasms, NOS", "Neoplastic Disease", "Neoplastic Growth", "tumor", "Tumor, NOS"], "nci_thesaurus_concept_id": "C3262", "name": "Other Neoplasm", "type": ["maintype"], "parents": ["C2991"]}, {"inclusion_indicator": "TREE", "is_lead_disease": true, "synonyms": ["Pediatric Disease", "Pediatric Disease or Disorder"], "nci_thesaurus_concept_id": "C89328", "name": "Pediatric Disorder", "type": ["subtype"], "parents": ["C2991"]}, {"inclusion_indicator": "TREE", "is_lead_disease": true, "synonyms": ["Hematopoietic and Lymphatic System Neoplasm", "Hematopoietic and Lymphoid System Tumor", "Neoplasm of uncertain behavior of lymphoid, hematopoietic and related tissue, unspecified"], "nci_thesaurus_concept_id": "C35813", "name": "Hematopoietic and Lymphoid System Neoplasm", "type": ["subtype"], "parents": ["C35814", "C3263"]}, {"inclusion_indicator": "TREE", "is_lead_disease": true, "synonyms": ["Neoplasm Recurrence", "Recurrence", "Recurrent", "Recurrent Tumor"], "nci_thesaurus_concept_id": "C4798", "name": "Recurrent Neoplasm", "type": ["stage"], "parents": ["C7062"]}, {"inclusion_indicator": "TREE", "is_lead_disease": true, "synonyms": ["Childhood Acute Myeloblastic Leukemia", "Childhood Acute Myelogenous Leukemia", "Childhood Acute Myeloid Leukemia", "Childhood Acute Myeloid Leukemia (AML)", "Childhood AML", "Pediatric Acute Myeloblastic Leukemia", "Pediatric Acute Myelogenous Leukemia", "Pediatric Acute Myeloid Leukemia", "Pediatric AML"], "nci_thesaurus_concept_id": "C9160", "name": "Acute Myeloid Leukemia (AML)", "type": ["subtype"], "parents": ["C187056", "C3171"]}, {"inclusion_indicator": "TREE", "is_lead_disease": true, "synonyms": [], "nci_thesaurus_concept_id": "C162702", "name": "Recurrent Childhood Malignant Neoplasm", "type": ["stage"], "parents": ["C4005", "C4813"]}, {"inclusion_indicator": "TREE", "is_lead_disease": true, "synonyms": ["Acute myeloblastic leukemia, in relapse", "Recurrent Acute Myeloid Leukemia"], "nci_thesaurus_concept_id": "C148427", "name": "Recurrent Acute Myeloid Leukemia (AML)", "type": ["stage"], "parents": ["C193431", "C3171", "C148429"]}, {"inclusion_indicator": "TREE", "is_lead_disease": true, "synonyms": ["Leukemia Granulocytic", "Leukemia Myeloid", "LEUKEMIA, GRANULOCYTIC, MALIGNANT", "Myelocytic Leukemia", "Myelogenous Leukemia", "Myeloid leukemia, NOS", "Non-Lymphoblastic Leukemia", "Non-Lymphocytic Leukemia"], "nci_thesaurus_concept_id": "C3172", "name": "Myeloid Leukemia", "type": ["maintype", "subtype"], "parents": ["C35501", "C9290", "C3161"]}, {"inclusion_indicator": "TREE", "is_lead_disease": true, "synonyms": ["Tumor Morphology", "Tumor_Morphology"], "nci_thesaurus_concept_id": "C4741", "name": "Neoplasm by Morphology", "type": ["subtype"], "parents": ["C3262"]}, {"inclusion_indicator": "TREE", "is_lead_disease": true, "synonyms": ["Acute leukemia of unspecified cell type, in relapse"], "nci_thesaurus_concept_id": "C148429", "name": "Recurrent Acute Leukemia", "type": ["stage"], "parents": ["C9300", "C148425"]}, {"inclusion_indicator": "TREE", "is_lead_disease": true, "synonyms": ["Bone Marrow Disease"], "nci_thesaurus_concept_id": "C34433", "name": "Bone Marrow Disorder", "type": ["subtype"], "parents": ["C35814"]}, {"inclusion_indicator": "TREE", "is_lead_disease": true, "synonyms": [], "nci_thesaurus_concept_id": "C172132", "name": "Recurrent Myeloid Neoplasm", "type": ["stage"], "parents": ["C9290", "C27358"]}, {"inclusion_indicator": "TREE", "is_lead_disease": true, "synonyms": [], "nci_thesaurus_concept_id": "C212203", "name": "Recurrent Childhood Acute Leukemia", "type": ["stage"], "parents": ["C148429", "C187056", "C213757"]}, {"inclusion_indicator": "TREE", "is_lead_disease": true, "synonyms": [], "nci_thesaurus_concept_id": "C7057", "name": "Disease, Disorder or Finding", "type": ["finding"], "parents": []}, {"inclusion_indicator": "TREE", "is_lead_disease": true, "synonyms": ["bone marrow cancer", "Malignant Bone Marrow Tumor"], "nci_thesaurus_concept_id": "C35501", "name": "Malignant Bone Marrow Neoplasm", "type": ["subtype"], "parents": ["C9305", "C35370"]}, {"inclusion_indicator": "TREE", "is_lead_disease": true, "synonyms": [], "nci_thesaurus_concept_id": "C9290", "name": "Myeloid Neoplasm", "type": ["maintype", "subtype"], "parents": ["C27134"]}, {"inclusion_indicator": "TREE", "is_lead_disease": true, "synonyms": ["Blood (Leukemia)", "Leukemia NOS", "Leukemia, Disease", "LEUKEMIA, MALIGNANT", "Leukemia, NOS", "Leukemias", "Leukemias, General"], "nci_thesaurus_concept_id": "C3161", "name": "Leukemia", "type": ["maintype", "subtype"], "parents": ["C9305", "C27134"]}, {"inclusion_indicator": "TREE", "is_lead_disease": true, "synonyms": ["Childhood Cancer", "Childhood Malignant Neoplasm", "Malignant Childhood Neoplasm", "Malignant Childhood Tumor", "Malignant Pediatric Neoplasm", "Malignant Pediatric Tumor", "Pediatric Cancer"], "nci_thesaurus_concept_id": "C4005", "name": "Malignant Neoplasm", "type": ["subtype"], "parents": ["C6283", "C9305"]}, {"inclusion_indicator": "TREE", "is_lead_disease": true, "synonyms": [], "nci_thesaurus_concept_id": "C208293", "name": "Childhood Hematopoietic and Lymphatic System Neoplasm", "type": ["subtype"], "parents": ["C6283", "C35813"]}, {"inclusion_indicator": "TREE", "is_lead_disease": true, "synonyms": [], "nci_thesaurus_concept_id": "C3263", "name": "Neoplasm by Site", "type": ["subtype"], "parents": ["C3262"]}, {"inclusion_indicator": "TREE", "is_lead_disease": true, "synonyms": [], "nci_thesaurus_concept_id": "C9300", "name": "Acute Leukemia", "type": ["subtype"], "parents": ["C3161"]}, {"inclusion_indicator": "TREE", "is_lead_disease": true, "synonyms": [], "nci_thesaurus_concept_id": "C213757", "name": "Recurrent Childhood Leukemia", "type": ["stage"], "parents": ["C162702", "C4989", "C148425"]}, {"inclusion_indicator": "TREE", "is_lead_disease": true, "synonyms": ["Disease by Site"], "nci_thesaurus_concept_id": "C27551", "name": "Disorder by Site", "type": ["subtype"], "parents": ["C2991"]}, {"inclusion_indicator": "TREE", "is_lead_disease": true, "synonyms": ["Pediatric Acute Leukemia"], "nci_thesaurus_concept_id": "C187056", "name": "Childhood Acute Leukemia", "type": ["subtype"], "parents": ["C9300", "C4989"]}], "_primary_purpose_sort_order": 0, "protocol_id": "ITCC-101/APAL2020D", "active_sites_count": 23, "lead_org_cancer_center": null, "arms": [{"interventions": [], "name": "Arm A: Control Arm without Venetoclax", "description": "During Cycle 1 (42-day-cycles), participants will receive 30 mg/m^2 of fludarabine\r\nfollowed by 2 g/m^2 of cytarabine on Days 1-5. Gemtuzumab 3 mg/m^2 will be given on Day 6\r\n(only for participants with CD33 expression on leukemia blasts).\r\n\r\nDuring Cycle 2 participants will receive 30 mg/m^2 of fludarabine followed by 2 g/m^2 of\r\ncytarabine on Days 1-5. After Cycle 2 participants are assessed for HSCT or azacitidine\r\nmaintenance therapy.", "type": "ACTIVE_COMPARATOR"}, {"interventions": [], "name": "Arm B: Experimental Arm with Venetoclax", "description": "During Cycle 1 (42-day-cycles), participants will receive 300 mg adult dose equivalent of\r\nvenetoclax once on Day 1 followed by 600 mg adult dose equivalent of venetoclax on Days\r\n2-21. Participants will also receive 30 mg/m^2 of fludarabine followed by 2 g/m^2 of\r\ncytarabine on Days 8-12. Gemtuzumab 3 mg/m^2 will be given on Day 13 (only for\r\nparticipants with CD33 expression on leukemia blasts).\r\n\r\nDuring Cycle 2, participants will receive 600 mg adult dose equivalent of venetoclax on\r\nDays 1-21. Participants will receive 30 mg/m^2 of fludarabine followed by 2 g/m^2 of\r\ncytarabine on Days 1-5. After Cycle 2 participants are assessed for HSCT or azacitidine\r\nmaintenance therapy in combination with venetoclax.", "type": "EXPERIMENTAL"}, {"interventions": [{"inclusion_indicator": "TREE", "synonyms": ["Antineoplastic Biotherapeutic", "Anticancer Biological", "Antineoplastic Biological", "Anti-cancer Biological Agent"], "nci_thesaurus_concept_id": "C129821", "name": "Antineoplastic Biological Agent", "description": null, "type": "Drug", "category": "agent category", "parents": ["C307", "C274"]}, {"inclusion_indicator": "TRIAL", "synonyms": [], "nci_thesaurus_concept_id": "C1094", "name": "Fludarabine", "description": null, "type": "Drug", "category": "agent", "parents": ["C2150", "C1556"]}, {"inclusion_indicator": "TREE", "synonyms": [], "nci_thesaurus_concept_id": "C1512", "name": "Immunoconjugate", "description": null, "type": "Drug", "category": "agent category", "parents": ["C308", "C307"]}, {"inclusion_indicator": "TREE", "synonyms": ["DNMT Inhibitor"], "nci_thesaurus_concept_id": "C2083", "name": "DNA Methyltransferase Inhibitor", "description": null, "type": "Drug", "category": "agent category", "parents": ["C132686", "C471"]}, {"inclusion_indicator": "TRIAL", "synonyms": ["Venclyxto", "Venclexta"], "nci_thesaurus_concept_id": "C103147", "name": "Venetoclax", "description": "An orally bioavailable, selective small molecule inhibitor of the anti-apoptotic protein Bcl-2, with potential antineoplastic activity. GDC-0199 mimics BH3-only proteins, the native ligands of Bcl-2 and apoptosis activators, by binding to the hydrophobic groove of Bcl-2 proteins  thereby repressing Bcl-2 activity and restoring apoptotic processes in tumor cells. Bcl-2 protein is overexpressed in some cancers and plays an important role in the regulation of apoptosis; its expression is associated with increased drug resistance and tumor cell survival. Compared to the Bcl-2 inhibitor navitoclax, this agent does not inhibit bcl-XL and does not cause bcl-XL-mediated thrombocytopenia. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)Health professional", "type": "Drug", "category": "agent", "parents": ["C159200"]}, {"inclusion_indicator": "TREE", "synonyms": [], "nci_thesaurus_concept_id": "C1557", "name": "Pyrimidine Antagonist", "description": null, "type": "Drug", "category": "agent category", "parents": ["C272"]}, {"inclusion_indicator": "TREE", "synonyms": [], "nci_thesaurus_concept_id": "C1908", "name": "Drug, Food, Chemical or Biomedical Material", "description": null, "type": "Drug", "category": "agent category", "parents": []}, {"inclusion_indicator": "TREE", "synonyms": ["Anti-CD33 ADC"], "nci_thesaurus_concept_id": "C2333", "name": "Anti-CD33 Antibody-drug Conjugate", "description": null, "type": "Drug", "category": "agent category", "parents": ["C129823"]}, {"inclusion_indicator": "TRIAL", "synonyms": ["Mylotarg"], "nci_thesaurus_concept_id": "C1806", "name": "Gemtuzumab Ozogamicin", "description": "A recombinant, humanized anti-CD33 monoclonal antibody attached to the cytotoxic antitumor antibiotic calicheamicin.  In this conjugate, the antibody binds to and is internalized by tumor cells expressing CD33 antigen (a sialic acid-dependent glycoprotein commonly found on the surface of leukemic blasts), thereby delivering the attached calicheamicin to CD33-expressing tumor cells. Calicheamicin binds to the minor groove of DNA, causing double strand DNA breaks and resulting in inhibition of DNA synthesis. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)Health professional", "type": "Drug", "category": "agent", "parents": ["C2333"]}, {"inclusion_indicator": "TRIAL", "synonyms": ["Starasid", "Cytarbel", "Aracytine", "Udicil", "ARA-cell", "Erpalfa", "Alexan", "Arabine", "Aracytin", "Cytosar"], "nci_thesaurus_concept_id": "C408", "name": "Cytarabine", "description": "An antimetabolite analogue of cytidine with a modified sugar moiety (arabinose instead of ribose). Cytarabine is converted to the triphosphate form within the cell and then competes with cytidine for incorporation into DNA.  Because the arabinose sugar sterically hinders the rotation of the molecule within DNA, DNA replication ceases, specifically during the S phase of the cell cycle.  This agent also inhibits DNA polymerase, resulting in a decrease in DNA replication and repair. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)Health professional", "type": "Drug", "category": "agent", "parents": ["C1557"]}, {"inclusion_indicator": "TREE", "synonyms": ["Bcl-2 Family Inhibitor"], "nci_thesaurus_concept_id": "C192025", "name": "Bcl-2 Family Protein Inhibitor", "description": null, "type": "Drug", "category": "agent category", "parents": ["C129839"]}, {"inclusion_indicator": "TREE", "synonyms": ["Drug-conjugated Antibody", "Antineoplastic Antibody-drug Conjugate", "Cancer-targeted Antibody Drug Conjugate", "Antineoplastic ADC"], "nci_thesaurus_concept_id": "C129823", "name": "Antineoplastic Antibody-Drug Conjugate", "description": null, "type": "Drug", "category": "agent category", "parents": ["C129821", "C1512"]}, {"inclusion_indicator": "TREE", "synonyms": ["Pharmacologic Agent", "Agent", "Drug Substance", "Drug", "Pharmaceutical Agent", "Pharmaceuticals", "Pharmacological Substance"], "nci_thesaurus_concept_id": "C1909", "name": "Pharmacologic Substance", "description": null, "type": "Drug", "category": "agent category", "parents": ["C1908"]}, {"inclusion_indicator": "TREE", "synonyms": ["Enzyme Antagonist", "Enzyme Inhibitor Agent", "Enzyme Inhibitor Drug"], "nci_thesaurus_concept_id": "C471", "name": "Enzyme Inhibitor", "description": null, "type": "Drug", "category": "agent category", "parents": ["C1909"]}, {"inclusion_indicator": "TREE", "synonyms": ["Purine Inhibitors"], "nci_thesaurus_concept_id": "C1556", "name": "Purine Antagonist", "description": null, "type": "Drug", "category": "agent category", "parents": ["C272"]}, {"inclusion_indicator": "TREE", "synonyms": ["Immunomodulating Agent", "Immune Mediators", "Immunotherapeutic Agent", "Immunomodulators", "Immune Regulators", "Immunomodulatory Agent", "BRM", "Biomodulators", "Immune Modulators", "Immunopotentiators", "Biological Response Modifier", "Immunotherapy Agent"], "nci_thesaurus_concept_id": "C308", "name": "Immunotherapy", "description": null, "type": "Drug", "category": "agent category", "parents": ["C1909"]}, {"inclusion_indicator": "TRIAL", "synonyms": ["Vidaza"], "nci_thesaurus_concept_id": "C288", "name": "Azacitidine", "description": "A pyrimidine nucleoside analogue of cytidine with antineoplastic activity. Azacitidine is incorporated into DNA, where it reversibly inhibits DNA methyltransferase, thereby blocking DNA methylation.  Hypomethylation of DNA by azacitidine may activate tumor suppressor genes silenced by hypermethylation, resulting in an antitumor effect. This agent is also incorporated into RNA, thereby disrupting normal RNA function and impairing tRNA cytosine-5-methyltransferase activity. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)Health professional", "type": "Drug", "category": "agent", "parents": ["C1557", "C2083"]}, {"inclusion_indicator": "TREE", "synonyms": ["DNA Methylation Inhibitor"], "nci_thesaurus_concept_id": "C132686", "name": "Demethylating Agent", "description": null, "type": "Drug", "category": "agent category", "parents": ["C274"]}, {"inclusion_indicator": "TREE", "synonyms": ["Biologics", "Biologicals", "Biological Products", "Biopharmaceuticals", "Immunologic, Immunochemical", "Immunologics"], "nci_thesaurus_concept_id": "C307", "name": "Biological Agent", "description": null, "type": "Drug", "category": "agent category", "parents": ["C1909"]}, {"inclusion_indicator": "TREE", "synonyms": ["Apoptotic Pathway-targeting Cancer Therapeutic"], "nci_thesaurus_concept_id": "C129839", "name": "Apoptotic Pathway-targeting Antineoplastic Agent", "description": null, "type": "Drug", "category": "agent category", "parents": ["C274"]}, {"inclusion_indicator": "TREE", "synonyms": ["Antineoplastic Cytotoxic Agent", "Cytotoxic Chemotherapy Agent", "Cytotoxic Antineoplastic Agent"], "nci_thesaurus_concept_id": "C186664", "name": "Cytotoxic Chemotherapeutic Agent", "description": null, "type": "Drug", "category": "agent category", "parents": ["C274"]}, {"inclusion_indicator": "TREE", "synonyms": ["Anti-Cancer Agents", "Anti-Tumor Agents", "Anti-Tumor Drugs", "Chemotherapeutic Agents, Neoplastic Disease", "Antiproliferative Drugs", "Cancer Drug", "Antineoplastic Drugs", "Antiproliferative Agents", "Antineoplastics", "Tumor-Specific Treatment Agents"], "nci_thesaurus_concept_id": "C274", "name": "Antineoplastic Agent", "description": null, "type": "Drug", "category": "agent category", "parents": ["C1909"]}, {"inclusion_indicator": "TREE", "synonyms": ["B-cell Lymphoma 2 Inhibitor", "BCL2 Inhibitor"], "nci_thesaurus_concept_id": "C159200", "name": "BCL-2 Inhibitor", "description": null, "type": "Drug", "category": "agent category", "parents": ["C192025"]}, {"inclusion_indicator": "TREE", "synonyms": [], "nci_thesaurus_concept_id": "C2150", "name": "Ribonucleotide Reductase Inhibitor", "description": null, "type": "Drug", "category": "agent category", "parents": ["C471"]}, {"inclusion_indicator": "TREE", "synonyms": ["Antimetabolites"], "nci_thesaurus_concept_id": "C272", "name": "Antimetabolite", "description": null, "type": "Drug", "category": "agent category", "parents": ["C186664"]}], "name": "Arm not specified", "description": null, "type": null}], "study_model_code": null, "nci_id": "NCI-2022-07200", "why_study_stopped": null, "brief_summary": "A study to evaluate if the randomized addition of venetoclax to a chemotherapy backbone\r\n(fludarabine/cytarabine/gemtuzumab ozogamicin [GO]) improves survival of\r\nchildren/adolescents/young adults with acute myeloid leukemia (AML) in 1st relapse who\r\nare unable to receive additional anthracyclines, or in 2nd relapse.", "brief_title": "Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)", "status_history": [{"status_date": "2022-08-01T00:00:00", "status": "ACTIVE"}], "study_population_description": null, "sampling_method_code": null, "minimum_target_accrual_number": 98, "prior_therapy": [], "_current_trial_status_sort_order": 0, "start_date": "2022-10-01", "record_verification_date": "2025-01-01", "ctep_id": null, "current_trial_status": "Active", "study_model_other_text": null, "masking": {"role_caregiver": null, "masking": null, "role_investigator": null, "role_outcome_assessor": null, "role_subject": null, "allocation_code": "Randomized Controlled Trial"}, "acronym": null, "nci_programs": [], "nci_funded": "Indirect", "anatomic_sites": ["Myeloid and Monocytic Leukemia"], "ccr_id": null, "start_date_type_code": "ACTUAL", "principal_investigator": null, "study_source": "Externally Peer Reviewed", "completion_date": "2031-04-01", "study_subtype_code": null, "study_protocol_type": "Interventional"}, {"other_ids": [], "amendment_date": null, "keywords": null, "dcp_id": null, "interventional_model": "Single Group", "lead_org": "Stanford Cancer Institute Palo Alto", "eligibility": {"unstructured": [{"inclusion_indicator": true, "display_order": 1, "description": "Prior morphologically-confirmed diagnosis of AML based on World Health Organization (WHO) Criteria."}, {"inclusion_indicator": true, "display_order": 2, "description": "Has previously failed all available and suitable therapies for AML. Disease relapse or the presence of refractory disease after >= 2 cycles of intensive chemotherapy; or >= 4 cycles of non-intensive chemotherapy or hypomethylating agents (HMAs) must be documented by bone marrow (BM) examination demonstrating >= 5% blasts in the BM by morphology or >= 1% blasts by flow cytometry, >= 5% blasts in the peripheral blood (confirmed by flow cytometry, cytogenetics or fluorescence in situ hybridization [FISH]), >= 1% minimal residual disease (MRD) + by flow cytometry, FISH, polymerase chain reaction (PCR) or next generation sequencing (NGS), and not attributable to another cause (EXCEPTION: subjects with frank disease progression in the face of treatment with HMA with or without venetoclax will be considered eligible regardless of treatment cycles administered if they meet the other eligibility criteria)."}, {"inclusion_indicator": true, "display_order": 3, "description": "Age >= 2 and =< 25 years."}, {"inclusion_indicator": true, "display_order": 4, "description": "Body surface area (BSA) =< 2.10 m^2, calculated per the Mostellar formula."}, {"inclusion_indicator": true, "display_order": 5, "description": "Must be able to tolerate oral (po) or nasogastric (ng) medications."}, {"inclusion_indicator": true, "display_order": 6, "description": "Performance status: \r\n* Subject =< 16 years old: Lansky >= 50 \r\n* Subject > 16 years old: Karnofsky >= 50%."}, {"inclusion_indicator": true, "display_order": 7, "description": "Life expectancy of greater than 4 weeks."}, {"inclusion_indicator": true, "display_order": 8, "description": "Platelets >= 10,000/mm^3 (for subjects with platelets < 10,000/mm^3 at baseline, platelet transfusion support is allowed)."}, {"inclusion_indicator": true, "display_order": 9, "description": "Measured or calculated creatinine clearance >= 60 mL/min/1.73 m^2 (by the Cockcroft-Gault method) within 14 days prior to treatment initiation."}, {"inclusion_indicator": true, "display_order": 10, "description": "Total bilirubin =< 2.0 x institutional upper limit of normal (ULN) within 14 days prior to treatment initiation (EXCEPTION: Subjects with Gilbert\u2019s syndrome may be included if the total bilirubin is =< 3.0 x ULN)."}, {"inclusion_indicator": true, "display_order": 11, "description": "Serum glutamic-oxaloacetic transaminase (SGOT) (aspartate aminotransferase [AST]) =< 3.0 x ULN and serum glutamate pyruvate transaminase (SGPT) (alanine aminotransferase [ALT]) =< 3.0 x ULN within 14 days prior to treatment initiation."}, {"inclusion_indicator": true, "display_order": 12, "description": "Patients must have received their last dose of anti-cancer therapy (chemotherapy, immunotherapy, targeted agents, radiotherapy or investigational therapy) at least 2 weeks or 3 half-lives prior to the start of study treatment, whichever is longer."}, {"inclusion_indicator": true, "display_order": 13, "description": "For patients who have received prior hematopoietic stem cell transplants (HSCT), no evidence of GvHD and must be > 60 days since the HSCT. HSCT recipients must have completed their last course of tacrolimus, cyclosporine, or mycophenolate > 4 weeks before initiation of niclosamide."}, {"inclusion_indicator": true, "display_order": 14, "description": "Females of reproductive potential (WOCBP) must have a negative pregnancy test within 14 days prior to study treatment. WOCBP must agree to use adequate contraception (eg, hormonal or barrier methods of birth control; abstinence; sterilized partner) from date of consent through the treatment period, and for 30 days after completion of niclosamide administration."}, {"inclusion_indicator": true, "display_order": 15, "description": "Men only: Men must agree to use adequate contraception (eg, hormonal or barrier methods of birth control; abstinence; sterilized partner) from date of consent through the treatment period, and for 30 days after completion of niclosamide administration."}, {"inclusion_indicator": true, "display_order": 16, "description": "Ability to understand the purpose and risks of the study and the willingness to sign a written informed consent document containing an authorization to use protected health information (in accordance with national and local subject privacy regulations."}, {"inclusion_indicator": false, "display_order": 17, "description": "Received anticancer therapy (chemotherapy, immunotherapy, radiotherapy, or investigational therapy) within 2 weeks prior to starting study treatment. Administration of hydroxyurea 10 to 20 mg/kg/day PO (maximum 1000 mg PO twice daily [BID]) to control high white blood cells (WBC) > 50 x 10^3/mm^3 is permitted at medical doctor (MD) discretion (however, hydroxyurea should be stopped at least 24 hours prior to protocol therapy start)."}, {"inclusion_indicator": false, "display_order": 18, "description": "Receiving any other investigational agents."}, {"inclusion_indicator": false, "display_order": 19, "description": "Unresolved toxicities due to prior anticancer therapy, defined as not having resolved to grade 0 or 1 (by Common Terminology Criteria for Adverse Events [CTCAE] version 5 criteria), unless otherwise defined in the inclusion/exclusion criteria with the exception of alopecia."}, {"inclusion_indicator": false, "display_order": 20, "description": "Acute promyelocytic leukemia (French-American-British class M3-AML)."}, {"inclusion_indicator": false, "display_order": 21, "description": "Known active central nervous system (CNS) leukemia; subjects can enroll on study if CNS disease can be cleared with intrathecal chemotherapy, in the judgement of the treating physician."}, {"inclusion_indicator": false, "display_order": 22, "description": "Known congenital bleeding disorders, including but not limited to hemophilia."}, {"inclusion_indicator": false, "display_order": 23, "description": "Known active uncontrolled systemic infection."}, {"inclusion_indicator": false, "display_order": 24, "description": "Malabsorption syndrome, disease significantly affecting gastrointestinal function, or resection of the stomach or small bowel, uncontrolled symptomatic inflammatory bowel disease or ulcerative colitis, or partial or complete bowel obstruction, at the time of study entry."}, {"inclusion_indicator": false, "display_order": 25, "description": "Inability to receive administration of niclosamide in the available formulation(s)."}, {"inclusion_indicator": false, "display_order": 26, "description": "Uncontrolled intercurrent illness including, but not limited to, uncontrolled active infection, or psychiatric illness/social situations that would limit compliance with study requirements."}, {"inclusion_indicator": false, "display_order": 27, "description": "Lactating or pregnant female."}, {"inclusion_indicator": false, "display_order": 28, "description": "Known active hepatitis C."}], "structured": {"max_age": "25 Years", "max_age_number": 25.0, "min_age_unit": "Years", "max_age_unit": "Years", "max_age_in_years": 25.0, "sex": "ALL", "accepts_healthy_volunteers": false, "min_age": "2 Years", "min_age_number": 2.0, "min_age_in_years": 2.0}}, "sites": [{"org_state_or_province": "CA", "contact_name": "Kathleen Miho Sakamoto", "contact_phone": "650-725-7126", "recruitment_status_date": "2022-11-04", "org_address_line_2": null, "org_va": false, "org_address_line_1": "875 Blake Wilbur Drive", "org_tty": null, "org_family": "Stanford Cancer Institute", "org_postal_code": "94304", "contact_email": "kmsakamo@stanford.edu", "recruitment_status": "ACTIVE", "org_city": "Palo Alto", "org_email": "ccto-office@stanford.edu", "org_country": "United States", "org_fax": null, "org_phone": "650-498-7061", "org_name": "Stanford Cancer Institute Palo Alto", "org_coordinates": {"lon": -122.1462, "lat": 37.4059}}], "completion_date_type_code": "ANTICIPATED", "detail_description": "PRIMARY OBJECTIVE: \r\nI. To identify and evaluate safety for the recommended phase 2 dose (RP2D) of niclosamide in combination with cytarabine for relapsed and/or refractory acute myeloid leukemia (AML).\r\n\r\nSECONDARY OBJECTIVE: \r\nI. To determine the pharmacodynamic effect of niclosamide in myeloid blasts with and without combination with cytarabine.\r\n\r\nEXPLORATORY OBJECTIVES: \r\nI. To evaluate the pharmacokinetics of niclosamide in children with relapsed and refractory AML.\r\nII. To assess the induction response rate (complete response [CR] + complete remission with incomplete count recovery [CRi]) of niclosamide given with cytarabine in subjects with relapsed/refractory AML.\r\n\r\nOUTLINE: This is a dose-escalation study of niclosamide. \r\n\r\nPatients receive niclosamide orally (PO) or nasogastrically (NG) and cytarabine intravenously (IV) on study. Patients also undergo bone marrow aspiration and biopsy and collection of blood samples at screening and on study.", "official_title": "Phase I Study of Niclosamide in Pediatric and Young Adult Patients with Relapsed and Refractory AML", "_phase_sort_order": 4, "collaborators": [], "associated_studies": [], "outcome_measures": [{"timeframe": "Up to 28 days (first cycle of treatment)", "name": "Incidence of dose-limiting toxicities", "description": "All participants receiving niclosamide will be evaluated for dose-limiting toxicities during the first cycle of treatment, including weekly laboratory testing, defined as any adverse event related to niclosamide therapy that is a >= grade 3 adverse event considered related to niclosamide treatment. Will be reported as the number of events, a number without dispersion.", "type_code": "PRIMARY"}, {"timeframe": "Up to 8 weeks", "name": "Niclosamide treatment response", "description": "All participants receiving niclosamide will undergo a bone marrow (BM) flow cytometric evaluation for the % of blasts in the BM, to determine if the participant achieves a complete response (CR); partial response (PR); has resistant disease with clinical benefit (RD-CB); or no response (NR), defined as the following:\r\n* CR: < 5% blasts in BM, with no evidence of extramedullary disease.\r\n* PR: >= 5% to =< 25% blasts in BM with decrease in BM blast percentage by 50%, and no evidence of extramedullary disease.\r\n* RD-CB: >= 5% to =< 25% blasts in BM OR a decrease in blast percentage by 50%, either with no evidence of extramedullary disease.\r\n* NR: BM disease that does not fall into the above categories.\r\nThe outcome will be reported as the number of participant that achieve a clinical benefit, defined as CR; PR; or RD-CB, a number without dispersion.", "type_code": "SECONDARY"}], "phase": "I", "central_contact": {"phone": null, "name": null, "type": null, "email": null}, "primary_purpose": "TREATMENT", "number_of_arms": 1, "_study_protocol_type_sort_order": 0, "nct_id": "NCT05188170", "biomarkers": [{"eligibility_criterion": "inclusion", "inclusion_indicator": "TREE", "synonyms": ["Residual Tumor", "residual_disease", "residual_tumor"], "nci_thesaurus_concept_id": "C4809", "name": "Residual Disease", "semantic_types": ["Finding"], "type": [], "ancestors": ["C50995", "C3367", "C35461"], "parents": ["C50995"], "assay_purpose": "Eligibility Criterion - Inclusion"}, {"eligibility_criterion": "inclusion", "inclusion_indicator": "TREE", "synonyms": ["Clinical Measurement", "Diagnostic Test Result"], "nci_thesaurus_concept_id": "C77140", "name": "Clinical Test Result", "semantic_types": ["Finding"], "type": [], "ancestors": ["C3367"], "parents": ["C3367"], "assay_purpose": "Eligibility Criterion - Inclusion"}, {"eligibility_criterion": "inclusion", "inclusion_indicator": "TREE", "synonyms": [], "nci_thesaurus_concept_id": "C35553", "name": "Abnormal Blood Chemistry and Hematology Test Result", "semantic_types": ["Laboratory or Test Result"], "type": [], "ancestors": ["C77140", "C82547", "C26683", "C3367", "C36292"], "parents": ["C26683"], "assay_purpose": "Eligibility Criterion - Inclusion"}, {"eligibility_criterion": "inclusion", "inclusion_indicator": "TRIAL", "synonyms": ["Blasts Greater than or Equal to 1 Percent of Bone Marrow Nucleated Cells"], "nci_thesaurus_concept_id": "C162512", "name": "Blasts 1 Percent or More of Bone Marrow Nucleated Cells", "semantic_types": ["Laboratory or Test Result"], "type": [], "ancestors": ["C36289", "C26683", "C35553", "C157653", "C35508", "C35883", "C190021", "C157287", "C36278", "C82547", "C36292", "C3367", "C35877", "C77140", "C35880"], "parents": ["C157287"], "assay_purpose": "Eligibility Criterion - Inclusion"}, {"eligibility_criterion": "inclusion", "inclusion_indicator": "TREE", "synonyms": ["LAB_RESULT", "Lab Findings", "Lab Value", "Laboratory Finding", "Laboratory Report", "Labs", "Test Result", "test_result"], "nci_thesaurus_concept_id": "C36292", "name": "Laboratory Test Result", "semantic_types": ["Laboratory or Test Result"], "type": [], "ancestors": ["C3367", "C77140"], "parents": ["C77140"], "assay_purpose": "Eligibility Criterion - Inclusion"}, {"eligibility_criterion": "inclusion", "inclusion_indicator": "TREE", "synonyms": [], "nci_thesaurus_concept_id": "C35508", "name": "Abnormal Bone Marrow Test Result", "semantic_types": ["Laboratory or Test Result"], "type": [], "ancestors": ["C36289", "C26683", "C35553", "C35877", "C36278", "C82547", "C36292", "C3367", "C190021", "C77140"], "parents": ["C190021", "C35877"], "assay_purpose": "Eligibility Criterion - Inclusion"}, {"eligibility_criterion": "inclusion", "inclusion_indicator": "TRIAL", "synonyms": ["Detectable Residual Disease", "MRD", "Measurable Residual Disease"], "nci_thesaurus_concept_id": "C3896", "name": "Minimal Residual Disease", "semantic_types": ["Finding"], "type": [], "ancestors": ["C4809", "C124433", "C35461", "C50995", "C3367"], "parents": ["C124433", "C4809"], "assay_purpose": "Eligibility Criterion - Inclusion"}, {"eligibility_criterion": "inclusion", "inclusion_indicator": "TREE", "synonyms": ["Disease Response to Treatment", "Disease Status", "Response", "Response to Treatment", "Treatment Response", "disease_response"], "nci_thesaurus_concept_id": "C50995", "name": "Disease Response", "semantic_types": ["Finding"], "type": [], "ancestors": ["C3367", "C35461"], "parents": ["C35461"], "assay_purpose": "Eligibility Criterion - Inclusion"}, {"eligibility_criterion": "inclusion", "inclusion_indicator": "TREE", "synonyms": ["Blasts Greater than or Equal to 1 Percent of Peripheral Blood White Cells"], "nci_thesaurus_concept_id": "C147055", "name": "Blasts 1 Percent or More of Peripheral Blood White Cells", "semantic_types": ["Laboratory or Test Result"], "type": [], "ancestors": ["C36289", "C26683", "C35553", "C36278", "C82547", "C35881", "C36292", "C3367", "C35877", "C77140", "C35880"], "parents": ["C35881"], "assay_purpose": "Eligibility Criterion - Inclusion"}, {"eligibility_criterion": "inclusion", "inclusion_indicator": "TREE", "synonyms": ["Clinical Course", "LONGCRSE", "Longitudinal Course"], "nci_thesaurus_concept_id": "C35461", "name": "Clinical Course of Disease", "semantic_types": ["Finding"], "type": [], "ancestors": ["C3367"], "parents": ["C3367"], "assay_purpose": "Eligibility Criterion - Inclusion"}, {"eligibility_criterion": "inclusion", "inclusion_indicator": "TREE", "synonyms": [], "nci_thesaurus_concept_id": "C35881", "name": "Blast Cells Present in Peripheral Blood", "semantic_types": ["Laboratory or Test Result"], "type": [], "ancestors": ["C36289", "C26683", "C35553", "C36278", "C82547", "C36292", "C3367", "C35877", "C77140", "C35880"], "parents": ["C35880"], "assay_purpose": "Eligibility Criterion - Inclusion"}, {"eligibility_criterion": "inclusion", "inclusion_indicator": "TREE", "synonyms": [], "nci_thesaurus_concept_id": "C82547", "name": "Abnormal Finding", "semantic_types": ["Finding"], "type": [], "ancestors": ["C3367", "C77140"], "parents": ["C77140"], "assay_purpose": "Eligibility Criterion - Inclusion"}, {"eligibility_criterion": "inclusion", "inclusion_indicator": "TREE", "synonyms": ["Bone Marrow Results"], "nci_thesaurus_concept_id": "C190021", "name": "Bone Marrow Test Result", "semantic_types": ["Laboratory or Test Result"], "type": [], "ancestors": ["C36289", "C3367", "C36278"], "parents": ["C36289"], "assay_purpose": "Eligibility Criterion - Inclusion"}, {"eligibility_criterion": "inclusion", "inclusion_indicator": "TREE", "synonyms": ["Blasts Greater than or Equal to 2 Percent of Bone Marrow Nucleated Cells"], "nci_thesaurus_concept_id": "C167155", "name": "Blasts 2 Percent or More of Bone Marrow Nucleated Cells", "semantic_types": ["Laboratory or Test Result"], "type": [], "ancestors": ["C36289", "C26683", "C35553", "C157653", "C35508", "C35883", "C190021", "C3367", "C157287", "C36278", "C82547", "C36292", "C162512", "C35877", "C77140", "C35880"], "parents": ["C162512"], "assay_purpose": "Eligibility Criterion - Inclusion"}, {"eligibility_criterion": "inclusion", "inclusion_indicator": "TREE", "synonyms": ["Blasts Greater than or Equal to 2 Percent of Peripheral Blood White Cells"], "nci_thesaurus_concept_id": "C155993", "name": "Blasts 2 Percent or More of Peripheral Blood White Cells", "semantic_types": ["Laboratory or Test Result"], "type": [], "ancestors": ["C36289", "C26683", "C77140", "C35553", "C36278", "C82547", "C35881", "C36292", "C3367", "C35877", "C147055", "C35880"], "parents": ["C147055"], "assay_purpose": "Eligibility Criterion - Inclusion"}, {"eligibility_criterion": "inclusion", "inclusion_indicator": "TREE", "synonyms": ["HEMATOPOIETIC SYSTEM", "Hematological"], "nci_thesaurus_concept_id": "C36289", "name": "Hematopoietic System Finding", "semantic_types": ["Finding"], "type": [], "ancestors": ["C3367", "C36278"], "parents": ["C36278"], "assay_purpose": "Eligibility Criterion - Inclusion"}, {"eligibility_criterion": "inclusion", "inclusion_indicator": "TREE", "synonyms": ["MRD Response", "MRDRESP", "MRD_RESULT", "Minimal Residual Disease Response"], "nci_thesaurus_concept_id": "C124433", "name": "Measurable Residual Disease Response", "semantic_types": ["Finding"], "type": [], "ancestors": ["C50995", "C3367", "C35461"], "parents": ["C50995"], "assay_purpose": "Eligibility Criterion - Inclusion"}, {"eligibility_criterion": "inclusion", "inclusion_indicator": "TREE", "synonyms": ["Circulating Blasts"], "nci_thesaurus_concept_id": "C35880", "name": "Blast Cells Present", "semantic_types": ["Laboratory or Test Result"], "type": [], "ancestors": ["C36289", "C26683", "C35553", "C36278", "C82547", "C36292", "C3367", "C35877", "C77140"], "parents": ["C35877"], "assay_purpose": "Eligibility Criterion - Inclusion"}, {"eligibility_criterion": "inclusion", "inclusion_indicator": "TREE", "synonyms": ["Blasts Greater than or Equal to 0.01 Percent of Bone Marrow Nucleated Cells"], "nci_thesaurus_concept_id": "C157653", "name": "Blasts 0.01 Percent or More of Bone Marrow Nucleated Cells", "semantic_types": ["Laboratory or Test Result"], "type": [], "ancestors": ["C36289", "C26683", "C35553", "C35508", "C35883", "C190021", "C36278", "C82547", "C36292", "C3367", "C35877", "C77140", "C35880"], "parents": ["C35883"], "assay_purpose": "Eligibility Criterion - Inclusion"}, {"eligibility_criterion": "inclusion", "inclusion_indicator": "TREE", "synonyms": ["Abnormal Lab Test Result", "Abnormal Laboratory Test", "Abnormal, NOS"], "nci_thesaurus_concept_id": "C26683", "name": "Abnormal Laboratory Test Result", "semantic_types": ["Laboratory or Test Result"], "type": [], "ancestors": ["C82547", "C36292", "C3367", "C77140"], "parents": ["C36292", "C82547"], "assay_purpose": "Eligibility Criterion - Inclusion"}, {"eligibility_criterion": "inclusion", "inclusion_indicator": "TREE", "synonyms": ["Observable Entity"], "nci_thesaurus_concept_id": "C3367", "name": "Finding", "semantic_types": ["Finding"], "type": ["branch"], "ancestors": [], "parents": [], "assay_purpose": "Eligibility Criterion - Inclusion"}, {"eligibility_criterion": "inclusion", "inclusion_indicator": "TRIAL", "synonyms": ["Blasts Greater than or Equal to 5 Percent of Peripheral Blood White Cells"], "nci_thesaurus_concept_id": "C141299", "name": "Blasts 5 Percent or More of Peripheral Blood White Cells", "semantic_types": ["Laboratory or Test Result"], "type": [], "ancestors": ["C36289", "C26683", "C77140", "C35553", "C155993", "C36278", "C82547", "C35881", "C36292", "C3367", "C35877", "C147055", "C35880"], "parents": ["C155993"], "assay_purpose": "Eligibility Criterion - Inclusion"}, {"eligibility_criterion": "inclusion", "inclusion_indicator": "TREE", "synonyms": [], "nci_thesaurus_concept_id": "C36278", "name": "Finding by Site or System", "semantic_types": ["Finding"], "type": [], "ancestors": ["C3367"], "parents": ["C3367"], "assay_purpose": "Eligibility Criterion - Inclusion"}, {"eligibility_criterion": "inclusion", "inclusion_indicator": "TREE", "synonyms": [], "nci_thesaurus_concept_id": "C35883", "name": "Blast Cells Increased in Bone Marrow", "semantic_types": ["Laboratory or Test Result"], "type": [], "ancestors": ["C36289", "C26683", "C35553", "C35877", "C35508", "C36278", "C82547", "C36292", "C3367", "C190021", "C77140", "C35880"], "parents": ["C35508", "C35880"], "assay_purpose": "Eligibility Criterion - Inclusion"}, {"eligibility_criterion": "inclusion", "inclusion_indicator": "TREE", "synonyms": ["Blasts Greater than or Equal to 0.1 Percent of Bone Marrow Nucleated Cells"], "nci_thesaurus_concept_id": "C157287", "name": "Blasts 0.1 Percent or More of Bone Marrow Nucleated Cells", "semantic_types": ["Laboratory or Test Result"], "type": [], "ancestors": ["C36289", "C26683", "C35553", "C157653", "C35508", "C35883", "C190021", "C36278", "C82547", "C36292", "C3367", "C35877", "C77140", "C35880"], "parents": ["C157653"], "assay_purpose": "Eligibility Criterion - Inclusion"}, {"eligibility_criterion": "inclusion", "inclusion_indicator": "TREE", "synonyms": [], "nci_thesaurus_concept_id": "C35877", "name": "Abnormal Hematology Test Result", "semantic_types": ["Laboratory or Test Result"], "type": [], "ancestors": ["C82547", "C77140", "C26683", "C3367", "C35553", "C36292", "C36289", "C36278"], "parents": ["C35553", "C36289"], "assay_purpose": "Eligibility Criterion - Inclusion"}, {"eligibility_criterion": "inclusion", "inclusion_indicator": "TRIAL", "synonyms": ["Blasts Greater than or Equal to 5 Percent of Bone Marrow Nucleated Cells"], "nci_thesaurus_concept_id": "C136411", "name": "Blasts 5 Percent or More of Bone Marrow Nucleated Cells", "semantic_types": ["Laboratory or Test Result"], "type": [], "ancestors": ["C36289", "C26683", "C35553", "C157653", "C35508", "C35883", "C190021", "C167155", "C3367", "C157287", "C36278", "C82547", "C36292", "C162512", "C35877", "C77140", "C35880"], "parents": ["C167155"], "assay_purpose": "Eligibility Criterion - Inclusion"}], "classification_code": null, "current_trial_status_date": "2022-11-04", "diseases": [{"inclusion_indicator": "TRIAL", "is_lead_disease": false, "synonyms": ["Refractory Acute Myeloid Leukemia", "Refractory AML"], "nci_thesaurus_concept_id": "C134319", "name": "Refractory Acute Myeloid Leukemia (AML)", "type": ["subtype"], "parents": ["C172281", "C148431", "C3171"]}, {"inclusion_indicator": "TRIAL", "is_lead_disease": true, "synonyms": ["Acute myeloblastic leukemia, in relapse", "Recurrent Acute Myeloid Leukemia"], "nci_thesaurus_concept_id": "C148427", "name": "Recurrent Acute Myeloid Leukemia (AML)", "type": ["stage"], "parents": ["C193431", "C3171", "C148429"]}, {"inclusion_indicator": "TREE", "is_lead_disease": true, "synonyms": ["bone marrow cancer", "Malignant Bone Marrow Tumor"], "nci_thesaurus_concept_id": "C35501", "name": "Malignant Bone Marrow Neoplasm", "type": ["subtype"], "parents": ["C9305", "C35370"]}, {"inclusion_indicator": "TREE", "is_lead_disease": true, "synonyms": ["Disease by Site"], "nci_thesaurus_concept_id": "C27551", "name": "Disorder by Site", "type": ["subtype"], "parents": ["C2991"]}, {"inclusion_indicator": "TREE", "is_lead_disease": true, "synonyms": ["Bone Marrow Disease"], "nci_thesaurus_concept_id": "C34433", "name": "Bone Marrow Disorder", "type": ["subtype"], "parents": ["C35814"]}, {"inclusion_indicator": "TREE", "is_lead_disease": true, "synonyms": ["Recurrent Hematologic Cancer", "Recurrent Hematologic Malignancy", "Relapsed Hematologic Cancer", "Relapsed Hematologic Malignancy"], "nci_thesaurus_concept_id": "C27358", "name": "Recurrent Hematopoietic and Lymphoid Cell Neoplasm", "type": ["stage"], "parents": ["C27134", "C4813"]}, {"inclusion_indicator": "TREE", "is_lead_disease": true, "synonyms": ["Hematopoietic and Lymphoid System Disorder"], "nci_thesaurus_concept_id": "C35814", "name": "Hematopoietic and Lymphatic System Disorder", "type": ["subtype"], "parents": ["C27551"]}, {"inclusion_indicator": "TREE", "is_lead_disease": true, "synonyms": ["Leukemia, unspecified, in relapse"], "nci_thesaurus_concept_id": "C148425", "name": "Recurrent Leukemia", "type": ["stage"], "parents": ["C3161", "C27358"]}, {"inclusion_indicator": "TREE", "is_lead_disease": true, "synonyms": ["Tumor Morphology", "Tumor_Morphology"], "nci_thesaurus_concept_id": "C4741", "name": "Neoplasm by Morphology", "type": ["subtype"], "parents": ["C3262"]}, {"inclusion_indicator": "TREE", "is_lead_disease": true, "synonyms": [], "nci_thesaurus_concept_id": "C9290", "name": "Myeloid Neoplasm", "type": ["maintype", "subtype"], "parents": ["C27134"]}, {"inclusion_indicator": "TREE", "is_lead_disease": true, "synonyms": [], "nci_thesaurus_concept_id": "C172132", "name": "Recurrent Myeloid Neoplasm", "type": ["stage"], "parents": ["C9290", "C27358"]}, {"inclusion_indicator": "TREE", "is_lead_disease": true, "synonyms": ["Acute Granulocytic Leukemia", "Acute Myeloblastic Leukemia", "Acute Myelocytic Leukemia", "Acute Myelogenous Leukemia", "Acute Myelogenous Leukemias", "Acute Myeloid Leukemia", "Acute Nonlymphocytic Leukemia", "AML", "AML - Acute Myeloid Leukemia", "ANLL", "Hematopoeitic - Acute Myleogenous Leukemia (AML)"], "nci_thesaurus_concept_id": "C3171", "name": "Acute Myeloid Leukemia (AML)", "type": ["maintype", "subtype"], "parents": ["C9300", "C3172"]}, {"inclusion_indicator": "TREE", "is_lead_disease": true, "synonyms": ["Neoplasm Recurrence", "Recurrence", "Recurrent", "Recurrent Tumor"], "nci_thesaurus_concept_id": "C4798", "name": "Recurrent Neoplasm", "type": ["stage"], "parents": ["C7062"]}, {"inclusion_indicator": "TREE", "is_lead_disease": true, "synonyms": ["Neoplasia", "Neoplasm", "Neoplasm, NOS", "Neoplasms, NOS", "Neoplastic Disease", "Neoplastic Growth", "tumor", "Tumor, NOS"], "nci_thesaurus_concept_id": "C3262", "name": "Other Neoplasm", "type": ["maintype"], "parents": ["C2991"]}, {"inclusion_indicator": "TREE", "is_lead_disease": true, "synonyms": ["Hematopoietic and Lymphatic System Neoplasm", "Hematopoietic and Lymphoid System Tumor", "Neoplasm of uncertain behavior of lymphoid, hematopoietic and related tissue, unspecified"], "nci_thesaurus_concept_id": "C35813", "name": "Hematopoietic and Lymphoid System Neoplasm", "type": ["subtype"], "parents": ["C35814", "C3263"]}, {"inclusion_indicator": "TREE", "is_lead_disease": true, "synonyms": [], "nci_thesaurus_concept_id": "C7062", "name": "Neoplasm by Special Category", "type": ["subtype"], "parents": ["C3262"]}, {"inclusion_indicator": "TREE", "is_lead_disease": true, "synonyms": ["Acute leukemia of unspecified cell type, in relapse"], "nci_thesaurus_concept_id": "C148429", "name": "Recurrent Acute Leukemia", "type": ["stage"], "parents": ["C9300", "C148425"]}, {"inclusion_indicator": "TREE", "is_lead_disease": true, "synonyms": [], "nci_thesaurus_concept_id": "C3263", "name": "Neoplasm by Site", "type": ["subtype"], "parents": ["C3262"]}, {"inclusion_indicator": "TREE", "is_lead_disease": true, "synonyms": ["Condition", "Diagnosis", "Disease", "Disease or Disorder", "Disease or Disorder, Non-Neoplastic", "disease term", "disease type", "disease_term", "disease_type", "Diseases", "Diseases and Disorders", "Disorder", "Disorders"], "nci_thesaurus_concept_id": "C2991", "name": "Other Disease", "type": ["maintype"], "parents": []}, {"inclusion_indicator": "TREE", "is_lead_disease": true, "synonyms": ["Blood (Leukemia)", "Leukemia NOS", "Leukemia, Disease", "LEUKEMIA, MALIGNANT", "Leukemia, NOS", "Leukemias", "Leukemias, General"], "nci_thesaurus_concept_id": "C3161", "name": "Leukemia", "type": ["maintype", "subtype"], "parents": ["C9305", "C27134"]}, {"inclusion_indicator": "TREE", "is_lead_disease": true, "synonyms": ["Leukemia Granulocytic", "Leukemia Myeloid", "LEUKEMIA, GRANULOCYTIC, MALIGNANT", "Myelocytic Leukemia", "Myelogenous Leukemia", "Myeloid leukemia, NOS", "Non-Lymphoblastic Leukemia", "Non-Lymphocytic Leukemia"], "nci_thesaurus_concept_id": "C3172", "name": "Myeloid Leukemia", "type": ["maintype", "subtype"], "parents": ["C35501", "C9290", "C3161"]}, {"inclusion_indicator": "TREE", "is_lead_disease": true, "synonyms": ["Myeloid leukemia, unspecified in relapse"], "nci_thesaurus_concept_id": "C193431", "name": "Recurrent Myeloid Leukemia", "type": ["stage"], "parents": ["C3172", "C172132", "C148425"]}, {"inclusion_indicator": "TREE", "is_lead_disease": true, "synonyms": ["Blood Disease", "Blood Disorder", "Hematologic and Lymphocytic Disorder", "Hematologic and Lymphoid Cell Disorder", "Hematologic Disorder", "Hematological Disorder"], "nci_thesaurus_concept_id": "C26323", "name": "Hematopoietic and Lymphoid Cell Disorder", "type": ["subtype"], "parents": ["C35814"]}, {"inclusion_indicator": "TREE", "is_lead_disease": true, "synonyms": [], "nci_thesaurus_concept_id": "C9300", "name": "Acute Leukemia", "type": ["subtype"], "parents": ["C3161"]}, {"inclusion_indicator": "TREE", "is_lead_disease": true, "synonyms": ["Hematologic Cancer", "Hematologic Neoplasm", "Hematological Neoplasm", "Hematopoietic and Lymphoid Neoplasm", "Hematopoietic malignancy, NOS", "Hematopoietic Neoplasm", "Hematopoietic Neoplasms Including Lymphomas", "HEMOLYMPHORETICULAR TUMOR, MALIGNANT", "Malignant Hematologic Neoplasm", "Malignant Hematopoietic Neoplasm", "Malignant neoplasm of lymphoid, hematopoietic and related tissue, unspecified"], "nci_thesaurus_concept_id": "C27134", "name": "Hematopoietic and Lymphoid Cell Neoplasm", "type": ["maintype"], "parents": ["C35813", "C26323", "C4741"]}, {"inclusion_indicator": "TREE", "is_lead_disease": true, "synonyms": ["Bone Marrow Tumor", "Neoplasm of Bone Marrow"], "nci_thesaurus_concept_id": "C35370", "name": "Bone Marrow Neoplasm", "type": ["subtype"], "parents": ["C35813", "C34433"]}, {"inclusion_indicator": "TREE", "is_lead_disease": true, "synonyms": [], "nci_thesaurus_concept_id": "C7057", "name": "Disease, Disorder or Finding", "type": ["finding"], "parents": []}, {"inclusion_indicator": "TREE", "is_lead_disease": true, "synonyms": ["Recurrence", "Recurrent Cancer", "Recurrent Malignant Tumor"], "nci_thesaurus_concept_id": "C4813", "name": "Recurrent Malignant Neoplasm", "type": ["stage"], "parents": ["C4798", "C9305"]}, {"inclusion_indicator": "TREE", "is_lead_disease": true, "synonyms": ["CA", "Cancer", "Malignancy", "Malignant Growth", "Malignant Neoplastic Disease", "Malignant Tumor", "Neoplasm, malignant", "Tumor, malignant, NOS", "Unclassified tumor, malignant"], "nci_thesaurus_concept_id": "C9305", "name": "Malignant Neoplasm", "type": ["subtype"], "parents": ["C7062"]}, {"inclusion_indicator": "TREE", "is_lead_disease": false, "synonyms": ["Refractory Hematologic Cancer"], "nci_thesaurus_concept_id": "C27357", "name": "Refractory Hematologic Malignancy", "type": ["subtype"], "parents": ["C27134", "C120186"]}, {"inclusion_indicator": "TREE", "is_lead_disease": false, "synonyms": [], "nci_thesaurus_concept_id": "C172281", "name": "Refractory Myeloid Neoplasm", "type": ["subtype"], "parents": ["C27357", "C9290"]}, {"inclusion_indicator": "TREE", "is_lead_disease": false, "synonyms": ["Refractory Tumor"], "nci_thesaurus_concept_id": "C7628", "name": "Refractory Neoplasm", "type": ["subtype"], "parents": ["C7062"]}, {"inclusion_indicator": "TREE", "is_lead_disease": false, "synonyms": [], "nci_thesaurus_concept_id": "C148431", "name": "Refractory Acute Leukemia", "type": ["subtype"], "parents": ["C9300", "C148426"]}, {"inclusion_indicator": "TREE", "is_lead_disease": false, "synonyms": ["Refractory Leukemia"], "nci_thesaurus_concept_id": "C148426", "name": "Advanced Leukemia", "type": ["subtype"], "parents": ["C27357", "C3161"]}, {"inclusion_indicator": "TREE", "is_lead_disease": false, "synonyms": ["clinical resistance", "Refractory Cancer", "resistant cancer"], "nci_thesaurus_concept_id": "C120186", "name": "Refractory Malignant Neoplasm", "type": ["subtype"], "parents": ["C7628", "C9305"]}], "_primary_purpose_sort_order": 0, "protocol_id": "PEDSHEMAML0007", "active_sites_count": 1, "lead_org_cancer_center": "Stanford Cancer Institute", "arms": [{"interventions": [{"inclusion_indicator": "TREE", "synonyms": ["Clinical Intervention or Procedure", "Procedure", "Intervention", "Intervention Strategies"], "nci_thesaurus_concept_id": "C25218", "name": "Intervention or Procedure", "description": null, "type": "Procedure/Surgery", "category": "other", "parents": ["C16203"]}, {"inclusion_indicator": "TREE", "synonyms": [], "nci_thesaurus_concept_id": "C1557", "name": "Pyrimidine Antagonist", "description": null, "type": "Drug", "category": "agent category", "parents": ["C272"]}, {"inclusion_indicator": "TREE", "synonyms": [], "nci_thesaurus_concept_id": "C215116", "name": "Body Organ or System Test", "description": null, "type": "Procedure/Surgery", "category": "other", "parents": ["C18020"]}, {"inclusion_indicator": "TRIAL", "synonyms": ["Starasid", "Alexan", "Aracytine", "Erpalfa", "Arabine", "ARA-cell", "Cytosar", "Cytarbel", "Aracytin", "Udicil"], "nci_thesaurus_concept_id": "C408", "name": "Cytarabine", "description": "An antimetabolite analogue of cytidine with a modified sugar moiety (arabinose instead of ribose). Cytarabine is converted to the triphosphate form within the cell and then competes with cytidine for incorporation into DNA.  Because the arabinose sugar sterically hinders the rotation of the molecule within DNA, DNA replication ceases, specifically during the S phase of the cell cycle.  This agent also inhibits DNA polymerase, resulting in a decrease in DNA replication and repair. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)Health professional", "type": "Drug", "category": "agent", "parents": ["C1557"]}, {"inclusion_indicator": "TREE", "synonyms": ["Antiparasitic Drugs", "Antiparasitic", "Antiparasitics"], "nci_thesaurus_concept_id": "C276", "name": "Antiparasitic Agent", "description": null, "type": "Drug", "category": "agent category", "parents": ["C254"]}, {"inclusion_indicator": "TREE", "synonyms": [], "nci_thesaurus_concept_id": "C1908", "name": "Drug, Food, Chemical or Biomedical Material", "description": null, "type": "Drug", "category": "agent category", "parents": []}, {"inclusion_indicator": "TREE", "synonyms": ["Antimetabolites"], "nci_thesaurus_concept_id": "C272", "name": "Antimetabolite", "description": null, "type": "Drug", "category": "agent category", "parents": ["C186664"]}, {"inclusion_indicator": "TREE", "synonyms": [], "nci_thesaurus_concept_id": "C16203", "name": "Clinical or Research Activity", "description": null, "type": "Procedure/Surgery", "category": "other", "parents": ["C43431"]}, {"inclusion_indicator": "TRIAL", "synonyms": [], "nci_thesaurus_concept_id": "C66240", "name": "Niclosamide", "description": null, "type": "Drug", "category": "agent", "parents": ["C250"]}, {"inclusion_indicator": "TRIAL", "synonyms": [], "nci_thesaurus_concept_id": "C92958", "name": "Bone Marrow Aspiration and Biopsy", "description": null, "type": "Procedure/Surgery", "category": "other", "parents": ["C215116"]}, {"inclusion_indicator": "TREE", "synonyms": ["Anthelmintic Agent", "Vermifuges", "Anthelminthics", "Antihelminthics", "Anthelminthic Agent", "Antihelminthic Drugs"], "nci_thesaurus_concept_id": "C250", "name": "Antihelminthic Agent", "description": null, "type": "Drug", "category": "agent category", "parents": ["C276"]}, {"inclusion_indicator": "TREE", "synonyms": ["Cytotoxic Chemotherapy Agent", "Cytotoxic Antineoplastic Agent", "Antineoplastic Cytotoxic Agent"], "nci_thesaurus_concept_id": "C186664", "name": "Cytotoxic Chemotherapeutic Agent", "description": null, "type": "Drug", "category": "agent category", "parents": ["C274"]}, {"inclusion_indicator": "TREE", "synonyms": ["AntiInfective Drugs", "AntiInfectives", "Anti-Infective Drugs", "AntiInfective Agents", "Anti-Infectives", "Anti-Infective Agents"], "nci_thesaurus_concept_id": "C254", "name": "Anti-Infective Agent", "description": null, "type": "Drug", "category": "agent category", "parents": ["C1909"]}, {"inclusion_indicator": "TREE", "synonyms": ["Diagnostic Technique", "Diagnostic Test", "Diagnostic Method"], "nci_thesaurus_concept_id": "C18020", "name": "Diagnostic Procedure", "description": null, "type": "Procedure/Surgery", "category": "other", "parents": ["C25218"]}, {"inclusion_indicator": "TREE", "synonyms": ["Cancer Drug", "Antineoplastics", "Chemotherapeutic Agents, Neoplastic Disease", "Antiproliferative Agents", "Antiproliferative Drugs", "Anti-Tumor Drugs", "Anti-Tumor Agents", "Antineoplastic Drugs", "Anti-Cancer Agents", "Tumor-Specific Treatment Agents"], "nci_thesaurus_concept_id": "C274", "name": "Antineoplastic Agent", "description": null, "type": "Drug", "category": "agent category", "parents": ["C1909"]}, {"inclusion_indicator": "TREE", "synonyms": [], "nci_thesaurus_concept_id": "C74944", "name": "Clinical Pathology Procedure", "description": null, "type": "Procedure/Surgery", "category": "other", "parents": ["C25294"]}, {"inclusion_indicator": "TREE", "synonyms": [], "nci_thesaurus_concept_id": "C43431", "name": "Activity", "description": null, "type": "Procedure/Surgery", "category": "other", "parents": []}, {"inclusion_indicator": "TRIAL", "synonyms": ["Biological Sample Collection"], "nci_thesaurus_concept_id": "C70945", "name": "Biospecimen Collection", "description": null, "type": "Procedure/Surgery", "category": "other", "parents": ["C74944"]}, {"inclusion_indicator": "TREE", "synonyms": ["Pharmacological Substance", "Drug", "Pharmaceuticals", "Pharmacologic Agent", "Pharmaceutical Agent", "Agent", "Drug Substance"], "nci_thesaurus_concept_id": "C1909", "name": "Pharmacologic Substance", "description": null, "type": "Drug", "category": "agent category", "parents": ["C1908"]}, {"inclusion_indicator": "TREE", "synonyms": ["Lab Test", "Tests", "Lab Tests", "Test", "Laboratory Test"], "nci_thesaurus_concept_id": "C25294", "name": "Laboratory Procedure", "description": null, "type": "Procedure/Surgery", "category": "other", "parents": ["C25218"]}], "name": "Treatment (niclosamide, cytarabine)", "description": "Patients receive niclosamide PO or NG and cytarabine IV on study. Patients also undergo bone marrow aspiration and biopsy and collection of blood samples at screening and on study.", "type": "EXPERIMENTAL"}], "study_model_code": null, "nci_id": "NCI-2022-09974", "why_study_stopped": null, "brief_summary": "This phase I trial tests the safety, side effects, and best dose of niclosamide in combination with cytarabine in treating pediatric patients with acute myeloid leukemia that does not respond to treatment (refractory) or that has come back (recurrent). Niclosamide causes deterioration of a receptor that is found on some types of cancer cells and which is associated with cancer progression and resistance to therapy. Chemotherapy drugs, like cytarabine, work in different ways to stop the growth of cancer cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving niclosamide together with cytarabine may be more effective at treating patients with relapsed of refractory acute myeloid leukemia.", "brief_title": "Niclosamide in Combination with Cytarabine for Treating Pediatric Patients with Relapsed or Refractory Acute Myeloid Leukemia", "status_history": [{"status_date": "2022-11-04T00:00:00", "status": "ACTIVE"}], "study_population_description": null, "sampling_method_code": null, "minimum_target_accrual_number": 16, "prior_therapy": [{"eligibility_criterion": "inclusion", "inclusion_indicator": "TRIAL", "synonyms": ["Anti-Cancer Agents", "Anti-Tumor Agents", "Anti-Tumor Drugs", "antineoplastic", "Antineoplastic Drug", "Antineoplastic Drugs", "ANTINEOPLASTIC_AGENT", "Antineoplastics", "Antiproliferative Agents", "Antiproliferative Drugs", "Cancer Drug", "chemotherapeutic agent", "Chemotherapeutic Agents, Neoplastic Disease", "Tumor-Specific Treatment Agents"], "nci_thesaurus_concept_id": "C274", "name": "Antineoplastic Agent", "semantic_types": ["Chemical Viewed Functionally"], "branch": "Drug, Food, Chemical or Biomedical Material", "ancestor_ids": ["C1908", "C1909"], "parents": ["C1909"]}, {"eligibility_criterion": "inclusion", "inclusion_indicator": "TREE", "synonyms": [], "nci_thesaurus_concept_id": "C1908", "name": "Drug, Food, Chemical or Biomedical Material", "semantic_types": ["Classification"], "branch": "Drug, Food, Chemical or Biomedical Material", "ancestor_ids": [], "parents": []}, {"eligibility_criterion": "inclusion", "inclusion_indicator": "TREE", "synonyms": ["Agent", "Drug", "Drug Substance", "Pharmaceutical Agent", "Pharmaceuticals", "Pharmacologic Agent", "Pharmacological Substance", "Therapeutic Agent", "therapeutic agents", "therapeutic_agents"], "nci_thesaurus_concept_id": "C1909", "name": "Pharmacologic Substance", "semantic_types": ["Pharmacologic Substance"], "branch": "Drug, Food, Chemical or Biomedical Material", "ancestor_ids": ["C1908"], "parents": ["C1908"]}], "_current_trial_status_sort_order": 0, "start_date": "2022-11-04", "record_verification_date": "2024-03-01", "ctep_id": null, "current_trial_status": "Active", "study_model_other_text": null, "masking": {"role_caregiver": null, "masking": null, "role_investigator": null, "role_outcome_assessor": null, "role_subject": null, "allocation_code": "NA"}, "acronym": null, "nci_programs": [], "nci_funded": "Indirect", "anatomic_sites": ["Myeloid and Monocytic Leukemia"], "ccr_id": null, "start_date_type_code": "ACTUAL", "principal_investigator": "Kathleen Miho Sakamoto", "study_source": "Externally Peer Reviewed", "completion_date": "2026-12-01", "study_subtype_code": null, "study_protocol_type": "Interventional"}, {"other_ids": [{"name": "Study Protocol Other Identifier", "value": "2016-002221-11"}], "amendment_date": null, "keywords": ["131-I-mIBG therapy", "ch14.18/CHO", "Nivolumab", "MiniVan"], "dcp_id": null, "interventional_model": "Single Group", "lead_org": "Southampton General Hospital", "eligibility": {"unstructured": [{"inclusion_indicator": true, "display_order": 0, "description": "At study entry patients must be > 1 year"}, {"inclusion_indicator": true, "display_order": 1, "description": "Relapsed or refractory high risk neuroblastoma (as defined by International Neuroblastoma Risk Group (INRG) criteria)"}, {"inclusion_indicator": true, "display_order": 2, "description": "MIBG avid disease on imaging within 4 weeks to study entry."}, {"inclusion_indicator": true, "display_order": 3, "description": "\u2265 3 months since any myeloablative chemotherapy / stem cell rescue"}, {"inclusion_indicator": true, "display_order": 4, "description": "\u2265 42 days since any other immunotherapy e.g. tumour vaccines. At least 3 half lives since last dose of any monoclonal antibody therapy."}, {"inclusion_indicator": true, "display_order": 5, "description": "Patients must have a performance status greater or equal 60% (Lansky Score or Karnofsky)"}, {"inclusion_indicator": true, "display_order": 6, "description": "Estimated life expectancy \u2265 12 weeks"}, {"inclusion_indicator": true, "display_order": 7, "description": "Adequate bone marrow function: Absolute Neutrophil Count (ANC) >1.0 x 10/L, platelets, 20 x 10/L and haemoglobin > 8.0 g/dL."}, {"inclusion_indicator": true, "display_order": 8, "description": "Adequate renal function: serum creatinine <1.5 mg/dL or a estimated creatinine clearance or radioisotope Glomerular Filtration Rate Study (GFR) of > 60 mL/minute/1.73m2."}, {"inclusion_indicator": true, "display_order": 9, "description": "Adequate cardiac function: shortening fraction of 28 % by echocardiogram."}, {"inclusion_indicator": true, "display_order": 10, "description": "Adequate hepatic function: Alanine transaminase (ALT) or Aspartate transaminase (AST) < 5 x ULN and a total bilirubin < 1.5 x Upper Limit of Normal (ULN)"}, {"inclusion_indicator": true, "display_order": 11, "description": "Adequate lung function: Forced Expiratory Volume in 1 Second (FEV1) and Forced Vital Capacity (FVC) >60% of the predicted by pulmonary function tests. Children unable to do Pulmonary Function Tests (PFTs) should have no dyspnea at rest and a pulse oximetry >94% on room air."}, {"inclusion_indicator": true, "display_order": 12, "description": "Adequate pancreatic function: serum lipase < 1.5 x upper limit normal"}, {"inclusion_indicator": true, "display_order": 13, "description": "Patients may have had prior Central Nervous System (CNS) metastasis at point of entry to study, but patients with mIBG avid parenchymal brain lesions will be excluded. All CNS disease must be treated and stable prior for at least 4 weeks prior to starting trial 131-I mIBG therapy (see section 4). Patients with extra-axial disease (e.g. skull (bone) metastasis that do not invade the dura) may be enrolled providing there is no evidence of brain oedema."}, {"inclusion_indicator": true, "display_order": 14, "description": "Patients must consent to the placement of a central venous line, if one has not already been placed."}, {"inclusion_indicator": true, "display_order": 15, "description": "Patients must have no immediate requirements for palliative chemotherapy, radiotherapy or surgery."}, {"inclusion_indicator": true, "display_order": 16, "description": "Females of childbearing potential must have a negative pregnancy test. Patients of childbearing potential must agree to use an effective birth control method. Female patients who are lactating must agree to stop breast-feeding."}, {"inclusion_indicator": true, "display_order": 17, "description": "Patients with seizure disorders may be enrolled if seizures are well controlled."}, {"inclusion_indicator": true, "display_order": 18, "description": "All patients and/or their parents or legal guardians must sign a written informed consent"}, {"inclusion_indicator": true, "display_order": 19, "description": "All institutional and national requirements for clinical trials must be met."}, {"inclusion_indicator": true, "display_order": 20, "description": "Expression of PD-L1 by tumour is not a pre-requisite"}, {"inclusion_indicator": true, "display_order": 21, "description": "Parents or carers willing and able to comply with radiation safety measures needed for 131-I mIBG administration."}, {"inclusion_indicator": true, "display_order": 22, "description": "Patient must be judged capable of tolerating isolation procedures associated with 131-I-mIBG therapy"}, {"inclusion_indicator": false, "display_order": 23, "description": "Patients who have previously received ch14.18 (CHO or SP2/0) will not be excluded unless they have had severe or life threatening toxicity necessitating withdrawal of treatment previously or if they have a strong/neutralizing Human Antichimeric Antibody (HACA) (\u2265 10 \u03bcg/ml)"}, {"inclusion_indicator": false, "display_order": 24, "description": "Patients who have had previous 131-I mIBG therapy will not be excluded"}, {"inclusion_indicator": false, "display_order": 25, "description": "Patients previously treated with Nivolumab or any other PD-1 or PD-L1 targeting antibodies will be excluded from the study"}, {"inclusion_indicator": false, "display_order": 26, "description": "Previous allogeneic stem cell transplant or solid organ transplant"}, {"inclusion_indicator": false, "display_order": 27, "description": "Patients should be excluded if they have an active, known or suspected autoimmune disease. Subjects are permitted to enroll if they have vitiligo, type I diabetes mellitus, residual hypothyroidism due to autoimmune condition only requiring hormone replacement, psoriasis not requiring systemic treatment, or conditions not expected to recur in the absence of an external trigger"}, {"inclusion_indicator": false, "display_order": 28, "description": "Patients receiving systemic corticosteroids (other than physiological replacement) or other immunosuppressive agents within 14 days prior to study entry"}, {"inclusion_indicator": false, "display_order": 29, "description": "Unable to maintain platelets \u2265 50 x 109/l without transfusion"}, {"inclusion_indicator": false, "display_order": 30, "description": "HIV or Hepatitis B or C infection"}, {"inclusion_indicator": false, "display_order": 31, "description": "Patients with significant intercurrent illnesses and/or any of the following:"}, {"inclusion_indicator": false, "display_order": 32, "description": "Patients with symptoms of congestive heart failure or uncontrolled cardiac rhythm disturbance."}, {"inclusion_indicator": false, "display_order": 33, "description": "Patients with significant psychiatric disabilities or uncontrolled seizure disorders."}, {"inclusion_indicator": false, "display_order": 34, "description": "Patients with active infections."}, {"inclusion_indicator": false, "display_order": 35, "description": "Patients with a clinically significant neurologic deficit or objective peripheral neuropathy (Grade >2) are ineligible."}, {"inclusion_indicator": false, "display_order": 36, "description": "Patients with clinically significant, symptomatic, pleural effusions."}, {"inclusion_indicator": false, "display_order": 37, "description": "Patients who require, or are likely to require, corticosteroid or other immunosuppressive drugs."}], "structured": {"max_age": "99 Years", "max_age_number": 99.0, "min_age_unit": "Years", "max_age_unit": "Years", "max_age_in_years": 99.0, "sex": "ALL", "accepts_healthy_volunteers": true, "min_age": "1 Years", "min_age_number": 1.0, "min_age_in_years": 1.0}}, "sites": [{"org_state_or_province": "WI", "contact_name": "Kenneth Brian De Santes", "contact_phone": null, "recruitment_status_date": "2024-06-28", "org_address_line_2": null, "org_va": false, "org_address_line_1": "4621 Eastpark Boulevard", "org_tty": null, "org_family": "University of Wisconsin Carbone Cancer Center", "org_postal_code": "53718", "contact_email": "kbdesantes@pediatrics.wisc.edu", "recruitment_status": "ACTIVE", "org_city": "Madison", "org_email": "clinicaltrials@cancer.wisc.edu", "org_country": "United States", "org_fax": null, "org_phone": "(800)-622-8922", "org_name": "University of Wisconsin Carbone Cancer Center - Eastpark Medical Center", "org_coordinates": {"lon": -89.2692, "lat": 43.108}}, {"org_state_or_province": "WI", "contact_name": null, "contact_phone": null, "recruitment_status_date": "2024-06-28", "org_address_line_2": null, "org_va": false, "org_address_line_1": "600 Highland Avenue", "org_tty": null, "org_family": "University of Wisconsin Carbone Cancer Center", "org_postal_code": "53792", "contact_email": null, "recruitment_status": "ACTIVE", "org_city": "Madison", "org_email": "clinicaltrials@cancer.wisc.edu", "org_country": "United States", "org_fax": null, "org_phone": "608-262-5223", "org_name": "University of Wisconsin Carbone Cancer Center - University Hospital", "org_coordinates": {"lon": -89.4329, "lat": 43.0769}}], "completion_date_type_code": "ANTICIPATED", "detail_description": null, "official_title": "A Phase I Study of 131-1 MIBG Followed by Nivolumab and Dinutuximab Beta in Children with Relapsed/refractory Neuroblastoma", "_phase_sort_order": 4, "collaborators": [{"name": "Joining Against Cancer in Kids", "functional_role": "LABORATORY"}, {"name": "Solving Kids' Cancer US/EU", "functional_role": "LABORATORY"}, {"name": "The Band of Parents", "functional_role": "LABORATORY"}, {"name": "University College London Hospitals", "functional_role": "LABORATORY"}, {"name": "University Hospital Greifswald", "functional_role": "LABORATORY"}, {"name": "University of Wisconsin Carbone Cancer Center - University Hospital", "functional_role": "LABORATORY"}], "associated_studies": [], "outcome_measures": [{"timeframe": "2 Years", "name": "Anti-tumour response in patients with measureable disease as measured by immunocytology, MIBG, CT and/or MRI in patients receiving 131-I-MIBG, ch14.18/CHO and Nivolumab in patients with relapsed and refractory high risk neuroblastoma", "description": "To document any evidence of efficacy of 131-I-MIBG, ch14.18/CHO and Nivolumab in patients\r\nwith relapsed and refractory high risk neuroblastoma (objective response rate)", "type_code": "SECONDARY"}, {"timeframe": "2 Years", "name": "Anti-tumour response in patients with measureable disease as measured by immunocytology, MIBG, CT and/or MRI in patients receiving 131-I-MIBG, ch14.18/CHO and Nivolumab in patients with relapsed and refractory high risk neuroblastoma", "description": "To document any evidence of efficacy of 131-I-MIBG, ch14.18/CHO and Nivolumab in patients\r\nwith relapsed and refractory high risk neuroblastoma (time to progression)", "type_code": "SECONDARY"}, {"timeframe": "2 Years", "name": "Incidence of Treatment-Emergent Adverse Events [Safety and tolerability] of 131-I-MIBG, ch14.18/CHO and Nivolumab in paediatric patients", "description": "\u2022 To determine the safety and tolerability of the novel combination of 131-I-MIBG,\r\nch14.18/CHO and Nivolumab in paediatric patients, assessed by nature, frequency, severity\r\nand timing of adverse events, including serious adverse events and immune related adverse\r\nevents during administration of ch14.18/CHO", "type_code": "PRIMARY"}, {"timeframe": "2 Years", "name": "KIR/KIR-Ligand genotype, Fc\u03b3R genotype", "description": "To provide descriptive analysis of any associations between KIR/KIR-Ligand genotype, Fc\u03b3R\r\ngenotype and response", "type_code": "SECONDARY"}], "phase": "I", "central_contact": {"phone": null, "name": null, "type": null, "email": null}, "primary_purpose": "TREATMENT", "number_of_arms": 1, "_study_protocol_type_sort_order": 0, "nct_id": "NCT02914405", "biomarkers": [], "classification_code": null, "current_trial_status_date": "2024-12-05", "diseases": [{"inclusion_indicator": "TRIAL", "is_lead_disease": false, "synonyms": [], "nci_thesaurus_concept_id": "C134153", "name": "Refractory Neuroblastoma", "type": ["subtype"], "parents": ["C3270", "C173565"]}, {"inclusion_indicator": "TRIAL", "is_lead_disease": true, "synonyms": ["High Risk Neuroblastoma"], "nci_thesaurus_concept_id": "C150281", "name": "High-Risk Neuroblastoma", "type": ["subtype"], "parents": ["C3270"]}, {"inclusion_indicator": "TRIAL", "is_lead_disease": false, "synonyms": ["Relapsed Neuroblastoma"], "nci_thesaurus_concept_id": "C7837", "name": "Recurrent Neuroblastoma", "type": ["stage"], "parents": ["C3270", "C27295", "C182030"]}, {"inclusion_indicator": "TREE", "is_lead_disease": true, "synonyms": ["embryonal tumor"], "nci_thesaurus_concept_id": "C3264", "name": "Embryonal Neoplasm", "type": ["maintype"], "parents": ["C7062"]}, {"inclusion_indicator": "TREE", "is_lead_disease": true, "synonyms": [], "nci_thesaurus_concept_id": "C7062", "name": "Neoplasm by Special Category", "type": ["subtype"], "parents": ["C3262"]}, {"inclusion_indicator": "TREE", "is_lead_disease": true, "synonyms": [], "nci_thesaurus_concept_id": "C7057", "name": "Disease, Disorder or Finding", "type": ["finding"], "parents": []}, {"inclusion_indicator": "TREE", "is_lead_disease": true, "synonyms": ["Neoplasia", "Neoplasm", "Neoplasm, NOS", "Neoplasms, NOS", "Neoplastic Disease", "Neoplastic Growth", "tumor", "Tumor, NOS"], "nci_thesaurus_concept_id": "C3262", "name": "Other Neoplasm", "type": ["maintype"], "parents": ["C2991"]}, {"inclusion_indicator": "TREE", "is_lead_disease": true, "synonyms": ["Condition", "Diagnosis", "Disease", "Disease or Disorder", "Disease or Disorder, Non-Neoplastic", "disease term", "disease type", "disease_term", "disease_type", "Diseases", "Diseases and Disorders", "Disorder", "Disorders"], "nci_thesaurus_concept_id": "C2991", "name": "Other Disease", "type": ["maintype"], "parents": []}, {"inclusion_indicator": "TREE", "is_lead_disease": true, "synonyms": ["Malignant Neoplasm of Nervous System", "Malignant Neoplasm of the Nervous System", "Malignant Nervous System Tumor", "Malignant Tumor of Nervous System", "Malignant Tumor of the Nervous System", "Nervous System Neoplasms, Malignant"], "nci_thesaurus_concept_id": "C4788", "name": "Malignant Nervous System Neoplasm", "type": ["subtype"], "parents": ["C3268", "C9305"]}, {"inclusion_indicator": "TREE", "is_lead_disease": true, "synonyms": [], "nci_thesaurus_concept_id": "C3263", "name": "Neoplasm by Site", "type": ["subtype"], "parents": ["C3262"]}, {"inclusion_indicator": "TREE", "is_lead_disease": true, "synonyms": ["CA", "Cancer", "Malignancy", "Malignant Growth", "Malignant Neoplastic Disease", "Malignant Tumor", "Neoplasm, malignant", "Tumor, malignant, NOS", "Unclassified tumor, malignant"], "nci_thesaurus_concept_id": "C9305", "name": "Malignant Neoplasm", "type": ["subtype"], "parents": ["C7062"]}, {"inclusion_indicator": "TREE", "is_lead_disease": true, "synonyms": ["Neural Crest Tumor, Malignant", "Neuroblastoma (NBL)", "Neuroblastoma (Schwannian Stroma-Poor)", "NEUROBLASTOMA, MALIGNANT", "Neuroblastoma, NOS"], "nci_thesaurus_concept_id": "C3270", "name": "Neuroblastoma", "type": ["maintype", "subtype"], "parents": ["C6963"]}, {"inclusion_indicator": "TREE", "is_lead_disease": true, "synonyms": ["Neuroectodermal Neoplasm", "Neuroectodermal Tumor", "Neuroepithelioma", "PNET", "PNET, NOS", "Primitive Neuroectodermal Neoplasm", "Primitive Neuroectodermal Tumor", "Primitive neuroectodermal tumor, NOS"], "nci_thesaurus_concept_id": "C3716", "name": "Primitive Neuroectodermal Tumor (PNET)", "type": ["maintype", "subtype"], "parents": ["C3264", "C9305"]}, {"inclusion_indicator": "TREE", "is_lead_disease": true, "synonyms": ["Disorder of Nervous System", "Neurologic Disorder", "Neurological Disorder", "Unspecified Nervous System Problem"], "nci_thesaurus_concept_id": "C26835", "name": "Nervous System Disorder", "type": ["subtype"], "parents": ["C27551"]}, {"inclusion_indicator": "TREE", "is_lead_disease": true, "synonyms": ["Disease by Site"], "nci_thesaurus_concept_id": "C27551", "name": "Disorder by Site", "type": ["subtype"], "parents": ["C2991"]}, {"inclusion_indicator": "TREE", "is_lead_disease": true, "synonyms": ["Neoplasm of Nervous System", "Neoplasm of the Nervous System", "Nervous System Neoplasm", "Nervous System Neoplasms", "Nervous System Tumour", "Tumor of Nervous System", "Tumor of the Nervous System"], "nci_thesaurus_concept_id": "C3268", "name": "Nervous System Tumor", "type": ["maintype"], "parents": ["C3263", "C26835"]}, {"inclusion_indicator": "TREE", "is_lead_disease": true, "synonyms": [], "nci_thesaurus_concept_id": "C6963", "name": "Neuroblastic Tumor", "type": ["subtype"], "parents": ["C3716", "C4788"]}, {"inclusion_indicator": "TREE", "is_lead_disease": false, "synonyms": ["Neoplasm Recurrence", "Recurrence", "Recurrent", "Recurrent Tumor"], "nci_thesaurus_concept_id": "C4798", "name": "Recurrent Neoplasm", "type": ["stage"], "parents": ["C7062"]}, {"inclusion_indicator": "TREE", "is_lead_disease": false, "synonyms": ["clinical resistance", "Refractory Cancer", "resistant cancer"], "nci_thesaurus_concept_id": "C120186", "name": "Refractory Malignant Neoplasm", "type": ["subtype"], "parents": ["C7628", "C9305"]}, {"inclusion_indicator": "TREE", "is_lead_disease": false, "synonyms": ["Refractory Tumor"], "nci_thesaurus_concept_id": "C7628", "name": "Refractory Neoplasm", "type": ["subtype"], "parents": ["C7062"]}, {"inclusion_indicator": "TREE", "is_lead_disease": false, "synonyms": [], "nci_thesaurus_concept_id": "C27295", "name": "Recurrent Primitive Neuroectodermal Tumor", "type": ["stage"], "parents": ["C3716", "C4813"]}, {"inclusion_indicator": "TREE", "is_lead_disease": false, "synonyms": [], "nci_thesaurus_concept_id": "C173565", "name": "Refractory Primitive Neuroectodermal Tumor", "type": ["subtype"], "parents": ["C3716", "C120186"]}, {"inclusion_indicator": "TREE", "is_lead_disease": false, "synonyms": [], "nci_thesaurus_concept_id": "C182030", "name": "Recurrent Nervous System Neoplasm", "type": ["stage"], "parents": ["C3268", "C4798"]}, {"inclusion_indicator": "TREE", "is_lead_disease": false, "synonyms": ["Recurrence", "Recurrent Cancer", "Recurrent Malignant Tumor"], "nci_thesaurus_concept_id": "C4813", "name": "Recurrent Malignant Neoplasm", "type": ["stage"], "parents": ["C4798", "C9305"]}], "_primary_purpose_sort_order": 0, "protocol_id": "RHM CHI0811", "active_sites_count": 2, "lead_org_cancer_center": null, "arms": [{"interventions": [{"inclusion_indicator": "TREE", "synonyms": ["Anti-GD-2 Monoclonal Antibody"], "nci_thesaurus_concept_id": "C155653", "name": "Anti-GD2 Monoclonal Antibody", "description": null, "type": "Biological/Vaccine", "category": "agent category", "parents": ["C20401", "C129822"]}, {"inclusion_indicator": "TREE", "synonyms": ["Pharmaceuticals", "Pharmacologic Agent", "Pharmacological Substance", "Pharmaceutical Agent", "Drug Substance", "Drug", "Agent"], "nci_thesaurus_concept_id": "C1909", "name": "Pharmacologic Substance", "description": null, "type": "Biological/Vaccine", "category": "agent category", "parents": ["C1908"]}, {"inclusion_indicator": "TREE", "synonyms": [], "nci_thesaurus_concept_id": "C141144", "name": "Immune Checkpoint Modulator", "description": null, "type": "Biological/Vaccine", "category": "agent category", "parents": ["C308"]}, {"inclusion_indicator": "TRIAL", "synonyms": ["Opdivo"], "nci_thesaurus_concept_id": "C68814", "name": "Nivolumab", "description": "A fully human monoclonal antibody directed against  the  negative immunoregulatory human cell surface receptor PD-1 (programmed death-1 or programmed cell death-1/PCD-1) with immunopotentiation activity.  Nivolumab binds to and blocks the activation of PD-1, an Ig superfamily transmembrane protein, by its ligands PD-L1 and PD-L2, resulting in the activation of T-cells and cell-mediated  immune responses against tumor cells or pathogens. Activated PD-1 negatively regulates T-cell activation and effector function through the suppression of P13k/Akt pathway activation.  Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)Health professional", "type": "Biological/Vaccine", "category": "agent", "parents": ["C128037", "C129822"]}, {"inclusion_indicator": "TRIAL", "synonyms": ["Unituxin", "Qarziba"], "nci_thesaurus_concept_id": "C1570", "name": "Dinutuximab", "description": "A chimeric mouse/human monoclonal antibody with potential antineoplastic activity. Dinutuximab  binds to the ganglioside GD2 and induces antibody-dependent cell-mediated cytotoxicity and complement-dependent cytotoxicity against GD2-expressing tumor cells.  GD2 is overexpressed in malignant melanoma, neuroblastoma, osteosarcoma, and small cell carcinoma of the lung. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)Health professional", "type": "Biological/Vaccine", "category": "agent", "parents": ["C155653"]}, {"inclusion_indicator": "TREE", "synonyms": ["Programmed Cell Death Protein 1 Inhibitor", "PD-1-targeting Agent", "PD-1 Inhibitor", "Protein PD-1 Inhibitor", "Anti-PD-1 Agent"], "nci_thesaurus_concept_id": "C124946", "name": "PD1 Inhibitor", "description": null, "type": "Biological/Vaccine", "category": "agent category", "parents": ["C143250"]}, {"inclusion_indicator": "TREE", "synonyms": ["Anti-cancer Biological Agent", "Antineoplastic Biological", "Antineoplastic Biotherapeutic", "Anticancer Biological"], "nci_thesaurus_concept_id": "C129821", "name": "Antineoplastic Biological Agent", "description": null, "type": "Biological/Vaccine", "category": "agent category", "parents": ["C307", "C274"]}, {"inclusion_indicator": "TREE", "synonyms": ["Anti-PD-1 Monoclonal Antibody"], "nci_thesaurus_concept_id": "C128037", "name": "Anti-PD1 Monoclonal Antibody", "description": null, "type": "Biological/Vaccine", "category": "agent category", "parents": ["C20401", "C124946"]}, {"inclusion_indicator": "TREE", "synonyms": ["Anti-Cancer Agents", "Anti-Tumor Agents", "Antiproliferative Drugs", "Chemotherapeutic Agents, Neoplastic Disease", "Antineoplastics", "Anti-Tumor Drugs", "Tumor-Specific Treatment Agents", "Cancer Drug", "Antineoplastic Drugs", "Antiproliferative Agents"], "nci_thesaurus_concept_id": "C274", "name": "Antineoplastic Agent", "description": null, "type": "Biological/Vaccine", "category": "agent category", "parents": ["C1909"]}, {"inclusion_indicator": "TREE", "synonyms": [], "nci_thesaurus_concept_id": "C1908", "name": "Drug, Food, Chemical or Biomedical Material", "description": null, "type": "Biological/Vaccine", "category": "agent category", "parents": []}, {"inclusion_indicator": "TREE", "synonyms": [], "nci_thesaurus_concept_id": "C143250", "name": "Immune Checkpoint Inhibitor", "description": null, "type": "Biological/Vaccine", "category": "agent category", "parents": ["C141144"]}, {"inclusion_indicator": "TREE", "synonyms": ["Monoclonal Antibodies", "Monoclonal Antibody"], "nci_thesaurus_concept_id": "C20401", "name": "Monoclonal Antibody Therapy", "description": null, "type": "Biological/Vaccine", "category": "agent category", "parents": ["C307", "C308"]}, {"inclusion_indicator": "TREE", "synonyms": ["Anti-cancer Antibody", "Anticancer Antibody", "Antineoplastic Ab"], "nci_thesaurus_concept_id": "C129822", "name": "Antineoplastic Antibody", "description": null, "type": "Biological/Vaccine", "category": "agent category", "parents": ["C129821"]}, {"inclusion_indicator": "TREE", "synonyms": ["Immunologics", "Biopharmaceuticals", "Biologicals", "Biologics", "Immunologic, Immunochemical", "Biological Products"], "nci_thesaurus_concept_id": "C307", "name": "Biological Agent", "description": null, "type": "Biological/Vaccine", "category": "agent category", "parents": ["C1909"]}, {"inclusion_indicator": "TREE", "synonyms": ["Immunomodulating Agent", "Immune Modulators", "Immune Mediators", "Immunotherapeutic Agent", "Biomodulators", "Immunopotentiators", "Immunomodulatory Agent", "BRM", "Immunomodulators", "Immune Regulators", "Biological Response Modifier", "Immunotherapy Agent"], "nci_thesaurus_concept_id": "C308", "name": "Immunotherapy", "description": null, "type": "Biological/Vaccine", "category": "agent category", "parents": ["C1909"]}], "name": "Arm not specified", "description": null, "type": null}, {"interventions": [], "name": "Treatment", "description": "The dose and schedule of 131-I mIBG will be constant, and the doses of ch14.18/ CHO and\r\nNivolumab determined by cohort:\r\n\r\n  -  Cohort I: 3 mg/kg Nivolumab (100% adult dose). No ch14.18/CHO. (3-6 patients)\r\n\r\n  -  Cohort II: 50mg/m2/cycle ch14.18/CHO (50% established Long Term Intervention (LTI)\r\n     dose) and 3 mg/kg Nivolumab (100% adult dose) (3-6 patients)\r\n\r\n  -  Cohort III: 100mg/m2/cycle ch14.18/CHO (100% established LTI dose) and 3 mg/kg\r\n     Nivolumab (100% adult dose) (initial 3-6 patients, expanded to 15 patient cohort if\r\n     tolerated)", "type": "EXPERIMENTAL"}], "study_model_code": null, "nci_id": "NCI-2019-08425", "why_study_stopped": null, "brief_summary": "Neuroblastoma, the most common extra-cranial solid tumour in children, remains one of the\r\nmajor challenges in paediatric oncology. A promising way to further improve outcome in\r\nthis disease appears to be the development of adjuvant therapeutic strategies. In this\r\nresearch the anti-GD2 antibody, which is a standard treatment, is to be combined with\r\n131-l Metaiodobenzylguanidine (mlBG) and anti-Programmed Cell Death Protein 1 (anti-PD1)\r\nantibody Nivolumab - the investigated drugs - with the aim of generating sustained\r\nanti-neuroblastoma immunity. In particular it will be determined the safety and\r\ntolerability of the novel combination as well as documented any evidence of efficacy in\r\npaediatric patients with relapsed and refractory high risk neuroblastoma.\r\n\r\nThis study is sponsored by the University Hospital Southampton and will take place in 4\r\nhospitals in the United Kingdom, Germany and USA. The estimated duration of the study is\r\n2 years, starting in December 2016.\r\n\r\nThis is an \"adaptive study\". Such design uses accumulating of data from the ongoing trial\r\nto modify aspects of the study (e.g. duration, number of treatments) without undermining\r\nits validity or integrity. There will be 3 cohorts of patients. As safety of Nivolumab is\r\nwell established, Cohort 1 will assess its safety and tolerability in combination with\r\n131-l mlBG. Cohort 2 will then add anti-GD2 to the drug combination, assessing safety and\r\ntolerability. Cohort 3 will escalate all 3 agents to the full 100% dose level to assure\r\nsafety for expanded analyses of clinical and laboratory data at that dose level.\r\n\r\nPatients will initially be recruited into Cohort 1. Patients must have completed at least\r\n12 weeks of trial treatment without reaching a Dose Limiting Toxicity before a patient\r\ncan be recruited to the next cohort.\r\n\r\nA minimum of 3 evaluable patients will be treated in cohorts 1-3. Assuming the full dose\r\ncombination therapy (cohort) is tolerable, 15 evaluable patients will be treated.", "brief_title": "Phase I Study of 131-I MIBG Followed by Nivolumab & Dinutuximab Beta Antibodies in Children with Relapsed/refractory Neuroblastoma", "status_history": [{"status_date": "2024-12-05T00:00:00.000001", "status": "CLOSED_TO_ACCRUAL"}, {"status_date": "2018-05-24T00:00:00", "status": "ACTIVE"}], "study_population_description": null, "sampling_method_code": null, "minimum_target_accrual_number": 44, "prior_therapy": [{"eligibility_criterion": "exclusion", "inclusion_indicator": "TRIAL", "synonyms": ["ABP 206", "BCD-263", "BMS 936558", "BMS-936558", "BMS936558", "CMAB819", "MDX 1106", "MDX-1106", "MDX1106", "NIVO", "Nivolumab Biosimilar ABP 206", "Nivolumab Biosimilar BCD-263", "Nivolumab Biosimilar CMAB819", "ONO 4538", "ONO-4538", "ONO4538", "Opdivo"], "nci_thesaurus_concept_id": "C68814", "name": "Nivolumab", "semantic_types": ["Amino Acid, Peptide, or Protein", "Immunologic Factor", "Pharmacologic Substance"], "branch": "Drug, Food, Chemical or Biomedical Material", "ancestor_ids": ["C124946", "C128037", "C129821", "C129822", "C141144", "C143250", "C1908", "C1909", "C20401", "C274", "C307", "C308"], "parents": ["C128037", "C129822"]}, {"eligibility_criterion": "exclusion", "inclusion_indicator": "TRIAL", "synonyms": ["Allogeneic", "Allogeneic Hematopoietic Cell Transplantation", "Allogeneic Stem Cell Transplantation", "HSC", "HSCT", "Stem Cell Transplantation, Allogeneic"], "nci_thesaurus_concept_id": "C46089", "name": "Allogeneic Hematopoietic Stem Cell Transplantation", "semantic_types": ["Therapeutic or Preventive Procedure"], "branch": "Activity", "ancestor_ids": ["C15329", "C15342", "C15388", "C15431", "C16203", "C165194", "C201922", "C25218", "C43431", "C49165", "C49236"], "parents": ["C15431"]}, {"eligibility_criterion": "exclusion", "inclusion_indicator": "TRIAL", "synonyms": [], "nci_thesaurus_concept_id": "C191377", "name": "Solid Organ Transplantation", "semantic_types": ["Therapeutic or Preventive Procedure"], "branch": "Activity", "ancestor_ids": ["C15289", "C15329", "C15342", "C16203", "C201922", "C25218", "C43431", "C49163", "C49165", "C49236", "C64982"], "parents": ["C15289"]}, {"eligibility_criterion": "exclusion", "inclusion_indicator": "TRIAL", "synonyms": [], "nci_thesaurus_concept_id": "C128057", "name": "Anti-PD-L1 Monoclonal Antibody", "semantic_types": ["Chemical Viewed Functionally", "Pharmacologic Substance"], "branch": "Drug, Food, Chemical or Biomedical Material", "ancestor_ids": ["C141144", "C143250", "C156893", "C1908", "C1909", "C191689", "C20401", "C307", "C308"], "parents": ["C191689", "C20401"]}, {"eligibility_criterion": "exclusion", "inclusion_indicator": "TRIAL", "synonyms": ["Anti-PD-1 Monoclonal Antibody"], "nci_thesaurus_concept_id": "C128037", "name": "Anti-PD1 Monoclonal Antibody", "semantic_types": ["Chemical Viewed Structurally", "Pharmacologic Substance"], "branch": "Drug, Food, Chemical or Biomedical Material", "ancestor_ids": ["C124946", "C141144", "C143250", "C1908", "C1909", "C20401", "C307", "C308"], "parents": ["C124946", "C20401"]}, {"eligibility_criterion": "exclusion", "inclusion_indicator": "TREE", "synonyms": ["Anti-cancer Biological Agent", "Anticancer Biological", "Antineoplastic Biological", "Antineoplastic Biotherapeutic"], "nci_thesaurus_concept_id": "C129821", "name": "Antineoplastic Biological Agent", "semantic_types": ["Pharmacologic Substance"], "branch": "Drug, Food, Chemical or Biomedical Material", "ancestor_ids": ["C1908", "C1909", "C274", "C307"], "parents": ["C274", "C307"]}, {"eligibility_criterion": "exclusion", "inclusion_indicator": "TREE", "synonyms": ["Stem Cell Treatment"], "nci_thesaurus_concept_id": "C165194", "name": "Stem Cell Therapy", "semantic_types": ["Therapeutic or Preventive Procedure"], "branch": "Activity", "ancestor_ids": ["C16203", "C25218", "C43431", "C49236"], "parents": ["C49236"]}, {"eligibility_criterion": "exclusion", "inclusion_indicator": "TREE", "synonyms": [], "nci_thesaurus_concept_id": "C49163", "name": "Surgical Procedure by Site or System", "semantic_types": ["Classification"], "branch": "Activity", "ancestor_ids": ["C15329", "C16203", "C25218", "C43431"], "parents": ["C15329"]}, {"eligibility_criterion": "exclusion", "inclusion_indicator": "TREE", "synonyms": ["Anti-cancer Antibody", "Anticancer Antibody", "Antineoplastic Ab"], "nci_thesaurus_concept_id": "C129822", "name": "Antineoplastic Antibody", "semantic_types": ["Pharmacologic Substance"], "branch": "Drug, Food, Chemical or Biomedical Material", "ancestor_ids": ["C129821", "C1908", "C1909", "C274", "C307"], "parents": ["C129821"]}, {"eligibility_criterion": "exclusion", "inclusion_indicator": "TREE", "synonyms": ["MAb", "MoAB", "Monoclonal Antibodies", "Monoclonal Antibody"], "nci_thesaurus_concept_id": "C20401", "name": "Monoclonal Antibody Therapy", "semantic_types": ["Amino Acid, Peptide, or Protein"], "branch": "Drug, Food, Chemical or Biomedical Material", "ancestor_ids": ["C1908", "C1909", "C307", "C308"], "parents": ["C307", "C308"]}, {"eligibility_criterion": "exclusion", "inclusion_indicator": "TREE", "synonyms": ["any therapy", "any_therapy", "Therapeutic", "Therapeutic Interventions", "Therapeutic Method", "Therapeutic Technique", "Therapy", "TREAT", "Treatment", "treatment or therapy", "treatment_or_therapy", "TX"], "nci_thesaurus_concept_id": "C49236", "name": "Therapeutic Procedure", "semantic_types": ["Therapeutic or Preventive Procedure"], "branch": "Activity", "ancestor_ids": ["C16203", "C25218", "C43431"], "parents": ["C25218"]}, {"eligibility_criterion": "exclusion", "inclusion_indicator": "TREE", "synonyms": ["Clinical Intervention or Procedure", "Intervention", "Intervention Strategies", "Interventional", "Interventional Procedure Type", "interventionDescription", "Procedure", "study intervention", "treatment type", "treatment_type"], "nci_thesaurus_concept_id": "C25218", "name": "Intervention or Procedure", "semantic_types": ["Health Care Activity"], "branch": "Activity", "ancestor_ids": ["C16203", "C43431"], "parents": ["C16203"]}, {"eligibility_criterion": "exclusion", "inclusion_indicator": "TREE", "synonyms": ["Anti-CD274 Agent", "Anti-PD-L1 Agent", "CD274-targeting Agent", "PD-L1-targeting Agent"], "nci_thesaurus_concept_id": "C191689", "name": "PD-L1 Inhibitor", "semantic_types": ["Pharmacologic Substance"], "branch": "Drug, Food, Chemical or Biomedical Material", "ancestor_ids": ["C141144", "C143250", "C156893", "C1908", "C1909", "C308"], "parents": ["C156893"]}, {"eligibility_criterion": "exclusion", "inclusion_indicator": "TREE", "synonyms": ["Anti-PD-1 Agent", "PD-1 Inhibitor", "PD-1-targeting Agent", "Programmed Cell Death Protein 1 Inhibitor", "Protein PD-1 Inhibitor"], "nci_thesaurus_concept_id": "C124946", "name": "PD1 Inhibitor", "semantic_types": ["Chemical Viewed Functionally"], "branch": "Drug, Food, Chemical or Biomedical Material", "ancestor_ids": ["C141144", "C143250", "C1908", "C1909", "C308"], "parents": ["C143250"]}, {"eligibility_criterion": "exclusion", "inclusion_indicator": "TREE", "synonyms": ["General activity"], "nci_thesaurus_concept_id": "C43431", "name": "Activity", "semantic_types": ["Activity"], "branch": "Activity", "ancestor_ids": [], "parents": []}, {"eligibility_criterion": "exclusion", "inclusion_indicator": "TREE", "synonyms": ["PD-1 Ligand-targeting Agent", "PD-1 Ligands Inhibitor"], "nci_thesaurus_concept_id": "C156893", "name": "PD-1 Ligand Inhibitor", "semantic_types": ["Pharmacologic Substance"], "branch": "Drug, Food, Chemical or Biomedical Material", "ancestor_ids": ["C141144", "C143250", "C1908", "C1909", "C308"], "parents": ["C143250"]}, {"eligibility_criterion": "exclusion", "inclusion_indicator": "TREE", "synonyms": ["Biologic", "biologic agent", "Biological Drug", "biological product", "Biological Products", "Biologicals", "Biologics", "Biopharmaceuticals", "Immunologic, Immunochemical", "Immunologics"], "nci_thesaurus_concept_id": "C307", "name": "Biological Agent", "semantic_types": ["Classification"], "branch": "Drug, Food, Chemical or Biomedical Material", "ancestor_ids": ["C1908", "C1909"], "parents": ["C1909"]}, {"eligibility_criterion": "exclusion", "inclusion_indicator": "TREE", "synonyms": [], "nci_thesaurus_concept_id": "C1908", "name": "Drug, Food, Chemical or Biomedical Material", "semantic_types": ["Classification"], "branch": "Drug, Food, Chemical or Biomedical Material", "ancestor_ids": [], "parents": []}, {"eligibility_criterion": "exclusion", "inclusion_indicator": "TREE", "synonyms": [], "nci_thesaurus_concept_id": "C49165", "name": "Surgical Procedure by Method", "semantic_types": ["Classification"], "branch": "Activity", "ancestor_ids": ["C15329", "C16203", "C25218", "C43431"], "parents": ["C15329"]}, {"eligibility_criterion": "exclusion", "inclusion_indicator": "TREE", "synonyms": [], "nci_thesaurus_concept_id": "C64982", "name": "Therapeutic Surgical Procedure", "semantic_types": ["Therapeutic or Preventive Procedure"], "branch": "Activity", "ancestor_ids": ["C15329", "C16203", "C25218", "C43431", "C49236"], "parents": ["C15329", "C49236"]}, {"eligibility_criterion": "exclusion", "inclusion_indicator": "TREE", "synonyms": [], "nci_thesaurus_concept_id": "C141144", "name": "Immune Checkpoint Modulator", "semantic_types": ["Chemical Viewed Functionally"], "branch": "Drug, Food, Chemical or Biomedical Material", "ancestor_ids": ["C1908", "C1909", "C308"], "parents": ["C308"]}, {"eligibility_criterion": "exclusion", "inclusion_indicator": "TREE", "synonyms": ["Anti-Cancer Agents", "Anti-Tumor Agents", "Anti-Tumor Drugs", "antineoplastic", "Antineoplastic Drug", "Antineoplastic Drugs", "ANTINEOPLASTIC_AGENT", "Antineoplastics", "Antiproliferative Agents", "Antiproliferative Drugs", "Cancer Drug", "chemotherapeutic agent", "Chemotherapeutic Agents, Neoplastic Disease", "Tumor-Specific Treatment Agents"], "nci_thesaurus_concept_id": "C274", "name": "Antineoplastic Agent", "semantic_types": ["Chemical Viewed Functionally"], "branch": "Drug, Food, Chemical or Biomedical Material", "ancestor_ids": ["C1908", "C1909"], "parents": ["C1909"]}, {"eligibility_criterion": "exclusion", "inclusion_indicator": "TREE", "synonyms": [], "nci_thesaurus_concept_id": "C16203", "name": "Clinical or Research Activity", "semantic_types": ["Activity"], "branch": "Activity", "ancestor_ids": ["C43431"], "parents": ["C43431"]}, {"eligibility_criterion": "exclusion", "inclusion_indicator": "TREE", "synonyms": ["Agent", "Drug", "Drug Substance", "Pharmaceutical Agent", "Pharmaceuticals", "Pharmacologic Agent", "Pharmacological Substance", "Therapeutic Agent", "therapeutic agents", "therapeutic_agents"], "nci_thesaurus_concept_id": "C1909", "name": "Pharmacologic Substance", "semantic_types": ["Pharmacologic Substance"], "branch": "Drug, Food, Chemical or Biomedical Material", "ancestor_ids": ["C1908"], "parents": ["C1908"]}, {"eligibility_criterion": "exclusion", "inclusion_indicator": "TREE", "synonyms": ["Grafting", "Grafting Procedure", "Surgery, Transplantation", "Transplant", "Transplant Procedure", "Transplantation Surgery"], "nci_thesaurus_concept_id": "C15342", "name": "Transplantation", "semantic_types": ["Therapeutic or Preventive Procedure"], "branch": "Activity", "ancestor_ids": ["C15329", "C16203", "C201922", "C25218", "C43431", "C49165"], "parents": ["C201922"]}, {"eligibility_criterion": "exclusion", "inclusion_indicator": "TREE", "synonyms": ["Biological Response Modifier", "Biomodulators", "BRM", "Immune Mediators", "Immune Modulators", "Immune Regulators", "Immunomodulating Agent", "Immunomodulators", "Immunomodulatory Agent", "Immunopotentiators", "Immunotherapeutic Agent", "Immunotherapeutic Drug", "Immunotherapy Agent"], "nci_thesaurus_concept_id": "C308", "name": "Immunotherapy", "semantic_types": ["Chemical Viewed Functionally"], "branch": "Drug, Food, Chemical or Biomedical Material", "ancestor_ids": ["C1908", "C1909"], "parents": ["C1909"]}, {"eligibility_criterion": "exclusion", "inclusion_indicator": "TREE", "synonyms": ["Infused", "Infusion"], "nci_thesaurus_concept_id": "C15388", "name": "Infusion Procedure", "semantic_types": ["Therapeutic or Preventive Procedure"], "branch": "Activity", "ancestor_ids": ["C16203", "C25218", "C43431", "C49236"], "parents": ["C49236"]}, {"eligibility_criterion": "exclusion", "inclusion_indicator": "TREE", "synonyms": ["Operation", "Surgery", "Surgery Type", "Surgery, NOS", "Surgical", "Surgical Intervention", "Surgical Interventions", "Surgical Procedures", "Surgically", "Type of Surgery"], "nci_thesaurus_concept_id": "C15329", "name": "Surgical Procedure", "semantic_types": ["Health Care Activity"], "branch": "Activity", "ancestor_ids": ["C16203", "C25218", "C43431"], "parents": ["C25218"]}, {"eligibility_criterion": "exclusion", "inclusion_indicator": "TREE", "synonyms": ["Implantation", "Implantation Surgery", "Surgical"], "nci_thesaurus_concept_id": "C201922", "name": "Surgical Implantation", "semantic_types": ["Health Care Activity"], "branch": "Activity", "ancestor_ids": ["C15329", "C16203", "C25218", "C43431", "C49165"], "parents": ["C49165"]}, {"eligibility_criterion": "exclusion", "inclusion_indicator": "TREE", "synonyms": ["HCT", "Hematopoietic Stem Cell Infusion", "HEMATOPOIETIC STEM CELL TRANSPLANT", "Hematopoietic Stem Cell Transplantation", "HSCT", "SCT", "Stem Cell Transplant", "stem cell transplantation", "Stem Cell Transplantation, NOS"], "nci_thesaurus_concept_id": "C15431", "name": "Hematopoietic Cell Transplantation", "semantic_types": ["Therapeutic or Preventive Procedure"], "branch": "Activity", "ancestor_ids": ["C15329", "C15342", "C15388", "C16203", "C165194", "C201922", "C25218", "C43431", "C49165", "C49236"], "parents": ["C15342", "C15388", "C165194"]}, {"eligibility_criterion": "exclusion", "inclusion_indicator": "TREE", "synonyms": ["ICI"], "nci_thesaurus_concept_id": "C143250", "name": "Immune Checkpoint Inhibitor", "semantic_types": ["Chemical Viewed Functionally"], "branch": "Drug, Food, Chemical or Biomedical Material", "ancestor_ids": ["C141144", "C1908", "C1909", "C308"], "parents": ["C141144"]}, {"eligibility_criterion": "exclusion", "inclusion_indicator": "TREE", "synonyms": ["Anatomical Gift", "Clinical, Transplantation, Organ", "Organ Donation", "Organ Donation Procedure", "organ grafting", "Organ Transplants"], "nci_thesaurus_concept_id": "C15289", "name": "Organ Transplantation", "semantic_types": ["Therapeutic or Preventive Procedure"], "branch": "Activity", "ancestor_ids": ["C15329", "C15342", "C16203", "C201922", "C25218", "C43431", "C49163", "C49165", "C49236", "C64982"], "parents": ["C15342", "C49163", "C64982"]}], "_current_trial_status_sort_order": 7, "start_date": "2018-05-24", "record_verification_date": "2024-12-01", "ctep_id": null, "current_trial_status": "Closed to Accrual", "study_model_other_text": null, "masking": {"role_caregiver": null, "masking": null, "role_investigator": null, "role_outcome_assessor": null, "role_subject": null, "allocation_code": "NA"}, "acronym": "MiniVan", "nci_programs": [], "nci_funded": "Indirect", "anatomic_sites": ["Brain and Nervous System"], "ccr_id": null, "start_date_type_code": "ACTUAL", "principal_investigator": null, "study_source": "Externally Peer Reviewed", "completion_date": "2025-07-31", "study_subtype_code": null, "study_protocol_type": "Interventional"}]}))</script>
</div>
</div>
</section>

</main>
<!-- /main column -->
<script id="quarto-html-after-body" type="application/javascript">
  window.document.addEventListener("DOMContentLoaded", function (event) {
    const icon = "î§‹";
    const anchorJS = new window.AnchorJS();
    anchorJS.options = {
      placement: 'right',
      icon: icon
    };
    anchorJS.add('.anchored');
    const isCodeAnnotation = (el) => {
      for (const clz of el.classList) {
        if (clz.startsWith('code-annotation-')) {                     
          return true;
        }
      }
      return false;
    }
    const onCopySuccess = function(e) {
      // button target
      const button = e.trigger;
      // don't keep focus
      button.blur();
      // flash "checked"
      button.classList.add('code-copy-button-checked');
      var currentTitle = button.getAttribute("title");
      button.setAttribute("title", "Copied!");
      let tooltip;
      if (window.bootstrap) {
        button.setAttribute("data-bs-toggle", "tooltip");
        button.setAttribute("data-bs-placement", "left");
        button.setAttribute("data-bs-title", "Copied!");
        tooltip = new bootstrap.Tooltip(button, 
          { trigger: "manual", 
            customClass: "code-copy-button-tooltip",
            offset: [0, -8]});
        tooltip.show();    
      }
      setTimeout(function() {
        if (tooltip) {
          tooltip.hide();
          button.removeAttribute("data-bs-title");
          button.removeAttribute("data-bs-toggle");
          button.removeAttribute("data-bs-placement");
        }
        button.setAttribute("title", currentTitle);
        button.classList.remove('code-copy-button-checked');
      }, 1000);
      // clear code selection
      e.clearSelection();
    }
    const getTextToCopy = function(trigger) {
      const outerScaffold = trigger.parentElement.cloneNode(true);
      const codeEl = outerScaffold.querySelector('code');
      for (const childEl of codeEl.children) {
        if (isCodeAnnotation(childEl)) {
          childEl.remove();
        }
      }
      return codeEl.innerText;
    }
    const clipboard = new window.ClipboardJS('.code-copy-button:not([data-in-quarto-modal])', {
      text: getTextToCopy
    });
    clipboard.on('success', onCopySuccess);
    if (window.document.getElementById('quarto-embedded-source-code-modal')) {
      const clipboardModal = new window.ClipboardJS('.code-copy-button[data-in-quarto-modal]', {
        text: getTextToCopy,
        container: window.document.getElementById('quarto-embedded-source-code-modal')
      });
      clipboardModal.on('success', onCopySuccess);
    }
      var localhostRegex = new RegExp(/^(?:http|https):\/\/localhost\:?[0-9]*\//);
      var mailtoRegex = new RegExp(/^mailto:/);
        var filterRegex = new RegExp('/' + window.location.host + '/');
      var isInternal = (href) => {
          return filterRegex.test(href) || localhostRegex.test(href) || mailtoRegex.test(href);
      }
      // Inspect non-navigation links and adorn them if external
     var links = window.document.querySelectorAll('a[href]:not(.nav-link):not(.navbar-brand):not(.toc-action):not(.sidebar-link):not(.sidebar-item-toggle):not(.pagination-link):not(.no-external):not([aria-hidden]):not(.dropdown-item):not(.quarto-navigation-tool):not(.about-link)');
      for (var i=0; i<links.length; i++) {
        const link = links[i];
        if (!isInternal(link.href)) {
          // undo the damage that might have been done by quarto-nav.js in the case of
          // links that we want to consider external
          if (link.dataset.originalHref !== undefined) {
            link.href = link.dataset.originalHref;
          }
        }
      }
    function tippyHover(el, contentFn, onTriggerFn, onUntriggerFn) {
      const config = {
        allowHTML: true,
        maxWidth: 500,
        delay: 100,
        arrow: false,
        appendTo: function(el) {
            return el.parentElement;
        },
        interactive: true,
        interactiveBorder: 10,
        theme: 'quarto',
        placement: 'bottom-start',
      };
      if (contentFn) {
        config.content = contentFn;
      }
      if (onTriggerFn) {
        config.onTrigger = onTriggerFn;
      }
      if (onUntriggerFn) {
        config.onUntrigger = onUntriggerFn;
      }
      window.tippy(el, config); 
    }
    const noterefs = window.document.querySelectorAll('a[role="doc-noteref"]');
    for (var i=0; i<noterefs.length; i++) {
      const ref = noterefs[i];
      tippyHover(ref, function() {
        // use id or data attribute instead here
        let href = ref.getAttribute('data-footnote-href') || ref.getAttribute('href');
        try { href = new URL(href).hash; } catch {}
        const id = href.replace(/^#\/?/, "");
        const note = window.document.getElementById(id);
        if (note) {
          return note.innerHTML;
        } else {
          return "";
        }
      });
    }
    const xrefs = window.document.querySelectorAll('a.quarto-xref');
    const processXRef = (id, note) => {
      // Strip column container classes
      const stripColumnClz = (el) => {
        el.classList.remove("page-full", "page-columns");
        if (el.children) {
          for (const child of el.children) {
            stripColumnClz(child);
          }
        }
      }
      stripColumnClz(note)
      if (id === null || id.startsWith('sec-')) {
        // Special case sections, only their first couple elements
        const container = document.createElement("div");
        if (note.children && note.children.length > 2) {
          container.appendChild(note.children[0].cloneNode(true));
          for (let i = 1; i < note.children.length; i++) {
            const child = note.children[i];
            if (child.tagName === "P" && child.innerText === "") {
              continue;
            } else {
              container.appendChild(child.cloneNode(true));
              break;
            }
          }
          if (window.Quarto?.typesetMath) {
            window.Quarto.typesetMath(container);
          }
          return container.innerHTML
        } else {
          if (window.Quarto?.typesetMath) {
            window.Quarto.typesetMath(note);
          }
          return note.innerHTML;
        }
      } else {
        // Remove any anchor links if they are present
        const anchorLink = note.querySelector('a.anchorjs-link');
        if (anchorLink) {
          anchorLink.remove();
        }
        if (window.Quarto?.typesetMath) {
          window.Quarto.typesetMath(note);
        }
        if (note.classList.contains("callout")) {
          return note.outerHTML;
        } else {
          return note.innerHTML;
        }
      }
    }
    for (var i=0; i<xrefs.length; i++) {
      const xref = xrefs[i];
      tippyHover(xref, undefined, function(instance) {
        instance.disable();
        let url = xref.getAttribute('href');
        let hash = undefined; 
        if (url.startsWith('#')) {
          hash = url;
        } else {
          try { hash = new URL(url).hash; } catch {}
        }
        if (hash) {
          const id = hash.replace(/^#\/?/, "");
          const note = window.document.getElementById(id);
          if (note !== null) {
            try {
              const html = processXRef(id, note.cloneNode(true));
              instance.setContent(html);
            } finally {
              instance.enable();
              instance.show();
            }
          } else {
            // See if we can fetch this
            fetch(url.split('#')[0])
            .then(res => res.text())
            .then(html => {
              const parser = new DOMParser();
              const htmlDoc = parser.parseFromString(html, "text/html");
              const note = htmlDoc.getElementById(id);
              if (note !== null) {
                const html = processXRef(id, note);
                instance.setContent(html);
              } 
            }).finally(() => {
              instance.enable();
              instance.show();
            });
          }
        } else {
          // See if we can fetch a full url (with no hash to target)
          // This is a special case and we should probably do some content thinning / targeting
          fetch(url)
          .then(res => res.text())
          .then(html => {
            const parser = new DOMParser();
            const htmlDoc = parser.parseFromString(html, "text/html");
            const note = htmlDoc.querySelector('main.content');
            if (note !== null) {
              // This should only happen for chapter cross references
              // (since there is no id in the URL)
              // remove the first header
              if (note.children.length > 0 && note.children[0].tagName === "HEADER") {
                note.children[0].remove();
              }
              const html = processXRef(null, note);
              instance.setContent(html);
            } 
          }).finally(() => {
            instance.enable();
            instance.show();
          });
        }
      }, function(instance) {
      });
    }
        let selectedAnnoteEl;
        const selectorForAnnotation = ( cell, annotation) => {
          let cellAttr = 'data-code-cell="' + cell + '"';
          let lineAttr = 'data-code-annotation="' +  annotation + '"';
          const selector = 'span[' + cellAttr + '][' + lineAttr + ']';
          return selector;
        }
        const selectCodeLines = (annoteEl) => {
          const doc = window.document;
          const targetCell = annoteEl.getAttribute("data-target-cell");
          const targetAnnotation = annoteEl.getAttribute("data-target-annotation");
          const annoteSpan = window.document.querySelector(selectorForAnnotation(targetCell, targetAnnotation));
          const lines = annoteSpan.getAttribute("data-code-lines").split(",");
          const lineIds = lines.map((line) => {
            return targetCell + "-" + line;
          })
          let top = null;
          let height = null;
          let parent = null;
          if (lineIds.length > 0) {
              //compute the position of the single el (top and bottom and make a div)
              const el = window.document.getElementById(lineIds[0]);
              top = el.offsetTop;
              height = el.offsetHeight;
              parent = el.parentElement.parentElement;
            if (lineIds.length > 1) {
              const lastEl = window.document.getElementById(lineIds[lineIds.length - 1]);
              const bottom = lastEl.offsetTop + lastEl.offsetHeight;
              height = bottom - top;
            }
            if (top !== null && height !== null && parent !== null) {
              // cook up a div (if necessary) and position it 
              let div = window.document.getElementById("code-annotation-line-highlight");
              if (div === null) {
                div = window.document.createElement("div");
                div.setAttribute("id", "code-annotation-line-highlight");
                div.style.position = 'absolute';
                parent.appendChild(div);
              }
              div.style.top = top - 2 + "px";
              div.style.height = height + 4 + "px";
              div.style.left = 0;
              let gutterDiv = window.document.getElementById("code-annotation-line-highlight-gutter");
              if (gutterDiv === null) {
                gutterDiv = window.document.createElement("div");
                gutterDiv.setAttribute("id", "code-annotation-line-highlight-gutter");
                gutterDiv.style.position = 'absolute';
                const codeCell = window.document.getElementById(targetCell);
                const gutter = codeCell.querySelector('.code-annotation-gutter');
                gutter.appendChild(gutterDiv);
              }
              gutterDiv.style.top = top - 2 + "px";
              gutterDiv.style.height = height + 4 + "px";
            }
            selectedAnnoteEl = annoteEl;
          }
        };
        const unselectCodeLines = () => {
          const elementsIds = ["code-annotation-line-highlight", "code-annotation-line-highlight-gutter"];
          elementsIds.forEach((elId) => {
            const div = window.document.getElementById(elId);
            if (div) {
              div.remove();
            }
          });
          selectedAnnoteEl = undefined;
        };
          // Handle positioning of the toggle
      window.addEventListener(
        "resize",
        throttle(() => {
          elRect = undefined;
          if (selectedAnnoteEl) {
            selectCodeLines(selectedAnnoteEl);
          }
        }, 10)
      );
      function throttle(fn, ms) {
      let throttle = false;
      let timer;
        return (...args) => {
          if(!throttle) { // first call gets through
              fn.apply(this, args);
              throttle = true;
          } else { // all the others get throttled
              if(timer) clearTimeout(timer); // cancel #2
              timer = setTimeout(() => {
                fn.apply(this, args);
                timer = throttle = false;
              }, ms);
          }
        };
      }
        // Attach click handler to the DT
        const annoteDls = window.document.querySelectorAll('dt[data-target-cell]');
        for (const annoteDlNode of annoteDls) {
          annoteDlNode.addEventListener('click', (event) => {
            const clickedEl = event.target;
            if (clickedEl !== selectedAnnoteEl) {
              unselectCodeLines();
              const activeEl = window.document.querySelector('dt[data-target-cell].code-annotation-active');
              if (activeEl) {
                activeEl.classList.remove('code-annotation-active');
              }
              selectCodeLines(clickedEl);
              clickedEl.classList.add('code-annotation-active');
            } else {
              // Unselect the line
              unselectCodeLines();
              clickedEl.classList.remove('code-annotation-active');
            }
          });
        }
    const findCites = (el) => {
      const parentEl = el.parentElement;
      if (parentEl) {
        const cites = parentEl.dataset.cites;
        if (cites) {
          return {
            el,
            cites: cites.split(' ')
          };
        } else {
          return findCites(el.parentElement)
        }
      } else {
        return undefined;
      }
    };
    var bibliorefs = window.document.querySelectorAll('a[role="doc-biblioref"]');
    for (var i=0; i<bibliorefs.length; i++) {
      const ref = bibliorefs[i];
      const citeInfo = findCites(ref);
      if (citeInfo) {
        tippyHover(citeInfo.el, function() {
          var popup = window.document.createElement('div');
          citeInfo.cites.forEach(function(cite) {
            var citeDiv = window.document.createElement('div');
            citeDiv.classList.add('hanging-indent');
            citeDiv.classList.add('csl-entry');
            var biblioDiv = window.document.getElementById('ref-' + cite);
            if (biblioDiv) {
              citeDiv.innerHTML = biblioDiv.innerHTML;
            }
            popup.appendChild(citeDiv);
          });
          return popup.innerHTML;
        });
      }
    }
  });
  </script>
</div> <!-- /content -->




</body></html>